<html class="gs_el_sm gs_pfcs"><head><title>‪Volker Straub‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.com/citations?user=C7N_dwsAAAAJ&amp;hl=en"><meta name="description" content="‪Newcastle University‬ - ‪‪Cited by 25,658‬‬ - ‪neuromuscular‬"><meta property="og:description" content="‪Newcastle University‬ - ‪‪Cited by 25,658‬‬ - ‪neuromuscular‬"><meta property="og:title" content="Volker Straub"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=C7N_dwsAAAAJ&amp;citpid=2"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"Ea05Yf7mGMX_mQGOg4WwDQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=C7N_dwsAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=C7N_dwsAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=C7N_dwsAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=C7N_dwsAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYTr-kfsTK2Rubl_EpNX_C3REtHnUCc2P"><input type="hidden" name="user" value="C7N_dwsAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">25658</td><td class="gsc_rsb_std">12821</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">82</td><td class="gsc_rsb_std">58</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">257</td><td class="gsc_rsb_std">226</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:838px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:792px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">2600</div><div class="gsc_g_xtl" style="top:73px;">1300</div><div class="gsc_g_xtl" style="top:113px;">650</div><div class="gsc_g_xtl" style="top:33px;">1950</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:153px;height:7px;z-index:24"><span class="gsc_g_al">115</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:152px;height:8px;z-index:23"><span class="gsc_g_al">140</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:141px;height:19px;z-index:22"><span class="gsc_g_al">311</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:147px;height:13px;z-index:21"><span class="gsc_g_al">227</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:140px;height:20px;z-index:20"><span class="gsc_g_al">327</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:132px;height:28px;z-index:19"><span class="gsc_g_al">457</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:132px;height:28px;z-index:18"><span class="gsc_g_al">458</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:127px;height:33px;z-index:17"><span class="gsc_g_al">552</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:130px;height:30px;z-index:16"><span class="gsc_g_al">493</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:127px;height:33px;z-index:15"><span class="gsc_g_al">547</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:126px;height:34px;z-index:14"><span class="gsc_g_al">559</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:118px;height:42px;z-index:13"><span class="gsc_g_al">684</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:113px;height:47px;z-index:12"><span class="gsc_g_al">768</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:96px;height:64px;z-index:11"><span class="gsc_g_al">1056</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:83px;height:77px;z-index:10"><span class="gsc_g_al">1254</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:75px;height:85px;z-index:9"><span class="gsc_g_al">1391</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:72px;height:88px;z-index:8"><span class="gsc_g_al">1445</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:64px;height:96px;z-index:7"><span class="gsc_g_al">1573</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:53px;height:107px;z-index:6"><span class="gsc_g_al">1750</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:46px;height:114px;z-index:5"><span class="gsc_g_al">1859</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:25px;height:135px;z-index:4"><span class="gsc_g_al">2201</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:17px;height:143px;z-index:3"><span class="gsc_g_al">2328</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:2px;height:158px;z-index:2"><span class="gsc_g_al">2582</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:34px;height:126px;z-index:1"><span class="gsc_g_al">2053</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=C7N_dwsAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dC7N_dwsAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>124 articles</span></div><div class="gsc_rsb_m_na"><div>24 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:16%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:117px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:73pt;height:80pt;}}</style><img alt="Volker Straub" sizes="print 73px,117px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=C7N_dwsAAAAJ&amp;citpid=2" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=C7N_dwsAAAAJ&amp;citpid=2 117w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=C7N_dwsAAAAJ&amp;citpid=2 233w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Volker Straub</div><div class="gsc_prf_il"><a href="/citations?view_op=view_org&amp;hl=en&amp;org=7687019144636890226" class="gsc_prf_ila">Newcastle University</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at ncl.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:neuromuscular" class="gsc_prf_inta gs_ibl">neuromuscular</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=C7N_dwsAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYTr-kfsTK2Rubl_EpNX_C3REtHnUCc2P"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=C7N_dwsAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=C7N_dwsAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=C7N_dwsAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=C7N_dwsAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=C7N_dwsAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:DrR-2ekChdkC" class="gsc_a_at">Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2&nbsp;…</a><div class="gs_gray">S Cirak, V Arechavala-Gomeza, M Guglieri, L Feng, S Torelli, K Anthony, ...</div><div class="gs_gray">The Lancet 378 (9791), 595-605<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15441570579532558916" class="gsc_a_ac gs_ibl">996</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:NDuN12AVoxsC" class="gsc_a_at">Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophies</a><div class="gs_gray">DE Michele, R Barresi, M Kanagawa, F Saito, RD Cohn, JS Satz, J Dollar, ...</div><div class="gs_gray">Nature 418 (6896), 417-421<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14235220779391228892" class="gsc_a_ac gs_ibl">837</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of&nbsp;…</a><div class="gs_gray">M Kinali, V Arechavala-Gomeza, L Feng, S Cirak, D Hunt, C Adkin, ...</div><div class="gs_gray">The Lancet Neurology 8 (10), 918-928<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=101121925811458065" class="gsc_a_ac gs_ibl">798</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1</a><div class="gs_gray">A Yoshida, K Kobayashi, H Manya, K Taniguchi, H Kano, M Mizuno, ...</div><div class="gs_gray">Developmental cell 1 (5), 717-724<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14820403415601594152" class="gsc_a_ac gs_ibl">784</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:ye4kPcJQO24C" class="gsc_a_at">The human phenotype ontology in 2017</a><div class="gs_gray">S Köhler, NA Vasilevsky, M Engelstad, E Foster, J McMurry, S Aymé, ...</div><div class="gs_gray">Nucleic acids research 45 (D1), D865-D876<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6287881565403571966" class="gsc_a_ac gs_ibl">584</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">Animal models for muscular dystrophy show different patterns of sarcolemmal disruption</a><div class="gs_gray">V Straub, JA Rafael, JS Chamberlain, KP Campbell</div><div class="gs_gray">The Journal of cell biology 139 (2), 375-385<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10189113750285067107" class="gsc_a_ac gs_ibl">544</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">Mutations in the fukutin-related protein gene (<i>FKRP</i>) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C</a><div class="gs_gray">M Brockington, Y Yuva, P Prandini, SC Brown, S Torelli, MA Benson, ...</div><div class="gs_gray">Human molecular genetics 10 (25), 2851-2859<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13012732311340691499" class="gsc_a_ac gs_ibl">537</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy</a><div class="gs_gray">KR Wagner, JL Fleckenstein, AA Amato, RJ Barohn, K Bushby, ...</div><div class="gs_gray">Annals of neurology 63 (5), 561-571<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4035337091390874409" class="gsc_a_ac gs_ibl">533</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population</a><div class="gs_gray">FLM Norwood, C Harling, PF Chinnery, M Eagle, K Bushby, V Straub</div><div class="gs_gray">Brain 132 (11), 3175-3186<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12125453857358670494" class="gsc_a_ac gs_ibl">469</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Muscular dystrophies and the dystrophin-glycoprotein complex</a><div class="gs_gray">V Straub, KP Campbell</div><div class="gs_gray">Current opinion in neurology 10, 168-175<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8937131732623728521" class="gsc_a_ac gs_ibl">461</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Prevalence and architecture of de novo mutations in developmental disorders</a><div class="gs_gray">TDDD Study</div><div class="gs_gray">Nature 542 (7642), 433<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4489378876587925736" class="gsc_a_ac gs_ibl">445</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Disruption of the sarcoglycan–sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy</a><div class="gs_gray">R Coral-Vazquez, RD Cohn, SA Moore, JA Hill, RM Weiss, RL Davisson, ...</div><div class="gs_gray">Cell 98 (4), 465-474<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12229704345838008" class="gsc_a_ac gs_ibl">424</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:YsrPvlHIBpEC" class="gsc_a_at">The TREAT‐NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations</a><div class="gs_gray">CL Bladen, D Salgado, S Monges, ME Foncuberta, K Kekou, K Kosma, ...</div><div class="gs_gray">Human mutation 36 (4), 395-402<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14933556517405885257" class="gsc_a_ac gs_ibl">400</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Refining genotype–phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan</a><div class="gs_gray">C Godfrey, E Clement, R Mein, M Brockington, J Smith, B Talim, V Straub, ...</div><div class="gs_gray">Brain 130 (10), 2725-2735<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4417648191862662320" class="gsc_a_ac gs_ibl">397</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Progressive muscular dystrophy in α-sarcoglycan–deficient mice</a><div class="gs_gray">F Duclos, V Straub, SA Moore, DP Venzke, RF Hrstka, RH Crosbie, ...</div><div class="gs_gray">The Journal of cell biology 142 (6), 1461-1471<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5718496510816157240" class="gsc_a_ac gs_ibl">390</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:1taIhTC69MYC" class="gsc_a_at">Improving genetic diagnosis in Mendelian disease with transcriptome sequencing</a><div class="gs_gray">BB Cummings, JL Marshall, T Tukiainen, M Lek, S Donkervoort, AR Foley, ...</div><div class="gs_gray">Science translational medicine 9 (386)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12625599547455041166" class="gsc_a_ac gs_ibl">378</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:k_7cPK9k7w8C" class="gsc_a_at">Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology&nbsp;…</a><div class="gs_gray">A Ferreiro, S Quijano-Roy, C Pichereau, B Moghadaszadeh, N Goemans, ...</div><div class="gs_gray">The American Journal of Human Genetics 71 (4), 739-749<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15687902113225465884" class="gsc_a_ac gs_ibl">345</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:JQOojiI6XY0C" class="gsc_a_at">Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study</a><div class="gs_gray">T Voit, H Topaloglu, V Straub, F Muntoni, N Deconinck, G Campion, ...</div><div class="gs_gray">The Lancet Neurology 13 (10), 987-996<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5524715228602176183" class="gsc_a_ac gs_ibl">341</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">Managing Duchenne muscular dystrophy–the additive effect of spinal surgery and home nocturnal ventilation in improving survival</a><div class="gs_gray">M Eagle, J Bourke, R Bullock, M Gibson, J Mehta, D Giddings, V Straub, ...</div><div class="gs_gray">Neuromuscular disorders 17 (6), 470-475<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15999646077608965993" class="gsc_a_ac gs_ibl">339</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;citation_for_view=C7N_dwsAAAAJ:lvd772isFD0C" class="gsc_a_at">Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker–Warburg syndrome</a><div class="gs_gray">DBV De Bernabé, T Voit, C Longman, A Steinbrecher, V Straub, Y Yuva, ...</div><div class="gs_gray">Journal of medical genetics 41 (5), e61-e61<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11145963983026523804" class="gsc_a_ac gs_ibl">259</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:EUQCXRtRnyEC" class="gsc_a_at"><i>RYR1</i> mutations are a common cause of congenital myopathies with central nuclei</a><div class="gs_gray">JM Wilmshurst, S Lillis, H Zhou, K Pillay, H Henderson, W Kress, ...</div><div class="gs_gray">Annals of neurology 68 (5), 717-726<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3400067376110619157" class="gsc_a_ac gs_ibl">240</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Phenotypic spectrum associated with mutations in the fukutin‐related protein gene</a><div class="gs_gray">E Mercuri, M Brockington, V Straub, S Quijano‐Roy, Y Yuva, R Herrmann, ...</div><div class="gs_gray">Annals of Neurology: Official Journal of the American Neurological&nbsp;…<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4003758951593846492" class="gsc_a_ac gs_ibl">230</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations</a><div class="gs_gray">A Rajab, V Straub, LJ McCann, D Seelow, R Varon, R Barresi, A Schulze, ...</div><div class="gs_gray">PLoS genetics 6 (3), e1000874<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6180461933996932430" class="gsc_a_ac gs_ibl">224</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy</a><div class="gs_gray">J Senderek, C Bergmann, C Stendel, J Kirfel, N Verpoorten, P De Jonghe, ...</div><div class="gs_gray">The American Journal of Human Genetics 73 (5), 1106-1119<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8736333258906019510" class="gsc_a_ac gs_ibl">218</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">A recessive form of central core disease, transiently presenting as multi‐minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene</a><div class="gs_gray">A Ferreiro, N Monnier, NB Romero, JP Leroy, C Bönnemann, ...</div><div class="gs_gray">Annals of Neurology: Official Journal of the American Neurological&nbsp;…<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8094334583507251020" class="gsc_a_ac gs_ibl">215</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:CYCckWUYoCcC" class="gsc_a_at">A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophy</a><div class="gs_gray">D Hicks, A Sarkozy, N Muelas, K Köehler, A Huebner, G Hudson, ...</div><div class="gs_gray">Brain 134 (1), 171-182<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5096769844080191346" class="gsc_a_ac gs_ibl">196</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial</a><div class="gs_gray">L Klinge, V Straub, U Neudorf, J Schaper, T Bosbach, K Görlinger, ...</div><div class="gs_gray">Neuromuscular Disorders 15 (1), 24-31<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11790798051373731518" class="gsc_a_ac gs_ibl">195</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene</a><div class="gs_gray">H Haravuori, A Vihola, V Straub, M Auranen, I Richard, S Marchand, ...</div><div class="gs_gray">Neurology 56 (7), 869-877<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3264248038754897411" class="gsc_a_ac gs_ibl">192</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:YlPif8NxrbYC" class="gsc_a_at">Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex</a><div class="gs_gray">RH Crosbie, CS Lebakken, KH Holt, DP Venzke, V Straub, JC Lee, ...</div><div class="gs_gray">The Journal of cell biology 145 (1), 153-165<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16537040195631273993" class="gsc_a_ac gs_ibl">187</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Direct visualization of the dystrophin network on skeletal muscle fiber membrane.</a><div class="gs_gray">V Straub, RE Bittner, JJ Léger, T Voit</div><div class="gs_gray">The Journal of cell biology 119 (5), 1183-1191<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11165748404697784994" class="gsc_a_ac gs_ibl">165</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Molecular mechanisms and phenotypic variation in <i>RYR1</i>-related congenital myopathies</a><div class="gs_gray">H Zhou, H Jungbluth, CA Sewry, L Feng, E Bertini, K Bushby, V Straub, ...</div><div class="gs_gray">Brain 130 (8), 2024-2036<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=863674958477544577" class="gsc_a_ac gs_ibl">164</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:XoXfffV-tXoC" class="gsc_a_at">An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1</a><div class="gs_gray">C Windpassinger, B Schoser, V Straub, S Hochmeister, A Noor, ...</div><div class="gs_gray">The American Journal of Human Genetics 82 (1), 88-99<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8447997182301519883" class="gsc_a_ac gs_ibl">158</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:ldfaerwXgEUC" class="gsc_a_at">AHNAK a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration</a><div class="gs_gray">Y Huang, SH Laval, A van Remoortere, J Baudier, C Benaud, ...</div><div class="gs_gray">The FASEB journal 21 (3), 732-742<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2855931991180703569" class="gsc_a_ac gs_ibl">156</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Recessive mutations in <i>RYR1</i> are a common cause of congenital fiber type disproportion</a><div class="gs_gray">NF Clarke, LB Waddell, ST Cooper, M Perry, RLL Smith, AJ Kornberg, ...</div><div class="gs_gray">Human mutation 31 (7), E1544-E1550<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5350883297740860774" class="gsc_a_ac gs_ibl">155</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Brain involvement in muscular dystrophies with defective dystroglycan glycosylation</a><div class="gs_gray">E Clement, E Mercuri, C Godfrey, J Smith, S Robb, M Kinali, V Straub, ...</div><div class="gs_gray">Annals of Neurology: Official Journal of the American Neurological&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=604482316429657273" class="gsc_a_ac gs_ibl">155</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Worldwide distribution and broader clinical spectrum of muscle–eye–brain disease</a><div class="gs_gray">K Taniguchi, K Kobayashi, K Saito, H Yamanouchi, A Ohnuma, ...</div><div class="gs_gray">Human molecular genetics 12 (5), 527-534<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8474193160787732240" class="gsc_a_ac gs_ibl">155</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using δ-sarcoglycan gene transfer</a><div class="gs_gray">KH Holt, LE Lim, V Straub, DP Venzke, F Duclos, RD Anderson, ...</div><div class="gs_gray">Molecular cell 1 (6), 841-848<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6802634434208008315" class="gsc_a_ac gs_ibl">149</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:mUJArPsKIAAC" class="gsc_a_at">Genotype–phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations</a><div class="gs_gray">F Geranmayeh, E Clement, LH Feng, C Sewry, J Pagan, R Mein, S Abbs, ...</div><div class="gs_gray">Neuromuscular disorders 20 (4), 241-250<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14855290165021448854" class="gsc_a_ac gs_ibl">148</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy</a><div class="gs_gray">R Herrmann, V Straub, M Blank, C Kutzick, N Franke, EN Jacob, ...</div><div class="gs_gray">Human Molecular Genetics 9 (15), 2335-2340<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11424183067158570040" class="gsc_a_ac gs_ibl">148</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:silx2ntsSuwC" class="gsc_a_at">Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2</a><div class="gs_gray">AR Foley, MP Menezes, A Pandraud, MA Gonzalez, A Al-Odaib, ...</div><div class="gs_gray">Brain 137 (1), 44-56<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8867659490836213501" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:rO6llkc54NcC" class="gsc_a_at">Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study</a><div class="gs_gray">TA Willis, KG Hollingsworth, A Coombs, ML Sveen, S Andersen, ...</div><div class="gs_gray">PloS one 8 (8), e70993<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3135467983100477415" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect</a><div class="gs_gray">J Senderek, JS Müller, M Dusl, TM Strom, V Guergueltcheva, I Diepolder, ...</div><div class="gs_gray">The American Journal of Human Genetics 88 (2), 162-172<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12771347708552979738" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2-chain</a><div class="gs_gray">V Allamand, Y Sunada, MAM Salih, V Straub, O Ozo, MHS Al-Turaiki, ...</div><div class="gs_gray">Human molecular genetics 6 (5), 747-752<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5528083182782490807" class="gsc_a_ac gs_ibl">146</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:8xutWZnSdmoC" class="gsc_a_at">Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)</a><div class="gs_gray">VD Nadarajah, M Van Putten, A Chaouch, P Garrood, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (8), 569-578<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11017200499421417357" class="gsc_a_ac gs_ibl">145</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:QUX0mv85b1cC" class="gsc_a_at">Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis</a><div class="gs_gray">N Dlamini, NC Voermans, S Lillis, K Stewart, EJ Kamsteeg, G Drost, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (7), 540-548<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15321561230441197501" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Muscle histology vs MRI in Duchenne muscular dystrophy</a><div class="gs_gray">M Kinali, V Arechavala-Gomeza, S Cirak, A Glover, M Guglieri, L Feng, ...</div><div class="gs_gray">Neurology 76 (4), 346-353<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4017244452805400513" class="gsc_a_ac gs_ibl">141</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:ILKRHgRFtOwC" class="gsc_a_at"><i>mdx</i> Muscle Pathology is Independent of nNOS Perturbation</a><div class="gs_gray">RH Crosbie, V Straub, HY Yun, JC Lee, JA Rafael, JS Chamberlain, ...</div><div class="gs_gray">Human molecular genetics 7 (5), 823-829<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7455534415581832673" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">The burden of Duchenne muscular dystrophy: an international, cross-sectional study</a><div class="gs_gray">E Landfeldt, P Lindgren, CF Bell, C Schmitt, M Guglieri, V Straub, ...</div><div class="gs_gray">Neurology 83 (6), 529-536<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9760123296854677861" class="gsc_a_ac gs_ibl">137</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials</a><div class="gs_gray">K Anthony, S Cirak, S Torelli, G Tasca, L Feng, V Arechavala-Gomeza, ...</div><div class="gs_gray">Brain 134 (12), 3547-3559<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2418292932020181785" class="gsc_a_ac gs_ibl">134</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:DXE8ND7PrJAC" class="gsc_a_at">229th ENMC international workshop: Limb girdle muscular dystrophies-Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017</a><div class="gs_gray">V Straub, A Murphy, B Udd, LGMD Workshop Study Group</div><div class="gs_gray">Neuromuscular disorders: NMD 28 (8), 702-710<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3061143979058799757" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study</a><div class="gs_gray">L Klinge, V Straub, U Neudorf, T Voit</div><div class="gs_gray">Neuropediatrics 36 (01), 6-11<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11864123793268918674" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Deficiency of α-dystroglycan in muscle–eye–brain disease</a><div class="gs_gray">H Kano, K Kobayashi, R Herrmann, M Tachikawa, H Manya, I Nishino, ...</div><div class="gs_gray">Biochemical and biophysical research communications 291 (5), 1283-1286<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2568347477542064130" class="gsc_a_ac gs_ibl">131</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene</a><div class="gs_gray">H Jungbluth, H Zhou, L Hartley, B Halliger-Keller, S Messina, C Longman, ...</div><div class="gs_gray">Neurology 65 (12), 1930-1935<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13167506364735362763" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:CNPyR2KL9-0C" class="gsc_a_at">Molecular pathogenesis of muscle degeneration in the δ-sarcoglycan-deficient hamster</a><div class="gs_gray">V Straub, F Duclos, DP Venzke, JC Lee, S Cutshall, CJ Leveille, ...</div><div class="gs_gray">The American journal of pathology 153 (5), 1623-1630<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17462432623484111285" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss</a><div class="gs_gray">M Baumann, C Giunta, B Krabichler, F Rüschendorf, N Zoppi, M Colombi, ...</div><div class="gs_gray">The American Journal of Human Genetics 90 (2), 201-216<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7939915701163145477" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">ε-Sarcoglycan replaces α-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex</a><div class="gs_gray">V Straub, AJ Ettinger, M Durbeej, DP Venzke, S Cutshall, JR Sanes, ...</div><div class="gs_gray">Journal of Biological Chemistry 274 (39), 27989-27996<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12891235016848918726" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene‐associated myopathies</a><div class="gs_gray">A Klein, S Lillis, I Munteanu, M Scoto, H Zhou, R Quinlivan, V Straub, ...</div><div class="gs_gray">Human mutation 33 (6), 981-988<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8952657010441682159" class="gsc_a_ac gs_ibl">127</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Limb–girdle muscular dystrophies</a><div class="gs_gray">M Guglieri, V Straub, K Bushby, H Lochmüller</div><div class="gs_gray">Current opinion in neurology 21 (5), 576-584<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5873663345035443759" class="gsc_a_ac gs_ibl">122</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:umqufdRvDiIC" class="gsc_a_at">Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy</a><div class="gs_gray">IT Zaharieva, M Calissano, M Scoto, M Preston, S Cirak, L Feng, J Collins, ...</div><div class="gs_gray">PloS one 8 (11), e80263<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9646763316315658434" class="gsc_a_ac gs_ibl">121</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:k_IJM867U9cC" class="gsc_a_at">Titin mutation segregates with hereditary myopathy with early respiratory failure</a><div class="gs_gray">G Pfeffer, HR Elliott, H Griffin, R Barresi, J Miller, J Marsh, A Evilä, ...</div><div class="gs_gray">Brain 135 (6), 1695-1713<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2173971869128896876" class="gsc_a_ac gs_ibl">119</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Characterization of δ-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy</a><div class="gs_gray">D Jung, F Duclos, B Apostol, V Straub, JC Lee, V Allamand, DP Venzke, ...</div><div class="gs_gray">Journal of Biological Chemistry 271 (50), 32321-32329<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13218004610321681105" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Development of exon skipping therapies for Duchenne muscular dystrophy: a critical review and a perspective on the outstanding issues</a><div class="gs_gray">A Aartsma-Rus, V Straub, R Hemmings, M Haas, G Schlosser-Weber, ...</div><div class="gs_gray">Nucleic acid therapeutics 27 (5), 251-259<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11474760128980716697" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:sSrBHYA8nusC" class="gsc_a_at">The TREAT‐NMD D uchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia</a><div class="gs_gray">CL Bladen, K Rafferty, V Straub, S Monges, A Moresco, H Dawkins, A Roy, ...</div><div class="gs_gray">Human mutation 34 (11), 1449-1457<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4068958145987993292" class="gsc_a_ac gs_ibl">108</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm&nbsp;…</a><div class="gs_gray">KG Hollingsworth, PL de Sousa, V Straub, PG Carlier</div><div class="gs_gray">Neuromuscular Disorders 22, S54-S67<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=835472924193505985" class="gsc_a_ac gs_ibl">108</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Affinity proteomics within rare diseases: a BIO‐NMD study for blood biomarkers of muscular dystrophies</a><div class="gs_gray">B Ayoglu, A Chaouch, H Lochmüller, L Politano, E Bertini, P Spitali, ...</div><div class="gs_gray">EMBO molecular medicine 6 (7), 918-936<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=127048247748609454" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy</a><div class="gs_gray">YH Chiu, MA Hornsey, L Klinge, LH Jørgensen, SH Laval, R Charlton, ...</div><div class="gs_gray">Human molecular genetics 18 (11), 1976-1989<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2087900437179987751" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:-uzm3Y7AvW0C" class="gsc_a_at">TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI: 25–26 February 2011, Rome, Italy</a><div class="gs_gray">V Straub, PG Carlier, E Mercuri</div><div class="gs_gray">Neuromuscular Disorders 22, S42-S53<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17543722951843665010" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Cardiac and respiratory failure in limb‐girdle muscular dystrophy 2I</a><div class="gs_gray">M Poppe, J Bourke, M Eagle, P Frosk, K Wrogemann, C Greenberg, ...</div><div class="gs_gray">Annals of Neurology: Official Journal of the American Neurological&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5703016597356635301" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:mWEH9CqjF64C" class="gsc_a_at">Contrast agent‐enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy</a><div class="gs_gray">V Straub, KM Donahue, V Allamand, RL Davisson, YR Kim, KP Campbell</div><div class="gs_gray">Magnetic resonance in medicine 44 (4), 655-659<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15329688661069287442" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:rCNdntzdTkkC" class="gsc_a_at">Histone lysine methylases and demethylases in the landscape of human developmental disorders</a><div class="gs_gray">V Faundes, WG Newman, L Bernardini, N Canham, J Clayton-Smith, ...</div><div class="gs_gray">The American Journal of Human Genetics 102 (1), 175-187<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=875560580219534839" class="gsc_a_ac gs_ibl">96</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Dystrophin quantification: Biological and translational research implications</a><div class="gs_gray">K Anthony, V Arechavala-Gomeza, LE Taylor, A Vulin, Y Kaminoh, ...</div><div class="gs_gray">Neurology 83 (22), 2062-2069<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13324556026321460983" class="gsc_a_ac gs_ibl">96</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:u-coK7KVo8oC" class="gsc_a_at">Dysferlin associates with the developing T‐tubule system in rodent and human skeletal muscle</a><div class="gs_gray">L Klinge, J Harris, C Sewry, R Charlton, L Anderson, S Laval, YH Chiu, ...</div><div class="gs_gray">Muscle &amp; Nerve: Official Journal of the American Association of&nbsp;…<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11072592835304398990" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:UxriW0iASnsC" class="gsc_a_at">From T‐tubule to sarcolemma: damage‐induced dysferlin translocation in early myogenesis</a><div class="gs_gray">L Klinge, S Laval, S Keers, F Haldane, V Straub, R Barresi, K Bushby</div><div class="gs_gray">The FASEB Journal 21 (8), 1768-1776<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3661168449425914398" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:N5tVd3kTz84C" class="gsc_a_at">Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation</a><div class="gs_gray">Z Odgerel, A Sarkozy, HS Lee, C McKenna, J Rankin, V Straub, ...</div><div class="gs_gray">Neuromuscular disorders 20 (7), 438-442<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5319196120452676218" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:rTD5ala9j4wC" class="gsc_a_at">Quantifying the burden of caregiving in Duchenne muscular dystrophy</a><div class="gs_gray">E Landfeldt, P Lindgren, CF Bell, M Guglieri, V Straub, H Lochmüller, ...</div><div class="gs_gray">Journal of neurology 263 (5), 906-915<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15318236163892823098" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A</a><div class="gs_gray">EJ Groen, R Charlton, R Barresi, LV Anderson, M Eagle, J Hudson, ...</div><div class="gs_gray">Brain 130 (12), 3237-3249<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8205196264741601847" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials</a><div class="gs_gray">V Arechavala-Gomeza, M Kinali, L Feng, M Guglieri, G Edge, M Main, ...</div><div class="gs_gray">Neuromuscular Disorders 20 (5), 295-301<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2765596879167051326" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:dshw04ExmUIC" class="gsc_a_at">Recessive and dominant mutations in <i>COL12A1</i> cause a novel EDS/myopathy overlap syndrome in humans and mice</a><div class="gs_gray">Y Zou, D Zwolanek, Y Izu, S Gandhy, G Schreiber, K Brockmann, ...</div><div class="gs_gray">Human molecular genetics 23 (9), 2339-2352<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10254591448483353186" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:0N-VGjzr574C" class="gsc_a_at">New aspects on patients affected by dysferlin deficient muscular dystrophy</a><div class="gs_gray">L Klinge, A Aboumousa, M Eagle, J Hudson, A Sarkozy, G Vita, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 81 (9), 946-953<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8527720703847178074" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:XiSMed-E-HIC" class="gsc_a_at">In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy</a><div class="gs_gray">A Shatunov, M Olivé, Z Odgerel, C Stadelmann-Nessler, K Irlbacher, ...</div><div class="gs_gray">European journal of human genetics 17 (5), 656-663<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3876706533923692237" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">Novel Mutations Widen the Phenotypic Spectrum of Slow Skeletal/β‐Cardiac Myosin (<i>MYH7</i>) Distal Myopathy</a><div class="gs_gray">PJ Lamont, W Wallefeld, D Hilton‐Jones, B Udd, Z Argov, AC Barboi, ...</div><div class="gs_gray">Human mutation 35 (7), 868-879<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10187207845877287018" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study</a><div class="gs_gray">TA Willis, KG Hollingsworth, A Coombs, ML Sveen, S Andersen, ...</div><div class="gs_gray">PLoS One 9 (2), e90377<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2640908481026112752" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Severe phenotype in infantile facioscapulohumeral muscular dystrophy</a><div class="gs_gray">L Klinge, M Eagle, ID Haggerty, CE Roberts, V Straub, KM Bushby</div><div class="gs_gray">Neuromuscular Disorders 16 (9-10), 553-558<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6555497228914020708" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:738O_yMBCRsC" class="gsc_a_at">Dysferlin‐deficient muscular dystrophy features amyloidosis</a><div class="gs_gray">S Spuler, M Carl, J Zabojszcza, V Straub, K Bushby, SA Moore, S Bähring, ...</div><div class="gs_gray">Annals of neurology 63 (3), 323-328<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3919516393702998552" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:C33y2ycGS3YC" class="gsc_a_at">Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe</a><div class="gs_gray">CL Bladen, R Thompson, JM Jackson, C Garland, C Wegel, A Ambrosini, ...</div><div class="gs_gray">Journal of neurology 261 (1), 152-163<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16764276260417009066" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance</a><div class="gs_gray">AK Lampe, Y Zou, D Sudano, KK O'brien, D Hicks, SH Laval, R Charlton, ...</div><div class="gs_gray">Human mutation 29 (6), 809-822<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8435109654945690980" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:PyEswDtIyv0C" class="gsc_a_at">Clinical outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database</a><div class="gs_gray">Z Koeks, CL Bladen, D Salgado, E Van Zwet, O Pogoryelova, ...</div><div class="gs_gray">Journal of neuromuscular diseases 4 (4), 293-306<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14210701536719686774" class="gsc_a_ac gs_ibl">79</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:owLR8QvbtFgC" class="gsc_a_at">Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations</a><div class="gs_gray">V Guergueltcheva, JS Müller, M Dusl, J Senderek, A Oldfors, C Lindbergh, ...</div><div class="gs_gray">Journal of neurology 259 (5), 838-850<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12868200640848540824,2944222701973140037" class="gsc_a_ac gs_ibl">79</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:eGYfIraVYiQC" class="gsc_a_at">Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months</a><div class="gs_gray">KG Hollingsworth, P Garrood, M Eagle, K Bushby, V Straub</div><div class="gs_gray">Muscle &amp; nerve 48 (4), 586-588<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16609629120635221074" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:UuEBAcK4md4C" class="gsc_a_at">Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations</a><div class="gs_gray">A Klein, H Jungbluth, E Clement, S Lillis, S Abbs, P Munot, M Pane, ...</div><div class="gs_gray">Archives of neurology 68 (9), 1171-1179<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15655938154926008430" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:nOiSByfp82kC" class="gsc_a_at">Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy</a><div class="gs_gray">DE Frank, FJ Schnell, C Akana, SH El-Husayni, CA Desjardins, J Morgan, ...</div><div class="gs_gray">Neurology 94 (21), e2270-e2282<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17304632413480394133" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:M7yex6snE4oC" class="gsc_a_at">Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants</a><div class="gs_gray">JC Van Den Bergen, M Hiller, S Böhringer, L Vijfhuizen, HB Ginjaar, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 86 (10), 1060-1065<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7756136967787537699" class="gsc_a_ac gs_ibl">76</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:kJDgFkosVoMC" class="gsc_a_at">Improving recognition of Duchenne muscular dystrophy: a retrospective case note review</a><div class="gs_gray">HJA van Ruiten, V Straub, K Bushby, M Guglieri</div><div class="gs_gray">Archives of disease in childhood 99 (12), 1074-1077<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16577054131687951237" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Congenital muscular dystrophy with laminin α2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry</a><div class="gs_gray">R Herrmann, V Straub, K Meyer, T Kahn, M Wagner, T Voit</div><div class="gs_gray">European journal of pediatrics 155 (11), 968-976<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11757542174778583869" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Limb-girdle muscular dystrophies—international collaborations for translational research</a><div class="gs_gray">R Thompson, V Straub</div><div class="gs_gray">Nature Reviews Neurology 12 (5), 294-309<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3529743960822947879" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">Natural history of pulmonary function in collagen VI-related myopathies</a><div class="gs_gray">AR Foley, S Quijano-Roy, J Collins, V Straub, M McCallum, N Deconinck, ...</div><div class="gs_gray">Brain 136 (12), 3625-3633<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14806236220119193812" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Fibronectin is a serum biomarker for D uchenne muscular dystrophy</a><div class="gs_gray">F Cynthia Martin, M Hiller, P Spitali, S Oonk, H Dalebout, M Palmblad, ...</div><div class="gs_gray">Proteomics–Clinical Applications 8 (3-4), 269-278<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3992624789464684888" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Contrasting effects of steroids and angiotensin‐converting‐enzyme inhibitors in a mouse model of dystrophin‐deficient cardiomyopathy</a><div class="gs_gray">R Bauer, V Straub, A Blain, K Bushby, GA MacGowan</div><div class="gs_gray">European journal of heart failure 11 (5), 463-471<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9932912160981455599" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">The most common mutation in <i>FKRP</i> causing limb girdle muscular dystrophy type 2I (LGMD2I) may have occurred only once and is present in Hutterites and other&nbsp;…</a><div class="gs_gray">P Frosk, CR Greenberg, AAP Tennese, R Lamont, E Nylen, C Hirst, ...</div><div class="gs_gray">Human mutation 25 (1), 38-44<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5800292075934015207" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=C7N_dwsAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Health‐related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross‐sectional study</a><div class="gs_gray">E Landfeldt, P Lindgren, CF Bell, M Guglieri, V Straub, H Lochmüller, ...</div><div class="gs_gray">Developmental Medicine &amp; Child Neurology 58 (5), 508-515<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12138681709877124049" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Muscle MRI findings in limb girdle muscular dystrophy type 2L</a><div class="gs_gray">A Sarkozy, M Deschauer, RY Carlier, B Schrank, J Seeger, MC Walter, ...</div><div class="gs_gray">Neuromuscular Disorders 22, S122-S129<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6655290391717392695" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">A refined diagnostic algorithm for Bethlem myopathy</a><div class="gs_gray">D Hicks, AK Lampe, R Barresi, R Charlton, C Fiorillo, CG Bonnemann, ...</div><div class="gs_gray">Neurology 70 (14), 1192-1199<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9314579446140123389" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers–Danlos syndrome</a><div class="gs_gray">T Müller, S Mizumoto, I Suresh, Y Komatsu, J Vodopiutz, M Dundar, ...</div><div class="gs_gray">Human molecular genetics 22 (18), 3761-3772<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8652859029080620475" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th–13th May 2007&nbsp;…</a><div class="gs_gray">E Mercuri, A Mayhew, F Muntoni, S Messina, V Straub, GJ Van Ommen, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (11), 894-903<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2638072983061418298" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure</a><div class="gs_gray">G Pfeffer, R Barresi, IJ Wilson, SA Hardy, H Griffin, J Hudson, HR Elliott, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 85 (3), 331-338<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9172901333514908297" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus: a rare brain malformation syndrome associated with mental retardation and seizures</a><div class="gs_gray">G Mirzaa, NN Dodge, I Glass, C Day, K Gripp, L Nicholson, V Straub, ...</div><div class="gs_gray">Neuropediatrics 35 (06), 353-359<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4097794534156509991" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Diagnosis of Pompe disease: muscle biopsy vs blood-based assays</a><div class="gs_gray">J Vissing, Z Lukacs, V Straub</div><div class="gs_gray">JAMA neurology 70 (7), 923-927<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=869084030789121245" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy</a><div class="gs_gray">V Straub, P Balabanov, K Bushby, M Ensini, N Goemans, A De Luca, ...</div><div class="gs_gray">The Lancet Neurology 15 (8), 882-890<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9838641617506621595" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:tzM49s52ZIMC" class="gsc_a_at">MR imaging in Duchenne muscular dystrophy: Quantification of T<sub>1</sub>‐weighted signal, contrast uptake, and the effects of exercise</a><div class="gs_gray">P Garrood, KG Hollingsworth, M Eagle, BS Aribisala, D Birchall, K Bushby, ...</div><div class="gs_gray">Journal of Magnetic Resonance Imaging: An Official Journal of the&nbsp;…<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5900734639274825539" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WZBGuue-350C" class="gsc_a_at">Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP)</a><div class="gs_gray">P Thornhill, D Bassett, H Lochmüller, K Bushby, V Straub</div><div class="gs_gray">Brain 131 (6), 1551-1561<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8096089180028658206" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:gV6rEsy15s0C" class="gsc_a_at">Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD</a><div class="gs_gray">E Mercuri, A Mayhew, F Muntoni, S Messina, V Straub, GJ Van Ommen, ...</div><div class="gs_gray">ENMC workshop on outcome measures, 12th–13th May<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11636860532704727010" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene</a><div class="gs_gray">S Løseth, NC Voermans, T Torbergsen, S Lillis, C Jonsrud, S Lindal, ...</div><div class="gs_gray">Journal of neurology 260 (6), 1504-1510<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12173300896758981311" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Aul-kAQHnToC" class="gsc_a_at">Prevention of cardiomyopathy in δ-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors</a><div class="gs_gray">C Goehringer, D Rutschow, R Bauer, S Schinkel, D Weichenhan, ...</div><div class="gs_gray">Cardiovascular research 82 (3), 404-410<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11071399297851118804" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:mel-f30kHHgC" class="gsc_a_at">Late onset in dysferlinopathy widens the clinical spectrum</a><div class="gs_gray">L Klinge, AF Dean, W Kress, P Dixon, R Charlton, JS Müller, LV Anderson, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (4), 288-290<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17870743841916644937" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MIg0yeAD4ggC" class="gsc_a_at">Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy</a><div class="gs_gray">D Hicks, GT Farsani, S Laval, J Collins, A Sarkozy, E Martoni, A Shah, ...</div><div class="gs_gray">Human molecular genetics 23 (9), 2353-2363<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2062501807631020979" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping</a><div class="gs_gray">K Anthony, V Arechavala-Gomeza, V Ricotti, S Torelli, L Feng, N Janghra, ...</div><div class="gs_gray">JAMA neurology 71 (1), 32-40<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3009855236287327956" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_kc_bZDykSQC" class="gsc_a_at">A heterozygous 21-bp deletion in <i>CAPN3</i> causes dominantly inherited limb girdle muscular dystrophy</a><div class="gs_gray">J Vissing, R Barresi, N Witting, M Van Ghelue, L Gammelgaard, ...</div><div class="gs_gray">Brain 139 (8), 2154-2163<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=837378612179392854" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8dzOF9BpDQoC" class="gsc_a_at">Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?</a><div class="gs_gray">L Klinge, G Dekomien, A Aboumousa, R Charlton, JT Epplen, R Barresi, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (12), 934-941<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17665733413813005366" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Muscle-derived proteins as serum biomarkers for monitoring disease progression in three forms of muscular dystrophy</a><div class="gs_gray">PM Burch, O Pogoryelova, R Goldstein, D Bennett, M Guglieri, V Straub, ...</div><div class="gs_gray">Journal of neuromuscular diseases 2 (3), 241-255<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9316887015974028617" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ijdKiLOsEJMC" class="gsc_a_at">Congenital titinopathy: comprehensive characterization and pathogenic insights</a><div class="gs_gray">EC Oates, KJ Jones, S Donkervoort, A Charlton, S Brammah, JE Smith III, ...</div><div class="gs_gray">Annals of neurology 83 (6), 1105-1124<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6422765508166499937" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Not all SCN1A epileptic encephalopathies are Dravet syndrome: early profound Thr226Met phenotype</a><div class="gs_gray">LG Sadleir, EI Mountier, D Gill, S Davis, C Joshi, C DeVile, MA Kurian, ...</div><div class="gs_gray">Neurology 89 (10), 1035-1042<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16087199105195905402" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">The classification, natural history and treatment of the limb girdle muscular dystrophies</a><div class="gs_gray">AP Murphy, V Straub</div><div class="gs_gray">Journal of neuromuscular diseases 2 (s2), S7-S19<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12716121327735173551" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Congenital muscular dystrophies in the UK population: Clinical and molecular spectrum of a large cohort diagnosed over a 12-year period</a><div class="gs_gray">M Sframeli, A Sarkozy, M Bertoli, G Astrea, J Hudson, M Scoto, R Mein, ...</div><div class="gs_gray">Neuromuscular Disorders 27 (9), 793-803<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12558015335635064026" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Caveolinopathy–new mutations and additional symptoms</a><div class="gs_gray">A Aboumousa, J Hoogendijk, R Charlton, R Barresi, R Herrmann, T Voit, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (7), 572-578<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4093919692712720098" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:TFP_iSt0sucC" class="gsc_a_at">β-sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate</a><div class="gs_gray">F Duclos, O Broux, N Bourg, V Straub, GL Feldman, Y Sunada, LE Lim, ...</div><div class="gs_gray">Neuromuscular Disorders 8 (1), 30-38<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2139703168272954263" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness</a><div class="gs_gray">Z Lukacs, PN Cobos, S Wenninger, TA Willis, M Guglieri, M Roberts, ...</div><div class="gs_gray">Neurology 87 (3), 295-298<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12388437717085371118" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Mutations in the mitochondrial citrate carrier SLC25A1 are associated with impaired neuromuscular transmission</a><div class="gs_gray">A Chaouch, V Porcelli, D Cox, S Edvardson, P Scarcia, A De Grassi, ...</div><div class="gs_gray">Journal of neuromuscular diseases 1 (1), 75-90<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4098396518332862135" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations</a><div class="gs_gray">U Schara, N Barisic, M Deschauer, C Lindberg, V Straub, N Strigl-Pill, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (12), 828-832<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2643149106154377772" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy</a><div class="gs_gray">S Lynn, A Aartsma-Rus, K Bushby, P Furlong, N Goemans, A De Luca, ...</div><div class="gs_gray">Neuromuscular Disorders 25 (1), 96-105<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4257009750384472149" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Oculopharyngodistal myopathy is a distinct entity: clinical and genetic features of 47 patients</a><div class="gs_gray">H Durmus, SH Laval, F Deymeer, Y Parman, E Kiyan, M Gokyigiti, ...</div><div class="gs_gray">Neurology 76 (3), 227-235<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11898943340243058887" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice</a><div class="gs_gray">V Allamand, KM Donahue, V Straub, RL Davisson, BL Davidson, ...</div><div class="gs_gray">Gene therapy 7 (16), 1385-1391<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5099552470584895700" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:FAceZFleit8C" class="gsc_a_at">Improving the informed consent process in international collaborative rare disease research: effective consent for effective research</a><div class="gs_gray">S Gainotti, C Turner, S Woods, A Kole, P McCormack, H Lochmüller, ...</div><div class="gs_gray">European Journal of Human Genetics 24 (9), 1248-1254<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8989416702224257635" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:uVUOdF_882EC" class="gsc_a_at">Preserved merosin M-chain (or laminin-α2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital&nbsp;…</a><div class="gs_gray">T Voit, CA Sewry, K Meyer, R Hermann, V Straub, F Muntoni, T Kahn, ...</div><div class="gs_gray">Neuropediatrics 26 (03), 148-155<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14549272559260039819" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Recent advances in the management of Duchenne muscular dystrophy</a><div class="gs_gray">EM Strehle, V Straub</div><div class="gs_gray">Archives of disease in childhood 100 (12), 1173-1177<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3670960240081505547" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Compliance to care guidelines for Duchenne muscular dystrophy</a><div class="gs_gray">E Landfeldt, P Lindgren, CF Bell, C Schmitt, M Guglieri, V Straub, ...</div><div class="gs_gray">Journal of neuromuscular diseases 2 (1), 63-72<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=653784503591618974" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ns9cj8rnVeAC" class="gsc_a_at"><i>ANO5</i> Gene Analysis in a Large Cohort of Patients with Anoctaminopathy: Confirmation of Male Prevalence and High Occurrence of the Common Exon 5 Gene&nbsp;…</a><div class="gs_gray">A Sarkozy, D Hicks, J Hudson, SH Laval, R Barresi, D Hilton‐Jones, ...</div><div class="gs_gray">Human mutation 34 (8), 1111-1118<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2481930651447916946" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ymY9cBF3mdcC" class="gsc_a_at">Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials</a><div class="gs_gray">J Diaz-Manera, R Fernandez-Torron, J LLauger, MK James, A Mayhew, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 89 (10), 1071-1081<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5410856147377998043" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Cyclosporine A treatment for Ullrich congenital muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescue</a><div class="gs_gray">D Hicks, AK Lampe, SH Laval, V Allamand, C Jimenez-Mallebrera, ...</div><div class="gs_gray">Brain 132 (1), 147-155<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1788425807132191931" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Interventions for muscular dystrophy: molecular medicines entering the clinic</a><div class="gs_gray">K Bushby, H Lochmüller, S Lynn, V Straub</div><div class="gs_gray">The Lancet 374 (9704), 1849-1856<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14585755724955841545" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RuPIJ_LgqDgC" class="gsc_a_at">The differential gene expression profiles of proximal and distal muscle groups are altered in pre-pathological dysferlin-deficient mice</a><div class="gs_gray">M von der Hagen, SH Laval, LM Cree, F Haldane, M Pocock, I Wappler, ...</div><div class="gs_gray">Neuromuscular Disorders 15 (12), 863-877<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17747424316705704039" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:oPLKW5k6eA4C" class="gsc_a_at">The Clinical Outcome Study for dysferlinopathy: An international multicenter study</a><div class="gs_gray">E Harris, CL Bladen, A Mayhew, M James, K Bettinson, U Moore, ...</div><div class="gs_gray">Neurology Genetics 2 (4)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18137721659373655723" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen</a><div class="gs_gray">K Anthony, L Feng, V Arechavala-Gomeza, M Guglieri, V Straub, ...</div><div class="gs_gray">Human Gene Therapy, Part B: Methods 23 (5), 336-345<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14098383571742886056" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Collaborating to bring new therapies to the patient-the TREAT-NMD model</a><div class="gs_gray">K Bushby, S Lynn, V Straub</div><div class="gs_gray">Acta Myologica 28 (1), 12<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3882912388092664389" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Developing standardized corticosteroid treatment for Duchenne muscular dystrophy</a><div class="gs_gray">M Guglieri, K Bushby, MP McDermott, KA Hart, R Tawil, WB Martens, ...</div><div class="gs_gray">Contemporary clinical trials 58, 34-39<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13681146752474112771" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:zwpXiJ37cpgC" class="gsc_a_at">Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI</a><div class="gs_gray">H Amthor, T Egelhof, I McKinnell, ME Ladd, I Janssen, J Weber, H Sinn, ...</div><div class="gs_gray">Neuromuscular disorders 14 (12), 791-796<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17400244710676865912" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:37UQlXuwjP4C" class="gsc_a_at">Why are some patients with Duchenne muscular dystrophy dying young: an analysis of causes of death in North East England</a><div class="gs_gray">HJA Van Ruiten, CM Bettolo, T Cheetham, M Eagle, H Lochmuller, ...</div><div class="gs_gray">european journal of paediatric neurology 20 (6), 904-909<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18332200343022117047" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree</a><div class="gs_gray">TD Miller, AP Jackson, R Barresi, CM Smart, M Eugenicos, D Summers, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 80 (5), 583-584<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4100364397524853915" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Prevalence, phenotype and architecture of developmental disorders caused by de novo mutation: The Deciphering Developmental Disorders Study</a><div class="gs_gray">JF McRae, S Clayton, TW Fitzgerald, J Kaplanis, E Prigmore, D Rajan, ...</div><div class="gs_gray">BioRxiv, 049056<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16522358475327474939" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:EBV337fEn3EC" class="gsc_a_at">CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language</a><div class="gs_gray">LS Blok, J Rousseau, J Twist, S Ehresmann, M Takaku, H Venselaar, ...</div><div class="gs_gray">Nature communications 9 (1), 1-12<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12573876735001092396" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8AbLer7MMksC" class="gsc_a_at">MRI in sarcoglycanopathies: a large international cohort study</a><div class="gs_gray">G Tasca, M Monforte, J Díaz-Manera, G Brisca, C Semplicini, A D’Amico, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 89 (1), 72-77<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4090491952794085089" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LhH-TYMQEocC" class="gsc_a_at">Association study of exon variants in the NF-κB and TGFβ pathways identifies CD40 as a modifier of Duchenne muscular dystrophy</a><div class="gs_gray">L Bello, KM Flanigan, RB Weiss, DM Dunn, KJ Swoboda, E Gappmaier, ...</div><div class="gs_gray">The American Journal of Human Genetics 99 (5), 1163-1171<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10612067362864033663" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Short stature and pubertal delay in Duchenne muscular dystrophy</a><div class="gs_gray">CL Wood, V Straub, M Guglieri, K Bushby, T Cheetham</div><div class="gs_gray">Archives of disease in childhood 101 (1), 101-106<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=762889979823587510" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:JP7YXuLIOvAC" class="gsc_a_at">Investigating the quantitative fidelity of prospectively undersampled chemical shift imaging in muscular dystrophy with compressed sensing and parallel imaging reconstruction</a><div class="gs_gray">KG Hollingsworth, DM Higgins, M McCallum, L Ward, A Coombs, V Straub</div><div class="gs_gray">Magnetic resonance in medicine 72 (6), 1610-1619<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17538453203225720626" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5awf1xo2G04C" class="gsc_a_at">The childhood limb-girdle muscular dystrophies</a><div class="gs_gray">V Straub, K Bushby</div><div class="gs_gray">Seminars in pediatric neurology 13 (2), 104-114<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5059981289518012855" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Reduced serum myostatin concentrations associated with genetic muscle disease progression</a><div class="gs_gray">PM Burch, O Pogoryelova, J Palandra, R Goldstein, D Bennett, L Fitz, ...</div><div class="gs_gray">Journal of neurology 264 (3), 541-553<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5502931988751297609" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changes</a><div class="gs_gray">T Loughran, DM Higgins, M McCallum, A Coombs, V Straub, ...</div><div class="gs_gray">Radiology 275 (2), 570-578<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6495444288011984552" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:TaaCk18tZOkC" class="gsc_a_at">Respiratory function in congenital muscular dystrophy and limb girdle muscular dystrophy 2I</a><div class="gs_gray">C Dohna-Schwake, R Ragette, U Mellies, V Straub, H Teschler, T Voit</div><div class="gs_gray">Neurology 62 (3), 513-514<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18218047478334238768" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SxCCDk4iOpsC" class="gsc_a_at">Long-term blocking of calcium channels in mdx mice results in differential effects on heart and skeletal muscle</a><div class="gs_gray">LH Jørgensen, A Blain, E Greally, SH Laval, AM Blamire, BJ Davison, ...</div><div class="gs_gray">The American journal of pathology 178 (1), 273-283<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17979308775379334559" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">98th ENMC International Workshop on Congenital Muscular Dystrophy (CMD), 7th Workshop of the International Consortium on CMD, 2nd Workshop of the MYO CLUSTER project GENRE: 26&nbsp;…</a><div class="gs_gray">F Muntoni, E Bertini, C Bönnemann, M Brockington, S Brown, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 12 (9), 889-896<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11785535178548684391" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study</a><div class="gs_gray">A van der Ploeg, PG Carlier, RY Carlier, JT Kissel, B Schoser, ...</div><div class="gs_gray">Molecular genetics and metabolism 119 (1-2), 115-123<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10681178591833039183" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:6VlyvFCUEfcC" class="gsc_a_at">Guidance in Social and Ethical Issues Related to Clinical, Diagnostic Care and Novel Therapies for Hereditary Neuromuscular Rare Diseases:“Translating “the Translational</a><div class="gs_gray">P McCormack, S Woods, A Aartsma-Rus, L Hagger, A Herczegfalvi, ...</div><div class="gs_gray">PLoS currents 5<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12837892490079825166,5360132194812274782" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Mutations in INPP5K, encoding a phosphoinositide 5-phosphatase, cause congenital muscular dystrophy with cataracts and mild cognitive impairment</a><div class="gs_gray">M Wiessner, A Roos, CJ Munn, R Viswanathan, T Whyte, D Cox, ...</div><div class="gs_gray">The American Journal of Human Genetics 100 (3), 523-536<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4193844878739728818" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Steroid treatment causes deterioration of myocardial function in the δ-sarcoglycan-deficient mouse model for dilated cardiomyopathy</a><div class="gs_gray">R Bauer, GA Macgowan, A Blain, K Bushby, V Straub</div><div class="gs_gray">Cardiovascular research 79 (4), 652-661<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7825364507142206755" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:GFxP56DSvIMC" class="gsc_a_at">The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases</a><div class="gs_gray">S Rodger, H Lochmüller, A Tassoni, K Gramsch, K König, K Bushby, ...</div><div class="gs_gray">Orphanet journal of rare diseases 8 (1), 1-12<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11021390464200196624" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BJtnxTr0fRcC" class="gsc_a_at">Revised upper limb module for spinal muscular atrophy: 12 month changes</a><div class="gs_gray">MC Pera, G Coratti, ES Mazzone, J Montes, M Scoto, R De Sanctis, ...</div><div class="gs_gray">Muscle &amp; nerve 59 (4), 426-430<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3898834042206198535" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hHIA4WEVY-EC" class="gsc_a_at">Exploration of new contrasts, targets, and MR imaging and spectroscopy techniques for neuromuscular disease–a workshop report of working group 3 of the biomedicine and&nbsp;…</a><div class="gs_gray">GJ Strijkers, ECA Araujo, N Azzabou, D Bendahan, A Blamire, ...</div><div class="gs_gray">Journal of neuromuscular diseases 6 (1), 1-30<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8695974475971184498" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:JWITY9-sCbMC" class="gsc_a_at">Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies</a><div class="gs_gray">P Spitali, K Hettne, R Tsonaka, M Charrout, J van den Bergen, Z Koeks, ...</div><div class="gs_gray">Journal of cachexia, sarcopenia and muscle 9 (4), 715-726<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16236927451252786831" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">The limb-girdle muscular dystrophies—diagnostic strategies</a><div class="gs_gray">K Bushby, F Norwood, V Straub</div><div class="gs_gray">Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1772 (2), 238-242<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11683079828577468723" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HeT0ZceujKMC" class="gsc_a_at">Where do we stand in trial readiness for autosomal recessive limb girdle muscular dystrophies?</a><div class="gs_gray">V Straub, M Bertoli</div><div class="gs_gray">Neuromuscular Disorders 26 (2), 111-125<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10564200860623764398" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:X9ykpCP0fEIC" class="gsc_a_at">114th ENMC international workshop on congenital muscular dystrophy (CMD) 17–19 January 2003, Naarden, The Netherlands:(8th workshop of the international consortium on CMD; 3rd&nbsp;…</a><div class="gs_gray">F Muntoni, BV De Bernabe, R Bittner, D Blake, H Van Bokhoven, ...</div><div class="gs_gray">Neuromuscular Disorders 13 (7), 579-588<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16520393760563379008" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy</a><div class="gs_gray">E Harris, A Topf, R Barresi, J Hudson, H Powell, J Tellez, D Hicks, ...</div><div class="gs_gray">Orphanet journal of rare diseases 12 (1), 1-12<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2817865556075492827" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Prophylactic oral bisphosphonate therapy in duchenne muscular dystrophy</a><div class="gs_gray">R Srinivasan, D Rawlings, CL Wood, T Cheetham, ACJ Moreno, ...</div><div class="gs_gray">Muscle &amp; nerve 54 (1), 79-85<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7009624668731741794" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Muscular dystrophy with large mitochondria associated with mutations in the CHKB gene in three British patients: extending the clinical and pathological phenotype</a><div class="gs_gray">R Quinlivan, S Mitsuahashi, C Sewry, S Cirak, C Aoyama, D Mooore, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (7), 549-556<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3015476310526046124" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9–11 November 2002, Naarden, The Netherlands</a><div class="gs_gray">H Jungbluth, A Beggs, C Bönnemann, K Bushby, C Ceuterick-de Groote, ...</div><div class="gs_gray">Neuromuscular Disorders 14 (11), 754-766<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3235733235682704543" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SnGPuo6Feq8C" class="gsc_a_at">Development and application of an ultrasensitive hybridization-based ELISA method for the determination of peptide-conjugated phosphorodiamidate morpholino oligonucleotides</a><div class="gs_gray">U Burki, J Keane, A Blain, L O'Donovan, MJ Gait, SH Laval, V Straub</div><div class="gs_gray">Nucleic acid therapeutics 25 (5), 275-284<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15361669680256226439,7164316284730139555" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BrOSOlqYqPUC" class="gsc_a_at">Two recurrent mutations are associated with GNE myopathy in the North of Britain</a><div class="gs_gray">A Chaouch, KM Brennan, J Hudson, C Longman, J McConville, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 85 (12), 1359-1365<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15086065367487742087" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:zdjWy_NXXwUC" class="gsc_a_at">δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches</a><div class="gs_gray">AM Blain, VW Straub</div><div class="gs_gray">Skeletal muscle 1 (1), 1-12<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16568323927891508831" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:otzGkya1bYkC" class="gsc_a_at">Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes</a><div class="gs_gray">JS Müller, CD Jepson, SH Laval, K Bushby, V Straub, H Lochmüller</div><div class="gs_gray">Human molecular genetics 19 (9), 1726-1740<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11897547085593223525" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ghEM2AJqZyQC" class="gsc_a_at">Structural analysis of pathogenic mutations in the <i>DYRK1A</i> gene in patients with developmental disorders</a><div class="gs_gray">JMG Evers, RA Laskowski, M Bertolli, J Clayton-Smith, C Deshpande, ...</div><div class="gs_gray">Human molecular genetics 26 (3), 519-526<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16595510760889736939" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy</a><div class="gs_gray">P Garrood, M Eagle, PE Jardine, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 18 (1), 71-73<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6730465107261311009" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:unp9ATQDT5gC" class="gsc_a_at">Phenotypic variability of TRPV4 related neuropathies</a><div class="gs_gray">T Evangelista, B Bansagi, A Pyle, H Griffin, K Douroudis, T Polvikoski, ...</div><div class="gs_gray">Neuromuscular Disorders 25 (6), 516-521<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17295477818580153605" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-DxkuPiZhfEC" class="gsc_a_at">Immunohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2A</a><div class="gs_gray">R Charlton, M Henderson, J Richards, J Hudson, V Straub, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (7), 449-457<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16495792518004038895" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:foquWX3nUaYC" class="gsc_a_at">Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains</a><div class="gs_gray">E Harris, U Burki, C Marini-Bettolo, M Neri, C Scotton, J Hudson, M Bertoli, ...</div><div class="gs_gray">Neuromuscular Disorders 27 (9), 861-872<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8392589188042375157" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DQNrXyjhriIC" class="gsc_a_at">Fractures and linear growth in a nationwide cohort of boys with Duchenne muscular dystrophy with and without glucocorticoid treatment: results from the UK NorthStar Database</a><div class="gs_gray">S Joseph, C Wang, K Bushby, M Guglieri, I Horrocks, V Straub, SF Ahmed, ...</div><div class="gs_gray">JAMA neurology 76 (6), 701-709<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4534993378859113872" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Re-evaluation of the phenotype caused by the common MATR3 p. Ser85Cys mutation in a new family</a><div class="gs_gray">J Palmio, A Evilä, A Bashir, F Norwood, K Viitaniemi, A Vihola, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 87 (4), 448-450<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11739194191489324076" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:J3LtWjKFLicC" class="gsc_a_at">A novel form of familial congenital muscular dystrophy in two adolescents</a><div class="gs_gray">MAM Salih, M Al Rayess, S Cutshall, JA Urtizberea, MHS Al-Turaiki, ...</div><div class="gs_gray">Neuropediatrics 29 (06), 289-293<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8779531299817684052" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:q1zXlPLtbUIC" class="gsc_a_at">Heterozygous variants in KMT2E cause a spectrum of neurodevelopmental disorders and epilepsy</a><div class="gs_gray">AH O’Donnell-Luria, LS Pais, V Faundes, JC Wood, A Sveden, V Luria, ...</div><div class="gs_gray">The American Journal of Human Genetics 104 (6), 1210-1222<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1499037105247903469" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Nonmolecular treatment for muscular dystrophies</a><div class="gs_gray">K Bushby, V Straub</div><div class="gs_gray">Current opinion in neurology 18 (5), 511-518<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5589013125316267294" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_tF6a-HnqWAC" class="gsc_a_at">The diagnostic value of MRI pattern recognition in distal myopathies</a><div class="gs_gray">E Bugiardini, JM Morrow, S Shah, CL Wood, DS Lynch, AM Pitmann, ...</div><div class="gs_gray">Frontiers in neurology 9, 456<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5275300765104703751" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">Elusive sources of variability of dystrophin rescue by exon skipping</a><div class="gs_gray">MC Vila, MB Klimek, JS Novak, S Rayavarapu, K Uaesoontrachoon, ...</div><div class="gs_gray">Skeletal muscle 5 (1), 1-12<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11848554674383862458" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Novel mutations in DNAJB6 gene cause a very severe early-onset limb-girdle muscular dystrophy 1D disease</a><div class="gs_gray">J Palmio, PH Jonson, A Evilä, M Auranen, V Straub, K Bushby, A Sarkozy, ...</div><div class="gs_gray">Neuromuscular Disorders 25 (11), 835-842<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2685272382730286287" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:s85pQhAUCrAC" class="gsc_a_at">Congenital muscular dystrophy with adducted thumbs, ptosis, external ophthalmoplegia, mental retardation and cerebellar hypoplasia: a novel form of CMD</a><div class="gs_gray">T Voit, E Parano, V Straub, JM Schröder, J Schaper, P Pavone, ...</div><div class="gs_gray">Neuromuscular Disorders 12 (7-8), 623-630<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18196480985150896440" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:rFyVMFCKTwsC" class="gsc_a_at">MYO-MRI diagnostic protocols in genetic myopathies</a><div class="gs_gray">JW Chardon, J Díaz-Manera, G Tasca, CG Bönnemann, D Gómez-Andrés, ...</div><div class="gs_gray">Neuromuscular Disorders 29 (11), 827-841<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11446552602448307196" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:bXQfdp6S9ecC" class="gsc_a_at">Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study</a><div class="gs_gray">V Ricotti, V Selby, D Ridout, J Domingos, V Decostre, A Mayhew, M Eagle, ...</div><div class="gs_gray">Neuromuscular Disorders 29 (4), 261-268<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2597710514548893960" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:H7nrzBkawXsC" class="gsc_a_at">Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained&nbsp;…</a><div class="gs_gray">K Johnson, M Bertoli, L Phillips, A Töpf, P Van den Bergh, J Vissing, ...</div><div class="gs_gray">Skeletal muscle 8 (1), 1-12<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8273429171093019398" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NxmKEeNBbOMC" class="gsc_a_at">The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research</a><div class="gs_gray">L Wood, I Cordts, A Atalaia, C Marini-Bettolo, P Maddison, M Phillips, ...</div><div class="gs_gray">Journal of neurology 264 (5), 979<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17371894822510468436" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Testosterone treatment of pubertal delay in Duchenne muscular dystrophy</a><div class="gs_gray">CL Wood, TD Cheetham, M Guglieri, K Bushby, C Owen, H Johnstone, ...</div><div class="gs_gray">Neuropediatrics 46 (06), 371-376<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13482949358945078773" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:GnPB-g6toBAC" class="gsc_a_at">The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development</a><div class="gs_gray">E Heslop, C Csimma, V Straub, J McCall, K Nagaraju, KR Wagner, ...</div><div class="gs_gray">Orphanet journal of rare diseases 10 (1), 1-6<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2414212249043666134" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Abnormal vascular development in zebrafish models for fukutin and FKRP deficiency</a><div class="gs_gray">AJ Wood, JS Müller, CD Jepson, SH Laval, H Lochmüller, K Bushby, ...</div><div class="gs_gray">Human molecular genetics 20 (24), 4879-4890<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8258576094403195675" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:dBIO0h50nwkC" class="gsc_a_at">A novel recessive TTN founder variant is a common cause of distal myopathy in the Serbian population</a><div class="gs_gray">S Perić, JN Glumac, A Töpf, D Savić-Pavićević, L Phillips, K Johnson, ...</div><div class="gs_gray">European Journal of Human Genetics 25 (5), 572-581<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10025189488588307921" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:T8_be82Iz5gC" class="gsc_a_at">MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement</a><div class="gs_gray">S Donkervoort, R Sabouny, P Yun, L Gauquelin, KR Chao, Y Hu, ...</div><div class="gs_gray">Acta neuropathologica 138 (6), 1013-1031<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3928179359353729344" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Economic evaluation in Duchenne muscular dystrophy: model frameworks for cost-effectiveness analysis</a><div class="gs_gray">E Landfeldt, L Alfredsson, V Straub, H Lochmüller, K Bushby, P Lindgren</div><div class="gs_gray">Pharmacoeconomics 35 (2), 249-258<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11169363151268560384" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I</a><div class="gs_gray">KG Hollingsworth, TA Willis, MGD Bates, BJ Dixon, H Lochmüller, ...</div><div class="gs_gray">European journal of heart failure 15 (9), 986-994<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2021385730861700602" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4DMP91E08xMC" class="gsc_a_at">Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy</a><div class="gs_gray">A Blain, E Greally, S Laval, A Blamire, V Straub, GA MacGowan</div><div class="gs_gray">PloS one 8 (2), e57260<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1194740774399122568" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PELIpwtuRlgC" class="gsc_a_at">Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene</a><div class="gs_gray">A Sarkozy, C Windpassinger, J Hudson, CF Dougan, B Lecky, ...</div><div class="gs_gray">European journal of human genetics 19 (10), 1038-1044<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4751492685588096837" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">Does δ-sarcoglycan-associated autosomal-dominant cardiomyopathy exist?</a><div class="gs_gray">R Bauer, J Hudson, HD Müller, C Sommer, G Dekomien, J Bourke, ...</div><div class="gs_gray">European journal of human genetics 17 (9), 1148-1153<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9611697546996440893" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Pompe disease</a><div class="gs_gray">M Baethmann, V Straub, AJJ Reuser, OA Bodamer, ...</div><div class="gs_gray">UNI-MED<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=331539521332552605" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:wGzT3bKASkAC" class="gsc_a_at">European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)</a><div class="gs_gray">A Barp, P Laforet, L Bello, G Tasca, J Vissing, M Monforte, E Ricci, ...</div><div class="gs_gray">Journal of neurology 267 (1), 45-56<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14358775193946714194" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:X5YyAB84Iw4C" class="gsc_a_at">Natural history of limb girdle muscular dystrophy R9 over 6 years: searching for trial endpoints</a><div class="gs_gray">AP Murphy, J Morrow, JR Dahlqvist, T Stojkovic, TA Willis, CDJ Sinclair, ...</div><div class="gs_gray">Annals of clinical and translational neurology 6 (6), 1033-1045<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7899581016901702175" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8VtEwCQfWZkC" class="gsc_a_at">Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy</a><div class="gs_gray">A Alonso-Jimenez, RH Kroon, A Alejaldre-Monforte, C Nuñez-Peralta, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 90 (5), 576-585<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10150771156537142997" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Limb girdle muscular dystrophy due to mutations in POMT2</a><div class="gs_gray">ST Østergaard, K Johnson, T Stojkovic, T Krag, W De Ridder, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 89 (5), 506-512<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6583537469581269282" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">Golodirsen induces exon skipping leading to sarcolemmal dystrophin expression in Duchenne muscular dystrophy patients with mutations amenable to exon 53 skipping (S22. 001)</a><div class="gs_gray">F Muntoni, D Frank, V Sardone, J Morgan, F Schnell, J Charleston, ...</div><div class="gs_gray">Neurology 90 (15 Supplement)<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12191917323172979177" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HJSXoJQnj-YC" class="gsc_a_at">Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy</a><div class="gs_gray">S Moreira, L Wood, D Smith, C Marini-Bettolo, M Guglieri, G McMacken, ...</div><div class="gs_gray">Journal of neurology 264 (6), 1271-1280<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15450716711973380633" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LGlY6t8CeOMC" class="gsc_a_at">Intolerance to β‐blockade in a mouse model of δ‐sarcoglycan‐deficient muscular dystrophy cardiomyopathy</a><div class="gs_gray">R Bauer, A Blain, E Greally, K Bushby, H Lochmüller, S Laval, V Straub, ...</div><div class="gs_gray">European journal of heart failure 12 (11), 1163-1170<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18109218526581122205" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:69ZgNCALVd0C" class="gsc_a_at">Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies</a><div class="gs_gray">V Straub, K Bushby</div><div class="gs_gray">Neurotherapeutics 5 (4), 619-626<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15353999888208508419" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:wkm4DBaukwsC" class="gsc_a_at">A multistage sequencing strategy pinpoints novel candidate alleles for Emery-Dreifuss muscular dystrophy and supports gene misregulation as its pathomechanism</a><div class="gs_gray">P Meinke, ARW Kerr, R Czapiewski, I Jose, CR Dixon, E Harris, H Kölbel, ...</div><div class="gs_gray">EBioMedicine 51, 102587<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2005491122179539743" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:uUvzmPk0f8oC" class="gsc_a_at">Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naive and&nbsp;…</a><div class="gs_gray">LDM Pena, RJ Barohn, BJ Byrne, C Desnuelle, O Goker-Alpan, S Ladha, ...</div><div class="gs_gray">Neuromuscular Disorders 29 (3), 167-186<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15180468308496669491" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QsKbpXNoaWkC" class="gsc_a_at">A checklist for clinical trials in rare disease: obstacles and anticipatory actions—lessons learned from the FOR-DMD trial</a><div class="gs_gray">RA Crow, KA Hart, MP McDermott, R Tawil, WB Martens, BE Herr, ...</div><div class="gs_gray">Trials 19 (1), 1-9<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17502625263010171679" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study</a><div class="gs_gray">UR Moore, M Jacobs, R Fernandez-Torron, J Jang, MK James, A Mayhew, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 89 (11), 1224-1226<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8599946471677880514" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Y0-TYkg6YM4C" class="gsc_a_at">FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutation</a><div class="gs_gray">K Mul, RJLF Lemmers, M Kriek, PJ van der Vliet, ML van den Boogaard, ...</div><div class="gs_gray">Neurology 91 (6), e562-e570<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6844637579746647629" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:sszUF3NjhM4C" class="gsc_a_at">Identification of GAA variants through whole exome sequencing targeted to a cohort of 606 patients with unexplained limb-girdle muscle weakness</a><div class="gs_gray">K Johnson, A Töpf, M Bertoli, L Phillips, KG Claeys, VR Stojanovic, ...</div><div class="gs_gray">Orphanet journal of rare diseases 12 (1), 1-11<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14315048292270400031" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Clinical and neuroimaging findings in two brothers with limb girdle muscular dystrophy due to LAMA2 mutations</a><div class="gs_gray">E Harris, M McEntagart, A Topf, H Lochmüller, K Bushby, C Sewry, ...</div><div class="gs_gray">Neuromuscular Disorders 27 (2), 170-174<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4665685582130776841" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:YTuZlYwrTOUC" class="gsc_a_at">Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion</a><div class="gs_gray">N Vasli, E Harris, J Karamchandani, E Bareke, J Majewski, NB Romero, ...</div><div class="gs_gray">Brain 140 (1), 37-48<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8060878937897585566" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kWvqk_afx_IC" class="gsc_a_at">Applications of MRI in muscle diseases</a><div class="gs_gray">PG Carlier, E Mercuri, V Straub</div><div class="gs_gray">Neuromuscular Disorders 22, S41<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14391117951972314302" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:L7vk9XBBNxgC" class="gsc_a_at">Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness</a><div class="gs_gray">A Töpf, K Johnson, A Bates, L Phillips, KR Chao, EM England, ...</div><div class="gs_gray">Genetics in medicine 22 (9), 1478-1488<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=621763073072164769" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:oAywNP-vUhwC" class="gsc_a_at">Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy</a><div class="gs_gray">M Signorelli, B Ayoglu, C Johansson, H Lochmüller, V Straub, F Muntoni, ...</div><div class="gs_gray">Journal of cachexia, sarcopenia and muscle 11 (2), 505-517<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5774331605126412562" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:xa5BkEQK8BgC" class="gsc_a_at">Accuracy of a machine learning muscle MRI-based tool for the diagnosis of muscular dystrophies</a><div class="gs_gray">J Verdú-Díaz, J Alonso-Pérez, C Nuñez-Peralta, G Tasca, J Vissing, ...</div><div class="gs_gray">Neurology 94 (10), e1094-e1102<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16911376956419603200" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nWoA1JPTheMC" class="gsc_a_at">SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of&nbsp;…</a><div class="gs_gray">RJLF Lemmers, N van der Stoep, PJ van der Vliet, SA Moore, ...</div><div class="gs_gray">Journal of medical genetics 56 (10), 693-700<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7445292657339031324" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy</a><div class="gs_gray">E Greally, BJ Davison, A Blain, S Laval, A Blamire, V Straub, ...</div><div class="gs_gray">Journal of Cardiovascular Magnetic Resonance 15 (1), 1-8<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11821123996334519851" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ZqE1mSdD_DYC" class="gsc_a_at">Spontaneous keloid formation in patients with Bethlem myopathy</a><div class="gs_gray">J Collins, AR Foley, V Straub, CG Bönnemann</div><div class="gs_gray">Neurology 79 (21), 2158<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17529742448309391520" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Xz60mAmATU4C" class="gsc_a_at">Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies</a><div class="gs_gray">HP Lo, E Bertini, M Mirabella, A Domazetovska, RC Dale, S Petrini, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (3), 194-203<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16069199390466563829" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:sgsej9ZJWHMC" class="gsc_a_at">Bi-allelic loss-of-function CACNA1B mutations in progressive epilepsy-dyskinesia</a><div class="gs_gray">KM Gorman, E Meyer, D Grozeva, E Spinelli, A McTague, A Sanchis-Juan, ...</div><div class="gs_gray">The American Journal of Human Genetics 104 (5), 948-956<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3469929931634724399" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:xm0LlTxljI0C" class="gsc_a_at">Report on the workshop: meaningful outcome measures for Duchenne muscular dystrophy, London, UK, 30–31 January 2017</a><div class="gs_gray">V Straub, E Mercuri, A Aartsma-Rus, D Athanasiou, P Balabanov, ...</div><div class="gs_gray">Neuromuscular Disorders 28 (8), 690-701<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=315190230848244226" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Outcomes of an international workshop on preconception expanded carrier screening: some considerations for governments</a><div class="gs_gray">CM Molster, K Lister, S Metternick-Jones, G Baynam, AJ Clarke, V Straub, ...</div><div class="gs_gray">Frontiers in public health 5, 25<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11182208260405895250" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy</a><div class="gs_gray">C Scotton, M Bovolenta, E Schwartz, MS Falzarano, E Martoni, ...</div><div class="gs_gray">Journal of cell science 129 (8), 1671-1684<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3209571174783164131" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3htObqc8RwsC" class="gsc_a_at">Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT)</a><div class="gs_gray">E Landfeldt, A Mayhew, M Eagle, P Lindgren, CF Bell, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 25 (12), 937-944<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10380494509856609257" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Attenuation of adverse cardiac effects in prednisolone-treated δ-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism</a><div class="gs_gray">R Bauer, A Blain, E Greally, H Lochmüller, K Bushby, GA MacGowan, ...</div><div class="gs_gray">Neuromuscular Disorders 20 (1), 21-28<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=424768082236574551" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PVqtIyvKoSUC" class="gsc_a_at">Muscular dystrophy with arrhythmia caused by loss-of-function mutations in BVES</a><div class="gs_gray">W De Ridder, I Nelson, B Asselbergh, B De Paepe, M Beuvin, RB Yaou, ...</div><div class="gs_gray">Neurology Genetics 5 (2)<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7292930825781312598" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Downregulation of miRNA-29,-23 and-21 in urine of Duchenne muscular dystrophy patients</a><div class="gs_gray">F Catapano, J Domingos, M Perry, V Ricotti, L Phillips, L Servais, ...</div><div class="gs_gray">Epigenomics 10 (7), 875-889<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7505996793585480238" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Lower limb radiology of distal myopathy due to the S60F myotilin mutation</a><div class="gs_gray">A McNeill, D Birchall, V Straub, L Goldfarb, P Reilich, MC Walter, ...</div><div class="gs_gray">European neurology 62 (3), 161-166<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8550821486030680404" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Br1UauaknNIC" class="gsc_a_at">Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK</a><div class="gs_gray">S Figueroa-Bonaparte, J Hudson, R Barresi, T Polvikoski, T Williams, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 87 (6), 680-681<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10721786304429533401" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DkZNVXde3BIC" class="gsc_a_at">Absence of cardiac benefit with early combination ACE inhibitor and beta blocker treatment in mdx mice</a><div class="gs_gray">A Blain, E Greally, SH Laval, AM Blamire, GA MacGowan, VW Straub</div><div class="gs_gray">Journal of cardiovascular translational research 8 (3), 198-207<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15287345914135815315" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1paMEeroeoQC" class="gsc_a_at">New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy</a><div class="gs_gray">J Alonso-Pérez, L González-Quereda, L Bello, M Guglieri, V Straub, ...</div><div class="gs_gray">Brain 143 (9), 2696-2708<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4810515452916378484" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cB__R-XWw9UC" class="gsc_a_at">Performance of Upper Limb module for Duchenne muscular dystrophy</a><div class="gs_gray">AG Mayhew, G Coratti, ES Mazzone, K Klingels, M James, M Pane, ...</div><div class="gs_gray">Developmental Medicine &amp; Child Neurology 62 (5), 633-639<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10245271977107873391" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Presymptomatic late-onset Pompe disease identified by the dried blood spot test</a><div class="gs_gray">M Wagner, A Chaouch, JS Müller, T Polvikoski, TA Willis, A Sarkozy, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (1), 89-92<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11152115362567226666" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SWgZeABleR0C" class="gsc_a_at">The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease</a><div class="gs_gray">JA Bevilacqua, MRG Ehuletche, A Perna, A Dubrovsky, MC Franca, ...</div><div class="gs_gray">Orphanet journal of rare diseases 15 (1), 1-11<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16975149449297146585,7940720521197412192" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LWqeokA2EBkC" class="gsc_a_at"><i>POPDC3</i> Gene Variants Associate with a New Form of Limb Girdle Muscular Dystrophy</a><div class="gs_gray">J Vissing, K Johnson, A Töpf, S Nafissi, J Díaz‐Manera, VM French, ...</div><div class="gs_gray">Annals of neurology 86 (6), 832-843<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11840301408798167488" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:x21FZCSn4ZoC" class="gsc_a_at">Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in <i>mdx</i> and <i>Cmah-/-mdx</i> mouse models of Duchenne&nbsp;…</a><div class="gs_gray">AM Blain, E Greally, G McClorey, R Manzano, CA Betts, C Godfrey, ...</div><div class="gs_gray">PloS one 13 (6), e0198897<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17943375144585335693" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Conserved expression of truncated telethonin in a patient with limb-girdle muscular dystrophy 2G</a><div class="gs_gray">R Barresi, C Morris, J Hudson, E Curtis, C Pickthall, K Bushby, NP Davies, ...</div><div class="gs_gray">Neuromuscular Disorders 25 (4), 349-352<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1459260074795509174" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_AeoHAGD03cC" class="gsc_a_at">S151A δ-sarcoglycan mutation causes a mild phenotype of cardiomyopathy in mice</a><div class="gs_gray">D Rutschow, R Bauer, C Göhringer, R Bekeredjian, S Schinkel, V Straub, ...</div><div class="gs_gray">European Journal of Human Genetics 22 (1), 119-125<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18206382871399025755" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:v_xunPV0uK0C" class="gsc_a_at">POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern</a><div class="gs_gray">E Servián-Morilla, M Cabrera-Serrano, K Johnson, A Pandey, A Ito, ...</div><div class="gs_gray">Acta neuropathologica 139 (3), 565-582<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6824563213089161529" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Azgs6IHzeyYC" class="gsc_a_at">A new mutation of the SCGA gene is the cause of a late onset mild phenotype limb girdle muscular dystrophy type 2D with axial involvement</a><div class="gs_gray">L Gonzalez-Quereda, E Gallardo, A Töpf, A Alonso-Jimenez, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 28 (8), 633-638<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7283642978567417087" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:c_xDhezhKKUC" class="gsc_a_at">A ‘second truncation’in TTN causes early onset recessive muscular dystrophy</a><div class="gs_gray">E Harris, A Töpf, A Vihola, A Evilä, R Barresi, J Hudson, P Hackman, ...</div><div class="gs_gray">Neuromuscular Disorders 27 (11), 1009-1017<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18388545903720072796" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4hFrxpcac9AC" class="gsc_a_at">A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy</a><div class="gs_gray">PYK Van den Bergh, Y Sznajer, V Van Parys, W van Tol, RA Wevers, ...</div><div class="gs_gray">Neuromuscular Disorders 27 (11), 1043-1046<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9550033122825319048,8681086970181568288" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:p2g8aNsByqUC" class="gsc_a_at">The role of muscle imaging in the diagnosis and assessment of children with genetic muscle disease</a><div class="gs_gray">JW Chardon, V Straub</div><div class="gs_gray">Neuropediatrics 48 (04), 233-241<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3707289148813449693" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">216th ENMC international workshop: clinical readiness in FKRP related myopathies January 15–17, 2016 Naarden, The Netherlands</a><div class="gs_gray">I Richard, JP Laurent, S Cirak, J Vissing, S Brown, K Campbell, E Gicquel, ...</div><div class="gs_gray">Neuromuscular Disorders 26 (10), 717-724<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3581504421786266281" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Xl6nMSl579sC" class="gsc_a_at">Cardiac involvement in hereditary myopathy with early respiratory failure: a cohort study</a><div class="gs_gray">HE Steele, E Harris, R Barresi, J Marsh, A Beattie, JP Bourke, V Straub, ...</div><div class="gs_gray">Neurology 87 (10), 1031-1035<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15743377879357473636" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ZysSsiWj_g4C" class="gsc_a_at">Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)</a><div class="gs_gray">R Willmann, J Lee, C Turner, K Nagaraju, A Aartsma-Rus, DJ Wells, ...</div><div class="gs_gray">Disease models &amp; mechanisms 13 (2), dmm042903<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13084596603705613604" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BPS1z4jHU5cC" class="gsc_a_at">Recurrent <i>TTN</i> metatranscript‐only c.39974–11T&gt;G splice variant associated with autosomal recessive arthrogryposis multiplex congenita and myopathy</a><div class="gs_gray">SJ Bryen, LJ Ewans, J Pinner, SC MacLennan, S Donkervoort, D Castro, ...</div><div class="gs_gray">Human mutation 41 (2), 403-411<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7299312929142931806" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nU66GSXDKhoC" class="gsc_a_at">Improved criteria for the classification of titin variants in inherited skeletal myopathies</a><div class="gs_gray">M Savarese, M Johari, K Johnson, M Arumilli, A Torella, A Töpf, ...</div><div class="gs_gray">Journal of neuromuscular diseases 7 (2), 153-166<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16457641674120758367" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:7H_MAutzIkAC" class="gsc_a_at">Mobility shift of beta-dystroglycan as a marker of GMPPB gene-related muscular dystrophy</a><div class="gs_gray">A Sarkozy, S Torelli, R Mein, M Henderson, R Phadke, L Feng, C Sewry, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 89 (7), 762-768<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12827763129578167634" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NhqRSupF_l8C" class="gsc_a_at">The effects of ageing on mouse muscle microstructure: a comparative study of time‐dependent diffusion MRI and histological assessment</a><div class="gs_gray">P Porcari, MG Hall, CA Clark, E Greally, V Straub, AM Blamire</div><div class="gs_gray">NMR in Biomedicine 31 (3), e3881<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3461630728954170151" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Serum peptide profiles of Duchenne Muscular Dystrophy (DMD) patients evaluated by data handling strategies for high resolution content</a><div class="gs_gray">VD Nadarajah, BJA Mertens, H Dalebout, M Bladergroen, S Alagaratnam, ...</div><div class="gs_gray">J Proteomics Bioinf 5, 96-103<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10580529517260315427" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hvmnpdAuIbkC" class="gsc_a_at">Congenital muscular dystrophy with short stature, proximal contractures and distal laxity</a><div class="gs_gray">E Mercuri, A Lampe, V Straub, Y Yuva, C Longman, M Wright, S Brown, ...</div><div class="gs_gray">Neuropediatrics 35 (04), 224-229<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17825929960104290769" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:60iIaj97TE0C" class="gsc_a_at">Noninvasive quantification of fibrosis in skeletal and cardiac muscle in <i>mdx</i> mice using EP3533 enhanced magnetic resonance imaging</a><div class="gs_gray">AP Murphy, E Greally, D O’Hogain, A Blamire, P Caravan, V Straub</div><div class="gs_gray">Magnetic resonance in medicine 81 (4), 2728-2735<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=244186161885131913" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:v_tt_AnqfNMC" class="gsc_a_at">Assessment of disease progression in dysferlinopathy: A 1-year cohort study</a><div class="gs_gray">U Moore, M Jacobs, MK James, AG Mayhew, R Fernandez-Torron, J Feng, ...</div><div class="gs_gray">Neurology 92 (5), e461-e474<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11410302261956257732" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:naSTrk-c4S8C" class="gsc_a_at">226th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20–22 January 2017, Heemskerk, The&nbsp;…</a><div class="gs_gray">A Aartsma-Rus, A Ferlini, EM McNally, P Spitali, HL Sweeney, ...</div><div class="gs_gray">Neuromuscular Disorders 28 (1), 77-86<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12558427808219019665" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">The impact of integrated omics technologies for patients with rare diseases</a><div class="gs_gray">L Johnston, R Thompson, C Turner, K Bushby, H Lochmüller, V Straub</div><div class="gs_gray">Expert Opinion on Orphan Drugs 2 (11), 1211-1219<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5202168303887212762" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">One gene, one or many diseases?: Simplifying dysferlinopathy</a><div class="gs_gray">K Bushby, V Straub</div><div class="gs_gray">Neurology 75 (4), 298-299<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3402832695835345326" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4vMrXwiscB8C" class="gsc_a_at">GP 1.08 Steroids in Duchenne muscular dystrophy (DMD): Natural history and clinical evaluation using the North Star Ambulatory Assessment (NSAA)</a><div class="gs_gray">M Eagle, E Scott, M Main, J Sheehan, M Michelle, M Guglieri, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 774<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10106335663228161681" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Airway nitric oxide in Duchenne muscular dystrophy</a><div class="gs_gray">V Straub, F Ratjen, H Amthor, T Voit, H Grasemann</div><div class="gs_gray">The Journal of pediatrics 141 (1), 132-134<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6819156677907834155" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:vjZqxyZ7hS4C" class="gsc_a_at"><i>GGPS1</i> Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome</a><div class="gs_gray">AR Foley, Y Zou, JE Dunford, J Rooney, G Chandra, H Xiong, V Straub, ...</div><div class="gs_gray">Annals of neurology 88 (2), 332-347<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4162890908012944914" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:2Q0AJrNhS-QC" class="gsc_a_at">High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia</a><div class="gs_gray">Z White, CH Hakim, M Theret, NN Yang, F Rossi, D Cox, GA Francis, ...</div><div class="gs_gray">Journal of Clinical Lipidology 14 (4), 459-469. e0<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=739501515215457500" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:J4E9jCG1tHUC" class="gsc_a_at">Clinical findings of 21 previously unreported probands with <i>HNRNPU</i>‐related syndrome and comprehensive literature review</a><div class="gs_gray">A Durkin, S Albaba, AE Fry, JE Morton, A Douglas, A Beleza, D Williams, ...</div><div class="gs_gray">American Journal of Medical Genetics Part A 182 (7), 1637-1654<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7753988331577190409" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:65Yg0jNCQDAC" class="gsc_a_at">Psychometric properties of the Zarit Caregiver Burden Interview administered to caregivers to patients with Duchenne muscular dystrophy: a Rasch analysis</a><div class="gs_gray">E Landfeldt, A Mayhew, V Straub, K Bushby, H Lochmüller, P Lindgren</div><div class="gs_gray">Disability and rehabilitation 41 (8), 966-973<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2268473595869875662" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Psychometric analysis of the pediatric quality of life inventory 3.0 neuromuscular module administered to patients with duchenne muscular dystrophy: A rasch analysis</a><div class="gs_gray">E Landfeldt, A Mayhew, V Straub, H Lochmüller, K Bushby, P Lindgren</div><div class="gs_gray">Muscle &amp; nerve 58 (3), 367-373<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=780559667141049081" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:c59VksA5Vz4C" class="gsc_a_at">The 220th ENMC workshop: Dystroglycan and the Dystroglycanopathies held on the 27-29 May 2016, Naarden, The Netherlands</a><div class="gs_gray">SC Brown, SJ Winder, ENMC DGpathy Study Group</div><div class="gs_gray">Neuromuscular Disorders 27 (4), 387-395<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8744957092276866466" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">Undiagnosed genetic muscle disease in the north of England: an in depth phenotype analysis</a><div class="gs_gray">E Harris, S Laval, J Hudson, R Barresi, L De Waele, V Straub, ...</div><div class="gs_gray">PLoS currents 5<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12464518987576531955" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">TO 3 Restoration of dystrophin expression in Duchenne muscular dystrophy: A single blind, placebo-controlled dose escalation study using morpholino oligomer AVI-4658</a><div class="gs_gray">M Kinali, V Arechavala-Gomeza, L Feng, S Cirak, D Hunt, C Adkin, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 659<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4302365399988983813" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:j7XjBeKFbTsC" class="gsc_a_at">The clinical, histologic, and genotypic spectrum of sepn1-related myopathy: A case series</a><div class="gs_gray">RN Villar-Quiles, M von Der Hagen, C Métay, V Gonzalez, S Donkervoort, ...</div><div class="gs_gray">Neurology 95 (11), e1512-e1527<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10290047335642984923" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Gpwnp1kGG20C" class="gsc_a_at">ANO5 mutations in the Polish limb girdle muscular dystrophy patients: effects on the protein structure</a><div class="gs_gray">A Jarmula, A Łusakowska, JP Fichna, M Topolewska, A Macias, ...</div><div class="gs_gray">Scientific reports 9 (1), 1-17<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14422486393575596228" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RMgMIBzvq-4C" class="gsc_a_at">BAG3 myopathy is not always associated with cardiomyopathy</a><div class="gs_gray">AG Andersen, F Fornander, HD Schrøder, T Krag, V Straub, M Duno, ...</div><div class="gs_gray">Neuromuscular Disorders 28 (9), 798-801<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7175415495729686335" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:N4u4nq0IxgcC" class="gsc_a_at">A novel compound heterozygous mutation in the POMK gene causing limb-girdle muscular dystrophy-dystroglycanopathy in a sib pair</a><div class="gs_gray">S Strang-Karlsson, K Johnson, A Töpf, L Xu, M Lek, DG MacArthur, ...</div><div class="gs_gray">Neuromuscular Disorders 28 (7), 614-618<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2956847712867309468" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:KUbvn5osdkgC" class="gsc_a_at">MEGF10 related myopathies: A new case with adult onset disease with prominent respiratory failure and review of reported phenotypes</a><div class="gs_gray">E Harris, C Marini-Bettolo, A Töpf, R Barresi, T Polvikoski, G Bailey, ...</div><div class="gs_gray">Neuromuscular Disorders 28 (1), 48-53<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7566546703283846390" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Muscle hypertrophy as the presenting sign in a patient with a complete <i>FHL1</i> deletion</a><div class="gs_gray">TA Willis, CL Wood, J Hudson, T Polvikoski, R Barresi, H Lochmüller, ...</div><div class="gs_gray">Clinical genetics 90 (2), 166-170<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=136556778827996762" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SPgmg5JLkoEC" class="gsc_a_at">The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy</a><div class="gs_gray">D Scaglioni, F Catapano, M Ellis, S Torelli, D Chambers, L Feng, M Beck, ...</div><div class="gs_gray">Acta Neuropathologica Communications 9 (1), 1-17<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16842010107344993880" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:bCjgOgSFrM0C" class="gsc_a_at">Improved diagnosis of rare disease patients through systematic detection of runs of homozygosity</a><div class="gs_gray">L Matalonga, S Laurie, A Papakonstantinou, D Piscia, E Mereu, G Bullich, ...</div><div class="gs_gray">The Journal of Molecular Diagnostics 22 (9), 1205-1215<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12385971264581748891" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:9LpHyFPp1DQC" class="gsc_a_at">Fat oxidation is impaired during exercise in lipin-1 deficiency</a><div class="gs_gray">D Raaschou-Pedersen, KL Madsen, MG Stemmerik, ASV Eisum, V Straub, ...</div><div class="gs_gray">Neurology 93 (15), e1433-e1438<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10024074312115258069" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:9DLIHnF0jcYC" class="gsc_a_at">Golodirsen induces exon skipping leading to sarcolemmal dystrophin expression in patients with genetic mutations amenable to exon 53 skipping</a><div class="gs_gray">F Muntoni, DE Frank, J Morgan, J Domingos, FJ Schnell, G Dickson, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S5<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15596342113108036033" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8k81kl-MbHgC" class="gsc_a_at">The MYO-SEQ project: Application of exome sequencing technologies of 1000 patients affected by limb-girdle weakness of unknown origin</a><div class="gs_gray">K Johnson, A Töpf, M Bertoli, L Phillips, A Blain, M Ensini, M Lek, L Xu, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S194<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=669778820756962641,8582486954040727577" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:G1UMdFYMoxkC" class="gsc_a_at">Bisphosphonate use in Duchenne Muscular Dystrophy–why, when to start and when to stop?</a><div class="gs_gray">CL Wood, C Marini Bettolo, K Bushby, V Straub, D Rawlings, A Sarkozy, ...</div><div class="gs_gray">Expert Opinion on Orphan Drugs 4 (4), 407-416<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17833116476195118090" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:TQgYirikUcIC" class="gsc_a_at">Impact of three decades of improvement in standards of care for Duchenne muscular dystrophy</a><div class="gs_gray">C Jimenez, M Eagle, A Mayhew, M James, V Straub, K Bushby</div><div class="gs_gray">Neuromuscular Disorders 25, S201-S202<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1815445094732432778" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:__bU50VfleQC" class="gsc_a_at">Psycho-organic symptoms as early manifestation of adult onset POMT1-related limb girdle muscular dystrophy</a><div class="gs_gray">J Haberlova, Z Mitrović, K Žarković, D Lovrić, V Barić, L Berlengi, K Bilić, ...</div><div class="gs_gray">Neuromuscular Disorders 24 (11), 990-992<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17275208528083431910" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SGW5VrABaM0C" class="gsc_a_at">Early cardiomyopathy in DMD</a><div class="gs_gray">GL Vita, R Kirk, H Lochmüller, K Bushby, V Straub</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 19 (8-9), 642-642<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15267691489856740456" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:jq04SsiGh3QC" class="gsc_a_at">Pathogenic variants in the myosin chaperone UNC-45B cause progressive myopathy with eccentric cores</a><div class="gs_gray">S Donkervoort, CE Kutzner, Y Hu, X Lornage, J Rendu, T Stojkovic, ...</div><div class="gs_gray">The American Journal of Human Genetics 107 (6), 1078-1095<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1303152472942672684" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:E8ajGqO0XoUC" class="gsc_a_at">First clinical and myopathological description of a myofibrillar myopathy with congenital onset and homozygous mutation in <i>FLNC</i></a><div class="gs_gray">H Kölbel, A Roos, PFM van Der Ven, T Evangelista, K Nolte, K Johnson, ...</div><div class="gs_gray">Human Mutation 41 (9), 1600-1614<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11818594216060906964" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5rMqqAh47xYC" class="gsc_a_at">Global FKRP Registry: observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9</a><div class="gs_gray">LB Murphy, O Schreiber‐Katz, K Rafferty, A Robertson, A Topf, TA Willis, ...</div><div class="gs_gray">Annals of clinical and translational neurology 7 (5), 757-766<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1593721652737125662" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:GtqhT-R7ZnwC" class="gsc_a_at">Cognitive impairment appears progressive in the mdx mouse</a><div class="gs_gray">E Bagdatlioglu, P Porcari, E Greally, AM Blamire, VW Straub</div><div class="gs_gray">Neuromuscular Disorders 30 (5), 368-388<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5066337321504571042" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Cvh0bltMcLgC" class="gsc_a_at">Time‐dependent diffusion MRI as a probe of microstructural changes in a mouse model of Duchenne muscular dystrophy</a><div class="gs_gray">P Porcari, MG Hall, CA Clark, E Greally, V Straub, AM Blamire</div><div class="gs_gray">NMR in Biomedicine 33 (5), e4276<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8195989509422294775" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:It0W0vAlS5QC" class="gsc_a_at">Multisystem proteinopathy due to a homozygous p. Arg159His VCP mutation: a tale of the unexpected</a><div class="gs_gray">W De Ridder, A Azmi, CS Clemen, L Eichinger, A Hofmann, R Schröder, ...</div><div class="gs_gray">Neurology 94 (8), e785-e796<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10497919955377820866" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yZoBfgUKqwcC" class="gsc_a_at">A comparison of the bone and growth phenotype of mdx, mdx: Cmah−/− and mdx: Utrn+/− murine models with the C57BL/10 wild-type mouse</a><div class="gs_gray">CL Wood, KJ Suchacki, R van’t Hof, WP Cawthorn, S Dillon, V Straub, ...</div><div class="gs_gray">Disease models &amp; mechanisms 13 (2)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4043446338312602154" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:rpSJNIKeXWsC" class="gsc_a_at">Normalized grip strength is a sensitive outcome measure through all stages of Duchenne muscular dystrophy</a><div class="gs_gray">JY Hogrel, V Decostre, I Ledoux, M de Antonio, E Niks, I de Groot, ...</div><div class="gs_gray">Journal of neurology 267 (7), 2022-2028<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12123790785105367635" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:S2WlVNSe3u4C" class="gsc_a_at">O. 28Safety and tolerability of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy: results from a phase 1 clinical trial</a><div class="gs_gray">K Wagner, H Phan, L Servais, T Gidaro, L Cripe, M Eagle, F Muntoni, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S124<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1097358542463833077" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:K4-iKlO5MD4C" class="gsc_a_at">Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein</a><div class="gs_gray">MP Milev, D Stanga, A Schaenzer, A Nascimento, D Saint-Dic, C Ortez, ...</div><div class="gs_gray">Scientific reports 9 (1), 1-15<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10352865029466135053" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:EaFouW7jFu4C" class="gsc_a_at">Extending the clinical and mutational spectrum of TRIM32-related myopathies in a non-Hutterite population</a><div class="gs_gray">K Johnson, W De Ridder, A Töpf, M Bertoli, L Phillips, P De Jonghe, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 90 (4), 490-493<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14003956489594575329" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IvSMUa3B7yYC" class="gsc_a_at">227th ENMC International Workshop:: Finalizing a plan to guarantee quality in translational research for neuromuscular diseases Heemskerk, Netherlands, 10–11 February 2017</a><div class="gs_gray">R Willmann, F Buccella, A De Luca, MD Grounds, J Versnel, E Vroom, ...</div><div class="gs_gray">Neuromuscular Disorders 28 (2), 185-192<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4385556342126142999" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:VLnqNzywnoUC" class="gsc_a_at">Exon skipping quantification by qRT-PCR in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen</a><div class="gs_gray">K Anthony, L Feng, V Arechavala-Gomeza, M Guglieri, V Straub, ...</div><div class="gs_gray">Human Gene Ther Methods 23, 336-345<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6248533877069674755" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BmWJbWwHJAwC" class="gsc_a_at">Emotional impact of a paediatric exon-skipping therapy trial</a><div class="gs_gray">ME Garralda, M Kinali, S Cirak, K Bushby, M Guglieri, V Straub, F Muntoni</div><div class="gs_gray">Developmental medicine and child neurology 53 (12), 1157<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18061527027312953631" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:tYavs44e6CUC" class="gsc_a_at">Muscle fat infiltration in limb girdle muscular dystrophy 2I: a comparison of qualitative T1w and quantitative Dixon imaging</a><div class="gs_gray">K Hollingsworth, T Willis, A Coombs, A Mayhew, M Eagle, A Blamire, ...</div><div class="gs_gray">Proc Int Soc Magn Reson Med 18, 853<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7583298359208927598" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ukw-9cB-YDkC" class="gsc_a_at">On the pathogenesis of collagen VI muscular dystrophies—Comment on article of Hicks <i>et al</i>.</a><div class="gs_gray">P Bernardi, P Bonaldo, NM Maraldi, L Merlini, P Sabatelli</div><div class="gs_gray">Brain 132 (10), e121-e121<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11662760747213575780" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Wq2b2clWBLsC" class="gsc_a_at">Progression of fat infiltration in calf, thigh and pelvic muscles in Duchenne Muscular Dystrophy: quantification by MRI over an 18 month period</a><div class="gs_gray">KG Hollingsworth, P Garrod, BS Aribisala, D Birchall, M Eagle, K Bushby</div><div class="gs_gray">Proc Intl Soc Mag Reson Med 17, 1916<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1394449088050579044" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HIFyuExEbWQC" class="gsc_a_at">Identification of a novel member of the sarcoglycan complex, zeta-sarcoglycan</a><div class="gs_gray">C Kutzick, R Herrmann, B Neumann, V Straub, M Zaik, T Voit</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 11 (6-7), 650-650<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10072666861772691052" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:X0DADzN9RKwC" class="gsc_a_at">Gene replacement therapy for muscular dystrophy</a><div class="gs_gray">KP Campbell, KH Holt, F Duclos, LE Lim, V Straub, B Davidson, ...</div><div class="gs_gray">US Patent 6,262,035<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18246149318009001258" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:UKB2i6g6GNMC" class="gsc_a_at">Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis</a><div class="gs_gray">P Mohassel, S Donkervoort, MA Lone, M Nalls, K Gable, SD Gupta, ...</div><div class="gs_gray">Nature Medicine, 1-8<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3229526387998949671" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cdwqcPQS8ssC" class="gsc_a_at">Expanding the disease phenotype of ADSSL1-associated myopathy in non-Korean patients</a><div class="gs_gray">M Mroczek, H Durmus, S Bijarnia-Mahay, A Töpf, R Ghaoui, S Bryen, ...</div><div class="gs_gray">Neuromuscular Disorders 30 (4), 310-314<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1977566676541943570" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hEXC_dOfxuUC" class="gsc_a_at">Patient and parent oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in SMA</a><div class="gs_gray">E Mercuri, S Messina, J Montes, F Muntoni, V Sansone</div><div class="gs_gray">Elsevier 30 (5), 431-436<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3228258748413348696" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qCpRzq7zkD8C" class="gsc_a_at">Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy</a><div class="gs_gray">CL Wood, TD Cheetham, KG Hollingsworth, M Guglieri, Y Ailins-Sahun, ...</div><div class="gs_gray">BMC pediatrics 19 (1), 1-12<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4443697567386961418" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:M_lZXyI38BkC" class="gsc_a_at">236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The&nbsp;…</a><div class="gs_gray">SC Wong, V Straub, LM Ward, R Quinlivan, J Adachi, SF Ahmed, ...</div><div class="gs_gray">Neuromuscular Disorders 29 (3), 251-259<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6848465351651723991" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant patients: implications for clinical trials</a><div class="gs_gray">J Domingos, M Eagle, A Moraux, J Butler, V Decostre, D Ridout, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S232-S233<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11252163096380594133" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:c1e4I3QdEKYC" class="gsc_a_at">Multidisciplinary clinics</a><div class="gs_gray">L Villard, E Nordmark-Andersson, B Crowley, V Straub, M Bertoli</div><div class="gs_gray">Journal of Pediatric Orthopaedics 37, S29-S30<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17281259536822099818" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">Assessment of ventricular function in mouse models of muscular dystrophy: A comparison of MRI with conductance catheter</a><div class="gs_gray">AM Blain, E Greally, SH Laval, AM Blamire, GA MacGowan, VW Straub</div><div class="gs_gray">Neuromuscular Disorders 25 (1), 24-31<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15288759705083282240" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">GP 97: prophylactic oral bisphosphonate therapy in Duchenne muscular dystrophy: the Newcastle upon Tyne experience</a><div class="gs_gray">A Sarkozy, R Srinivasan, D Rawlings, M Guglieri, C Owen, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 824<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13563293446153799409" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RJOyoaXV5v8C" class="gsc_a_at">Detection rate of Pompe disease in undiagnosed neuromuscular patients from four major centres in the UK-results of a 12 month prospective audit</a><div class="gs_gray">T Willis, M Roberts, D Hilton-Jones, R Quinlivan, M Hanna, V Straub</div><div class="gs_gray">BMC Musculoskeletal Disorders 14 (2), 1-1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16663005954920361170" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Bethlem myopathy, autosomal dominant and X-linked Emery Dreifuss muscular dystrophy-comparison of contractural phenotypes</a><div class="gs_gray">AK Lampe, JE Hoogendijk, M Eagle, MRH Buddles, L Demay, P Richard, ...</div><div class="gs_gray">Neuromuscular Disorders: 10th International Congress of the World Muscle Society<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11077454238126007880" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:43bX7VzcjpAC" class="gsc_a_at">Dystrophin and nNOS double knockout mice maintain dystrophic phenotype</a><div class="gs_gray">RH Crosbie, V Straub, DP Vnzke, HY Yun, JS Chamberlain, VL Dawson, ...</div><div class="gs_gray">FASEB Journal 11 (9), A1417<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12091296818205668159" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:gkldIfsazJcC" class="gsc_a_at">Assessing dysferlinopathy patients over three years with a new motor scale</a><div class="gs_gray">MB Jacobs, MK James, LP Lowes, LN Alfano, M Eagle, R Muni Lofra, ...</div><div class="gs_gray">Annals of neurology 89 (5), 967-978<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=683296035296460320" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:oFn-K-OQSCAC" class="gsc_a_at">Skeletal muscle magnetic resonance imaging in Pompe disease</a><div class="gs_gray">J Díaz‐Manera, G Walter, V Straub</div><div class="gs_gray">Muscle &amp; Nerve 63 (5), 640-650<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7458157716151792901" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:o9ULDYDKYbIC" class="gsc_a_at">The clinical-phenotype continuum in DYNC1H1-related disorders—genomic profiling and proposal for a novel classification</a><div class="gs_gray">LL Becker, HS Dafsari, J Schallner, D Abdin, M Seifert, F Petit, T Smol, ...</div><div class="gs_gray">Journal of human genetics 65 (11), 1003-1017<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=517951201368427235" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_IsBomjs8bsC" class="gsc_a_at">Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in Duchenne muscular dystrophy</a><div class="gs_gray">C Passarelli, R Selvatici, A Carrieri, FR Di Raimo, MS Falzarano, ...</div><div class="gs_gray">Frontiers in genetics 11, 605<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15129514917364638374" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8gBurD7jEYQC" class="gsc_a_at">Four Individuals with a Homozygous Mutation in Exon 1f of the PLEC Gene and Associated Myasthenic Features</a><div class="gs_gray">M Mroczek, H Durmus, A Töpf, Y Parman, V Straub</div><div class="gs_gray">Genes 11 (7), 716<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1616513384931403935" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DGzKIA18-3YC" class="gsc_a_at">Collagen VI-related limb-girdle syndrome caused by frequent mutation in COL6A3 gene with conflicting reports of pathogenicity</a><div class="gs_gray">J Stavusis, I Micule, NT Wright, V Straub, A Topf, L Panadés-de Oliveira, ...</div><div class="gs_gray">Neuromuscular Disorders 30 (6), 483-491<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7532706342514290925" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:u_mOZUIutIEC" class="gsc_a_at">Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms</a><div class="gs_gray">CRS Banerji, P Cammish, T Evangelista, PS Zammit, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 30 (4), 315-328<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5550771231258092037" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IHkkN1K1AlAC" class="gsc_a_at">A decade of optimizing drug development for rare neuromuscular disorders through TACT</a><div class="gs_gray">KR Wagner, A De Luca, D Caizergues, J Dowling, N Goemans, ...</div><div class="gs_gray">Nature Reviews Drug Discovery 19 (1), 1-2<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15854087811169505819" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hKjooKYXoHIC" class="gsc_a_at">Functional characterization of GYG1 variants in two patients with myopathy and glycogenin-1 deficiency</a><div class="gs_gray">C Hedberg-Oldfors, W De Ridder, O Kalev, K Böck, K Visuttijai, ...</div><div class="gs_gray">Neuromuscular Disorders 29 (12), 951-960<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12015688499760921442" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3MwzVuqRcA0C" class="gsc_a_at">A simple and rapid immunoassay predicts dysferlinopathies in peripheral blood film</a><div class="gs_gray">D Cox, M Henderson, V Straub, R Barresi</div><div class="gs_gray">Neuromuscular Disorders 29 (11), 874-880<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2821544928181151939" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:M0j1y4EgrScC" class="gsc_a_at">P. 301Myo-Guide: A new artificial intelligence MRI-based tool to aid diagnosis of patients with muscular dystrophies</a><div class="gs_gray">J Verdú-díaz, J Alonso-Pérez, C Nuñez-Peralta, G Tasca, J Vissing, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S155<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11301260623960449759" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:0sTkTiv_uMkC" class="gsc_a_at">Golodirsen induces exon skipping leading to sarcolemmal dystrophin expression in patients with genetic mutations amenable to exon 53 skipping</a><div class="gs_gray">D Frank, F Mercuri, L Servais, V Straub, J Morgan, J Domingos, F Schnell, ...</div><div class="gs_gray">ANNALS OF NEUROLOGY 84, S390-S391<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10808207495821217369" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3_LpOwP6eMYC" class="gsc_a_at">Bones and muscular dystrophies: what do we know?</a><div class="gs_gray">CL Wood, V Straub</div><div class="gs_gray">Current opinion in neurology 31 (5), 583-591<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15340764015846441594" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cF7EPgIk0B4C" class="gsc_a_at">SRP-4053 induces exon skipping leading to sarcolemmal dystrophin expression in Duchenne muscular dystrophy patients amenable to exon 53 skipping</a><div class="gs_gray">F Muntoni, D Frank, V Sardone, J Morgan, F Schnell, J Charleston, ...</div><div class="gs_gray">Poster presented at: 22nd International Annual Congress of the World Muscle&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17060671084944890464" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:L_l9e5I586QC" class="gsc_a_at">North Star Assessment for dysferlinopathy: Longitudinal performance in the clinical outcome study of dysferlinopathy</a><div class="gs_gray">M James, A Mayhew, M Eagle, RM Lofra, E Maron, R Gee, M Harman, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S145<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16988696923993163187" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-7ulzOJl1JYC" class="gsc_a_at">Ultrasensitive hybridization-based ELISA method for the determination of phosphorodiamidate morpholino oligonucleotides in biological samples</a><div class="gs_gray">U Burki, V Straub</div><div class="gs_gray">Morpholino Oligomers, 265-277<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13915454052536157488" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Phase 1 exploratory efficacy of the novel enzyme replacement therapy neoGAA in treatment-naive and alglucosidase alfa-treated late-onset Pompe disease patients</a><div class="gs_gray">L Pena, R Barohn, B Byrne, C Desnuelle, O Goker-Alpan, S Ladha, ...</div><div class="gs_gray">Neurology 86<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9967921993582107474" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MAUkC_7iAq8C" class="gsc_a_at">Standards of care in neuromuscular fields</a><div class="gs_gray">V Straub</div><div class="gs_gray">BMC Musculoskeletal Disorders 14 (2), 1-1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13991778066057998720" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:wE-fMHVdjMkC" class="gsc_a_at">Congenital Muscular Dystrophies</a><div class="gs_gray">S Quijano-Roy, D Avila-Smirnow, RY Carlier, TA Willis, V Straub</div><div class="gs_gray">Neuromuscular Imaging, 177-198<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16583268495001529464" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">O12 Assessing muscle pathology by MRI in LGMD2I</a><div class="gs_gray">T Willis, KG Hollingsworth, ML Sveen, JM Morrow, CDJ Sinclair, ...</div><div class="gs_gray">Neuromuscular Disorders, S4-S5<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11828744618689662671,2286873353884054078" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:L1USKYWJimsC" class="gsc_a_at">GP 1.04 An autosomal-recessive form of centronuclear myopathy is caused by mutations in the skeletal muscle ryanodine receptor (RYR1) gene</a><div class="gs_gray">J Wilmshurst, S Lillis, H Zhou, W Kress, R Solomon, A Ndondo, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 557<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12973888838058585676" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:anf4URPfarAC" class="gsc_a_at">GP 12.10 Delayed development and learning difficulties as a predominant symptom in female carriers of Duchenne and Becker muscular dystrophy</a><div class="gs_gray">M Guglieri, A Aboumousa, M Eagle, J Bourke, V Straub, K Bushby</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 806<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9239373875299029305" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:raTqNPD5sRQC" class="gsc_a_at">Differential Diagnosis and Potential Misdiagnoses of Pompe Disease</a><div class="gs_gray">V Straub</div><div class="gs_gray">Clinical Therapeutics, S6-S7<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14935227167141626325" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Morbus Pompe: Grundlagen, Diagnose und Therapie</a><div class="gs_gray">M Baethmann, V Straub</div><div class="gs_gray">UNI-MED-Verlag<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1326892063206088307" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Muscle-Eye-Brain-Like disease with abnormal expression of alpha-dystroglycan not caused by mutations in POMGnT1 gene</a><div class="gs_gray">A Steinbrecher, R Herrmann, V Straub, U Grieben, J Sperner, U Eckel, ...</div><div class="gs_gray">JOURNAL OF THE NEUROLOGICAL SCIENCES 199, S105-S105<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7605015368448930536" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Ic1VZgkJnDsC" class="gsc_a_at">Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease</a><div class="gs_gray">L Klinge, V Straub, U Neudorf, K Goerlinger, T Voit</div><div class="gs_gray">EUROPEAN JOURNAL OF HUMAN GENETICS 10, 301-301<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18399423716140387216" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:M05iB0D1s5AC" class="gsc_a_at">δ-sarcoglycan nucleic acid sequences</a><div class="gs_gray">KP Campbell, D Jung, F Duclos, V Straub, J McPherson</div><div class="gs_gray">US Patent 5,837,537<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2890418556715579063" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:mgoTDWlsYNUC" class="gsc_a_at">Elevation of fast but not slow troponin I in the circulation of patients with Becker and Duchenne muscular dystrophy</a><div class="gs_gray">BL Barthel, D Cox, M Barbieri, M Ziemba, V Straub, EP Hoffman, ...</div><div class="gs_gray">Muscle &amp; Nerve 64 (1), 43-49<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11601043094260883999" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:f2PrUAIjnKUC" class="gsc_a_at">Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy‐related cardiomyopathy</a><div class="gs_gray">AP Murphy, A Johnson, V Straub, A Heads‐Baister, S Lord, JP Bourke</div><div class="gs_gray">Muscle &amp; Nerve<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15109046662105955112" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qSd0DAb9jMoC" class="gsc_a_at">Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients</a><div class="gs_gray">P Kishnani, S Attarian, J Borges, F Bouhourd, YH Chien, YC Choi, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6817084760748709111" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5F1dSjz1ScoC" class="gsc_a_at">Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead</a><div class="gs_gray">E Heslop, C Turner, A Irvin, F Muntoni, V Straub, M Guglieri</div><div class="gs_gray">Neuromuscular Disorders 31 (1), 69<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11037777506491749473" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:6Zm5LS9gQ5UC" class="gsc_a_at">Three individuals with PURA syndrome in a cohort of patients with neuromuscular disease</a><div class="gs_gray">M Mroczek, D Zafeiriou, J Gurgel-Gianetti, BVM de Azevedo, A Roos, ...</div><div class="gs_gray">Neuropediatrics<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8310348845591619506" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IyxfXMz2bNAC" class="gsc_a_at">Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging</a><div class="gs_gray">G Giacomucci, M Monforte, J Diaz‐Manera, K Mul, R Fernandez Torrón, ...</div><div class="gs_gray">European Journal of Neurology 27 (12), 2604-2615<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3065573928089901275" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:TiIbgCYny7sC" class="gsc_a_at">247th ENMC International Workshop: Muscle magnetic resonance imaging-Implementing muscle MRI as a diagnostic tool for rare genetic myopathy cohorts. Hoofddorp, The Netherlands&nbsp;…</a><div class="gs_gray">J Warman-Chardon, J Diaz-Manera, G Tasca, V Straub</div><div class="gs_gray">Neuromuscular Disorders 30 (11), 938-947<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7201026644829252900" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5VjbC5aozO0C" class="gsc_a_at">Adult‐onset very‐long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD)</a><div class="gs_gray">F Fatehi, AA Okhovat, Y Nilipour, M Mroczek, V Straub, A Töpf, A Palibrk, ...</div><div class="gs_gray">European Journal of Neurology 27 (11), 2257-2266<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14627993861789710965" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:jRIwE-1ttnoC" class="gsc_a_at">SMA–THERAPY: P. 258 Onasemnogene aveparvovec gene therapy for spinal muscular atrophy type 1 (SMA1): Phase 3 study update (STR1VE-EU)</a><div class="gs_gray">E Mercuri, G Baranello, R Masson, O Boespflug-Tanguy, C Bruno, S Corti, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S121<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9478959101401263541" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cOfwuRB03ygC" class="gsc_a_at">NEW GENES IN NEUROMUSCULAR DISEASES: O. 04 Heterozygous frameshift variants in hnRNPA2B1 cause a novel oculopharyngodistal muscular dystrophy</a><div class="gs_gray">P Mohassel, S Donkervoort, H Kim, A Foley, X Lornage, N Foulds, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S47<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5372871207395826600" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:h1pkognVyKwC" class="gsc_a_at">249th ENMC International Workshop: The role of brain dystrophin in muscular dystrophy: Implications for clinical care and translational research, Hoofddorp, The Netherlands&nbsp;…</a><div class="gs_gray">JGM Hendriksen, M Thangarajh, HE Kan, F Muntoni, Y Aoki, P Collin, ...</div><div class="gs_gray">Neuromuscular Disorders 30 (9), 782-794<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11317017224664704189" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:CRzUtm-VnGAC" class="gsc_a_at">GOLODIRSEN TREATMENT INDUCES DYSTROPHIN EXPRESSION AND IS WELL-TOLERATED IN ELIGIBLE PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY</a><div class="gs_gray">DE Frank, E Mercuri, L Servais, V Straub, J Morgan, F Schnell, G Dickson, ...</div><div class="gs_gray">MUSCLE &amp; NERVE 60, S7-S7<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=355909942618728603" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:htyGaKyDgHMC" class="gsc_a_at">Design of a Phase 2/3 randomized controlled trial of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy amenable to exon 51 skipping</a><div class="gs_gray">K Wagner, L Cripe, M Eagle, F Muntoni, E Niks, H Phan, V Straub, X Hu, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 29, S176-S177<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8159180255807785574" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:i91s68tWr-MC" class="gsc_a_at">P. 183Functional progression in dysferlinopathy: results of a 3-year natural history study</a><div class="gs_gray">M Jacobs, M James, A Mayhew, H Hilsden, H Sutherland, S Spuler, J Day, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S102<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14413760320136140670" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NtGNdKbuCngC" class="gsc_a_at">P. 188The clinical outcome study for dysferlinopathy: pregnancy in dysferlinopathy</a><div class="gs_gray">U Moore, M James, M Jacobs, A Mayhew, S Spuler, J Day, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S104<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6692759502528682417" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:G36d5HCDkJYC" class="gsc_a_at">Golodirsen Leads to Sarcolemmal Dystrophin Expression in Patients With Genetic Mutations Amenable to Exon 53 Skipping</a><div class="gs_gray">DE Frank, F Muntoni, J Morgan, J Domingos, F Schnell, JG Dickson, ...</div><div class="gs_gray">Pediatrics 144 (2 MeetingAbstract), 241-241<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5365431826120323670" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:17ZO-CJnx_8C" class="gsc_a_at">A multistage sequencing strategy pinpoints many novel and candidate disease alleles for orphan disease Emery-Dreifuss Muscular Dystrophy and supports gene misregulation as its&nbsp;…</a><div class="gs_gray">P Meinke, ARW Kerr, R Czapiewski, I Jose, E Harris, H Kölbel, F Muntoni, ...</div><div class="gs_gray">bioRxiv, 705780<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13075459439706858606" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PlWzFYVEG4EC" class="gsc_a_at">LGMD AUTOSOMAL RESSESSIVE AND DOMINANT: P. 100BVES loss-of-function mutations in limb-girdle muscular dystrophy 2X with cardiac conduction disorders</a><div class="gs_gray">I Nelson, W De Ridder, B Asselbergh, B De Paepe, M Beuvin, RB Yaou, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S59-S60<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=345894445185581691" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:g_UdREhPGEoC" class="gsc_a_at">Golodirsen induces exon skipping leading to sarcolemmal dystrophin expression in patients with genetic mutations amenable to exon 53 skipping</a><div class="gs_gray">J Morgan, M Guglieri, DE Frank, J Domingos, F Schnell, G Dickson, ...</div><div class="gs_gray">MUSCLE &amp; NERVE 58, S13-S13<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15230586682112752706" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:M0leSnx2MbUC" class="gsc_a_at">The use of nusinersen in the “real world”: the UK and Ireland experience with the expanded access program (EAP)</a><div class="gs_gray">M Scoto, A Manzur, M Main, P Munot, R Tillmann, CM Bettolo, A Mayhew, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S25<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17681254390179239700" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hNSvKAmkeYkC" class="gsc_a_at">Downregulation of miR-29 and miR-23 in urine of Duchenne muscular dystrophy patients</a><div class="gs_gray">F Catapano, J Domingos, M Perry, V Ricotti, L Phillips, L Servais, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S18-S19<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16718069737914630199" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1r-w4gtu6w8C" class="gsc_a_at">Is cardiac dysfunction a feature of dysferlinopathy? Data from the Clinical Outcome Study of Dysferlinopathy</a><div class="gs_gray">M Tiet, R Fernandez-Torrón, J Bourke, K Bettinson, E Harris, H Hilsden, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S5-S6<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9838561354004895529" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IWHjjKOFINEC" class="gsc_a_at">Do titin developmental isoforms contribute to the pathogenesis of congenital titinopathy?</a><div class="gs_gray">E Oates, K Yau, K Jones, J Smith, B Cummings, M Farrar, S Cooper, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S237-S238<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1576211462292768767" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Facilitating orphan drug development: proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA</a><div class="gs_gray">EP Hoffman, C Bonnemann, M Boutin, B Brais, F Buccella, A Burghes, ...</div><div class="gs_gray">Neuromuscular Disorders 27 (7), 693-701<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11460927354443419792" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Zh0EY9V9P6UC" class="gsc_a_at">Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: implications for clinical trials</a><div class="gs_gray">J Domingos, M Eagle, A Moraux, J Butler, V Decostre, D Ridout, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S12<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17619017260482092419" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SIv7DqKytYAC" class="gsc_a_at">Quantitative magnetic resonance imaging of the skeletal muscle in a multi-center dysferlinopathy study: 1-year follow-up</a><div class="gs_gray">FE Smith, N Azzabou, H Reyngoudt, I Wilson, R Fernandez-Torrón, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S10<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15811282574616155414" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Mortality cost of Duchenne muscular dystrophy</a><div class="gs_gray">E Landfeldt, M Eagle, V Straub, H Lochmüller, K Bushby, P Lindgren</div><div class="gs_gray">Global &amp; Regional Health Technology Assessment 4 (1), grhta. 5000260<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4561248086499039546" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:prdVHNxh-e8C" class="gsc_a_at">Movement monitoring at home and during study visits identifies sources of variability in 6MWT performance in Duchenne muscular dystrophy</a><div class="gs_gray">L Servais, M Grelet, A Seferian, E Gasnier, E Gargaun, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S152-S153<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13005163169611409812" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">RD-Connect: Data sharing and analysis for rare disease research within the integrated platform and through GA4GH beacon and matchmaker exchange</a><div class="gs_gray">A Roos, S Beltran, D Piscia, S Laurie, J Protasio, J Fernández, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S160-S161<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10741391502728364080" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Longitudinal results of magneto-inertial motion analysis in Duchenne muscular dystrophy ambulant patients</a><div class="gs_gray">A Seferian, E Gargaun, M Grelet, E Gasnier, C Lilien, S Gillabert, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S184-S185<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8633178550326871472" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Phase 1 safety and pharmacokinetics of the novel enzyme replacement therapy neoGAA in treatment-naïve and alglucosidase alfa-treated late-onset Pompe disease patients (S38. 005)</a><div class="gs_gray">J Trivedi, A Van Der Ploeg, R Barohn, B Byrne, C Desnuelle, ...</div><div class="gs_gray">Neurology 86 (16 Supplement)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9776622675116904357" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:jgBuDB5drN8C" class="gsc_a_at">Overview of morbidity, mortality and survival in Duchenne muscular dystrophy in the North East of England</a><div class="gs_gray">CM Bettolo, H van Ruiten, M Guglieri, M Eagle, V Straub, H Lochmüller, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S301-S302<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12055419090393388472" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">A novel STIM1 mutation at p. 340 causes tubular aggregate myopathy with miosis without additional features of Stormorken syndrome</a><div class="gs_gray">E Harris, J Hudson, J Marsh, CM Bettolo, M Neri, A Ferlini, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S289<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10592077083935339250" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:OTTXONDVkokC" class="gsc_a_at">NeurOmics: EU-funded-omics research for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases</a><div class="gs_gray">C Turner, A Brice, K Bushby, O Riess, M Hanna, G van Ommen, F Muntoni, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S298-S299<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9856380364451855665" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Cautionary tale in Duchenne muscular dystrophy–Opioids in neuromuscular disorders</a><div class="gs_gray">CM Bettolo, M Guglieri, H van Ruiten, V Straub, K Bushby, H Lochmüller</div><div class="gs_gray">Neuromuscular Disorders 25, S200<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2953622164375163120" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">A phase 4 prospective study in patients with adult pompe disease treated with alglucosidase alfa</a><div class="gs_gray">BL Thurberg, P Carlier, JT Kissel, B Schoser, A Pestronk, RJ Barohn, ...</div><div class="gs_gray">Journal of neuromuscular diseases 2 (s1), S72-S73<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13053722179223934128" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">AP 6: Autosomal recessive myofibrillar myopathy caused by ACTA1 mutations</a><div class="gs_gray">M Guglieri, N Sambuughin, A Sarkozy, R Barresi, H Lochmüller, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 832<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=46459894561061917" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IsPWOBWtZBwC" class="gsc_a_at">P. 20.15 Assessing T cell-mediated immune response to dystrophin in the natural history of Duchenne muscular dystrophy</a><div class="gs_gray">K Anthony, V Ricotti, M Guglieri, L Servais, T Voit, K Bushby, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (9), 843<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15507072495650391644" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:OBSaB-F7qqsC" class="gsc_a_at">P. 15.7 A founder mutation in the titin gene is a common cause of myofibrillar myopathy with early respiratory failure</a><div class="gs_gray">G Pfeffer, R Barresi, IJ Wilson, SA Hardy, H Griffin, J Hudson, HR Elliott, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (9), 820<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14093528924198035020" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:fEOibwPWpKIC" class="gsc_a_at">O. 4 Proteomic analysis confirms that HMERF associated with mutations in A-band titin is a new subtype of myofibrillar myopathies</a><div class="gs_gray">A Maerkens, G Pfeffer, A Sarkozy, F Chevessier, J Uzkoreit, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (9), 740<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6164672712635272202" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">Plasma membrane proteins: dysferlin, caveolin, PTRF/cavin, integrin Α7, and integrin Α9</a><div class="gs_gray">V Straub, L DeWaele, R Barresi</div><div class="gs_gray">Muscle Disease: Pathology and Genetics, 108-117<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11175687974773305020" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Enzymes: Cytosolic Proteins Calpain‐3, SEPN1, and GNE</a><div class="gs_gray">V Straub, L De Waele, R Barresi</div><div class="gs_gray">Muscle Disease: Pathology and Genetics, 225-233<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3328288523996182963" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:t6usbXjVLHcC" class="gsc_a_at">P2. 23 Exploratory Rasch analysis of adapted North Star ambulatory assessment in LGMD 2I</a><div class="gs_gray">AG Mayhew, M Eagle, TA Willis, V Straub</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 667<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4452190019870641742" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MNNNGtAgD4EC" class="gsc_a_at">Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring Duchenne muscular dystrophy (DMD) disease progression</a><div class="gs_gray">PAC t Hoen, VD Nadarajah, M van Putten, A Chaouch, P Garrood, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14715040691146554893" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:JTqpx9DYBaYC" class="gsc_a_at">Exon skipping and dystrophin restoration in Duchenne Muscular Dystrophy patients after systemic phosphorodiamidate morpholino oligomer treatment</a><div class="gs_gray">S Cirak, V Arechavala-Gomeza, M Guglieri, L Feng, S Torelli, K Anthony, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (1), S7-S8<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12254559097261213620" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">GP 6.02 MRI in Duchenne muscular dystrophy: Tracking progression</a><div class="gs_gray">P Garrood, KG Hollingsworth, B Aribisala, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 774<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11288998453940545684" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MDX3w3dAD3YC" class="gsc_a_at">MD-NET--muscular dystrophy network</a><div class="gs_gray">H Lochmüller, V Straub</div><div class="gs_gray">Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 50 (12&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12341406025465786298" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:geHnlv5EZngC" class="gsc_a_at">CP 3.06 Spectrum of brain changes and genotype-phenotype correlations in secondary dystroglycanopathies</a><div class="gs_gray">E Clement, E Mercuri, M Rutherford, J Smith, K North, M Kinali, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 871<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4081311855124394232" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_axFR9aDTf0C" class="gsc_a_at">TREAT-NMD</a><div class="gs_gray">K Bushby, V Straub</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 17 (3), 270-271<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8670849101033040941" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">PO 1 Molecular genetic analysis of 6 glycosyltransferases in a large population of dystroglycanopathy patients significantly widens the spectrum of phenotypes resulting from&nbsp;…</a><div class="gs_gray">C Godfrey, R Mein, M Brockington, E Elson, H Topaloglu, J Smith, ...</div><div class="gs_gray">Neuromuscular Disorders 16 (9), 683<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1489115240327891671,17801806710752016199" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:oursBaop5wYC" class="gsc_a_at">Erkrankungen des Nervensystems</a><div class="gs_gray">H Todt, OS Ipsiroglu, J Krägeloh-Mann, M Schöning, S Stöckler-Ipsiroglu, ...</div><div class="gs_gray">Pädiatrie, 280<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16573081892491483997" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">The impact of corticosteroids on forced vital capacity in Duchenne muscular dystrophy</a><div class="gs_gray">M Eagle, M McCallum, S Blyth, V Straub, K Bushby</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 15 (9-10), 689-689<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13292555104881103321" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Altered protein localisation during muscle regeneration in humans and rats</a><div class="gs_gray">RG Charlton, J Walsh, K Davison, CR Slater, SH Laval, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders: 10th International Congress of the World Muscle Society<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10431591455431222842" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">A new mutation in the transmembrane domain of Caveolin-3 in a patient with percussion-induced rapid muscle contractions</a><div class="gs_gray">R Herrmann, J Ratke, C Kutzick, L Anderson, M Barrow, T Voit, K Bushby, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 14 (8-9), 606-607<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4127363419913320402" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hkOj_22Ku90C" class="gsc_a_at">O-glycosylation defects with structural changes of the central nervous system–new members of the CDG family</a><div class="gs_gray">S Grünewald, M Zaik, R Wevers, V Straub, T Voit</div><div class="gs_gray">Neuropediatrics 35 (01), V12<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5425592173317697273" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hfzGNhXhx5MC" class="gsc_a_at">A NEW SUBGROUP OF CONGENITAL DISORDERS OF GLYCOSYLATION: ABNORMAL O-GLYCO-SYLATION IN CONGENITAL MUSCULAR DYSTROPHIES</a><div class="gs_gray">S Grünewald, M Zaik, R Wevers, T Voit, V Straub</div><div class="gs_gray">Journal of Inherited Metabolic Disease 26<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4793431084922539967" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">A novel caveolin-3 mutation in autosomal dominant rippling muscle disease</a><div class="gs_gray">RH Herrmann, S Hertel, C Kutzick, V Straub, T Voit</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 12 (7-8), 723-723<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3243811898888892168" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Prevention of muscular dystrophy in alpha-sarcoglycan-deficient mice by early adenoviral-mediated gene transfer</a><div class="gs_gray">V Allamand, KM Donahue, V Straub, RL Davisson, BL Davidson, ...</div><div class="gs_gray">Neuromuscular Disorders 11 (6-7), 674-674<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13917017738370975613" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Genetic characterisation of multi-minicore disease: identification of a first locus and evidence for genetic heterogeneity</a><div class="gs_gray">A Ferreiro, B Estournet, C Laroche, A Cabello, E Gutierrez, V Straub, ...</div><div class="gs_gray">NEUROMUSCULAR DISORD 11 (6-7), 622-622<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4218943803358896066" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:0aBXIfxlw9sC" class="gsc_a_at">Method for aiding in the diagnosis of in-frame deletion type congenital muscular dystrophy</a><div class="gs_gray">KP Campbell, V Allamand, Y Sunada, V Straub, M Salih</div><div class="gs_gray">US Patent 6,136,546<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16637266299201930828" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Evans Blue Uptake Demonstrates Sarcolemmal Disruption in theMyodystrophy Mouse</a><div class="gs_gray">K Mathews, V Straub, K Campbell</div><div class="gs_gray">Neurology 50 (4)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6616331142852780754" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:x2hKVfJWtf0C" class="gsc_a_at">Measurement of salivary testosterone in adolescents and young men with Duchenne muscular dystrophy</a><div class="gs_gray">YA Sahun, T Cheetham, C Boot, V Straub, CL Wood</div><div class="gs_gray">BMC endocrine disorders 21 (1), 1-5<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:xlVdBZVQT58C" class="gsc_a_at">TREAT-NMD stakeholder meeting for natural history studies in limb girdle muscular dystrophy 18th June 2019, Amsterdam, The Netherlands</a><div class="gs_gray">M Guglieri, J Díaz-Manera, V Straub</div><div class="gs_gray">Neuromuscular disorders: NMD, S0960-8966 (21) 00165-6<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:r56sNq9gaawC" class="gsc_a_at">Workshop Report: TREAT-NMD stakeholder meeting for natural history studies in limb girdle muscular dystrophy</a><div class="gs_gray">M Guglieri, J Díaz-Manera, V Straub</div><div class="gs_gray">Neuromuscular Disorders<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:09LM3QYkMKUC" class="gsc_a_at">Minimal important differences and self-identifying treatment response in chronic inflammatory demyelinating polyneuropathy</a><div class="gs_gray">BL Barthel, D Cox, M Barbieri, M Ziemba, V Straub, EP Hoffman, ...</div><div class="gs_gray">MUSCLE &amp; NERVE 64 (1), 43-49<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:h9G0ZmjYpDoC" class="gsc_a_at">North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up</a><div class="gs_gray">G Coratti, M Pane, C Brogna, V Ricotti, S Messina, A D’Amico, C Bruno, ...</div><div class="gs_gray">Plos one 16 (6), e0253882<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:lPDSu1ZU3VAC" class="gsc_a_at">Gene replacement therapy for symptomatic spinal muscular atrophy type 1: final results of the Phase III STR1VE-EU study</a><div class="gs_gray">F Muntoni, G Baranello, R Masson, O Boespflug-Tanguy, C Bruno, S Corti, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 28, 834-834<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:svGagg1hbZMC" class="gsc_a_at">Biallelic variants in the molecular chaperone DNAJB4 are a genetic cause of myopathy with respiratory muscle involvement</a><div class="gs_gray">C Dominguez-Gonzalez, M Mroczek, S Kapetanovic, A AlSaman, R Gogoi, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 28, 90-90<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:aNch6Af-aFkC" class="gsc_a_at">NEO-EXT: Skeletal Muscle% Fat in Late-Onset Pompe Disease After Long-Term Avalglucosidase Alfa (3-point Dixon MRI)</a><div class="gs_gray">P Carlier, J Vissing, JD Manera, R Barohn, B Byrne, O Goker-Alpan, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 28, 333-333<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:JTtNqH-x4gYC" class="gsc_a_at">Decline of respiratory function in patients with dysferlinopathy (LGMD2B)</a><div class="gs_gray">E Juanola Mayos, U Moore, M Mccallum, D Moat, J Sodhi, M Richardson, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 28, 641-641<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:R6EwkKsDylYC" class="gsc_a_at">Novel diagnostic index test CATCH2 improves detection of acute vestibular stroke (EMVERT study)</a><div class="gs_gray">C Dominguez-Gonzalez, M Mroczek, S Kapetanovic, A AlSaman, R Gogoi, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 28, 89-89<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:rJyh6hJnyfgC" class="gsc_a_at">Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients</a><div class="gs_gray">B Schoser, S Attarian, J Borges, F Bouhour, Y Chien, Y Choi, P Clemens, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 28, 68-68<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4tNoA7Af41QC" class="gsc_a_at">Deep phenotyping of an international series of patients with late‐onset dysferlinopathy</a><div class="gs_gray">G Fernández‐Eulate, G Querin, U Moore, A Behin, M Masingue, G Bassez, ...</div><div class="gs_gray">European Journal of Neurology 28 (6), 2092-2102<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LlXTz_FrCmAC" class="gsc_a_at">The Phenotypic and Genotypic Features of a Scottish Cohort with McArdle Disease</a><div class="gs_gray">SE Gandhi, C Longman, RKH Petty, KM Brennan, W Stewart, K Kinch, ...</div><div class="gs_gray">Neuromuscular Disorders<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_AkkBXT-jcoC" class="gsc_a_at">Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering</a><div class="gs_gray">J Alonso-Pérez, A Casasús, Á Gimenez-Muñoz, J Duff, R Rojas-Garcia, ...</div><div class="gs_gray">Neuromuscular Disorders<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-fu4zM_6qcIC" class="gsc_a_at">High prevalence of sporadic late-onset nemaline myopathy in a cohort of whole-exome sequencing negative myopathy patients</a><div class="gs_gray">W De Ridder, P De Jonghe, V Straub, J Baets</div><div class="gs_gray">Neuromuscular Disorders<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:tFzHCjejgA0C" class="gsc_a_at">A form of muscular dystrophy associated with pathogenic variants in JAG2</a><div class="gs_gray">S Coppens, AM Barnard, S Puusepp, S Pajusalu, K Õunap, ...</div><div class="gs_gray">The American Journal of Human Genetics 108 (5), 840-856<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:fF_gHTpLxhAC" class="gsc_a_at">Description of clinical symptoms of a large international cohort of patients with valosin-containing-protein related disease (1833)</a><div class="gs_gray">M Caballero-Ávila, C Ikenaga, C Marini-Bettolo, M Guglieri, V Straub, ...</div><div class="gs_gray">Neurology 96 (15 Supplement)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1Aeql8wG3wEC" class="gsc_a_at">Efficacy and Safety Results of the Avalglucosidase alfa Phase 3 COMET Trial in Late-Onset Pompe Disease Patients (4195)</a><div class="gs_gray">H Kushlaf, S Attarian, JL Borges, F Bouhour, YH Chien, YC Choi, ...</div><div class="gs_gray">Neurology 96 (15 Supplement)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:w0odbtu79TwC" class="gsc_a_at">A cryptic intronic LAMA2 insertion in a boy with mild congenital muscular dystrophy type 1A</a><div class="gs_gray">S Specht, J Duff, R Charlton, T Polvikoski, R Barresi, A Töpf, V Straub</div><div class="gs_gray">Neuromuscular Disorders<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yKzB5RS27GgC" class="gsc_a_at">Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease</a><div class="gs_gray">U Moore, H Gordish, J Diaz-Manera, MK James, AG Mayhew, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 31 (4), 265-280<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:6pF0wJmtdfAC" class="gsc_a_at">Episodic hyperCKaemia may be a feature of α‐methylacyl‐coenzyme A racemase deficiency</a><div class="gs_gray">B Krett, V Straub, J Vissing</div><div class="gs_gray">European Journal of Neurology 28 (2), 729-731<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1_W9tMSvGuwC" class="gsc_a_at">A survey of the feasibility of developing osteoporosis clinical trials in Duchenne muscular dystrophy: Survey of the opinion of young people with Duchenne muscular dystrophy&nbsp;…</a><div class="gs_gray">S Choong Wong, S Joseph, N Capaldi, MD Marco, J Dunne, M Guglieri, ...</div><div class="gs_gray">Clinical Trials 18 (1), 39-50<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:j8pvxH-kN2QC" class="gsc_a_at">Resting-state functional MRI shows altered default-mode network functional connectivity in Duchenne muscular dystrophy patients</a><div class="gs_gray">N Doorenweerd, M de Rover, C Marini-Bettolo, KG Hollingsworth, ...</div><div class="gs_gray">Brain Imaging and Behavior, 1-11<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DwWRdx-KAo4C" class="gsc_a_at">Defective X-gating caused by de novo gain-of-function mutations in KCNK3 underlies a developmental disorder with sleep apnea</a><div class="gs_gray">J Soermann, M Schewe, P Proks, T Jouen-Tachoire, S Rao, EB Riel, ...</div><div class="gs_gray">medRxiv<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DPO9WFcz7UcC" class="gsc_a_at">Use of EP3533-enhanced magnetic resonance imaging as a measure of disease progression in skeletal muscle of mdx mice</a><div class="gs_gray">AP Murphy, E Greally, D O'Hogain, A Blamire, P Caravan, V Straub</div><div class="gs_gray">Frontiers in Neurology 12<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Lo8V22OuN40C" class="gsc_a_at">Specific heterozygous frameshift variants in hnRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy</a><div class="gs_gray">HJ Kim, P Mohassel, S Donkervoort, L Guo, K O’Donovan, M Coughlin, ...</div><div class="gs_gray">medRxiv<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:bbjcffOLshcC" class="gsc_a_at">Elevation of fast but not slow troponin I in the circulation of patients with Becker and Duchenne muscular dystrophy</a><div class="gs_gray">MB BA</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:dMpQl7XwOw4C" class="gsc_a_at">NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in participants with late-onset pompe disease (LOPD)</a><div class="gs_gray">MM Dimachkie, RJ Barohn, B Byrne, O Goker-Alpan, PS Kishnani, ...</div><div class="gs_gray">Molecular Genetics and Metabolism 132 (2), S34-S34<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DUFsPKDdMi0C" class="gsc_a_at">Intensive Teenage Activity Is Associated With Greater Muscle Hyperintensity on T1W Magnetic Resonance Imaging in Adults With Dysferlinopathy</a><div class="gs_gray">U Moore, M Jacobs, R Fernandez-Torron, J LLauger Rossello, FE Smith, ...</div><div class="gs_gray">Frontiers in neurology 11, 1709<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:oXKBmVzQOggC" class="gsc_a_at">Trial readiness, trial endpoints and stakeholder collaboration</a><div class="gs_gray">V Straub</div><div class="gs_gray">EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 26-27<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:dhpJJ7xvgBgC" class="gsc_a_at">Investigating the pathogenicity of CAPN3 c. 1746-20C&gt; G splicing variant and its association with LGMD R1 calpain3-related</a><div class="gs_gray">M Mroczek, J Hudson, A Topf, R Barresi, J Duff, E England, K Chao, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 434-435<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RgznTc0nqo4C" class="gsc_a_at">Detection and interpretation of variants in dystroglycanopathy-causing genes in a cohort of 1,803 patients with unexplained limb-girdle muscle weakness</a><div class="gs_gray">A Topf, AB Casasus, R Barresi, K Johnson, M Mroczek, J Duff, L Phillips, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 439-439<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QeguYG95ZbAC" class="gsc_a_at">Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein (vol 9, pg 14036, 2019)</a><div class="gs_gray">MP Milev, D Stanga, A Schanzer, A Nascimento, D Saint-Dic, C Ortez, ...</div><div class="gs_gray">SCIENTIFIC REPORTS 10 (1)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:FQ36aI_S1AEC" class="gsc_a_at">Publisher Correction: Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein</a><div class="gs_gray">MP Milev, D Stanga, A Schänzer, A Nascimento, D Saint-Dic, C Ortez, ...</div><div class="gs_gray">Scientific Reports 10 (1), 1-1<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:9tXw7Op4-u0C" class="gsc_a_at">Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy</a><div class="gs_gray">F Catapano, D Scaglioni, K Maresh, P Ala, J Domingos, V Selby, V Ricotti, ...</div><div class="gs_gray">Epigenomics 12 (21), 1899-1915<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QtA78RmWg5MC" class="gsc_a_at">Episodic hyperCKemia may be a feature of α-methylacyl-CoA racemase deficiency.</a><div class="gs_gray">B Krett, V Straub, J Vissing</div><div class="gs_gray">European Journal of Neurology<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BFa5h04uPMwC" class="gsc_a_at">A survey of the feasibility of developing osteoporosis clinical trials in Duchenne muscular dystrophy: Survey of the opinion of young people with Duchenne muscular dystrophy&nbsp;…</a><div class="gs_gray">S Joseph, N Capaldi, MD Marco, J Dunne, M Guglieri, I Horrocks, ...</div><div class="gs_gray">Clinical Trials (London, England), 1740774520958395-1740774520958395<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:tSVUDDkujAIC" class="gsc_a_at">LIMB GIRDLE MUSCULAR DYSTROPHIES: P. 150 Four individuals with a homozygous mutation in exon 1f of the PLEC gene and associated myasthenic features</a><div class="gs_gray">M Mroczek, H Durmus, A Töpf, Y Parman, V Straub</div><div class="gs_gray">Neuromuscular Disorders 30, S90<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nroGzMJTTpEC" class="gsc_a_at">Broadening fibroadipose replacement pattern in patients with sarcoglycanopathies: towards whole body MRI approaches</a><div class="gs_gray">LC Comellas, A Sanchez-Montanez, L Maggi, J Diaz-Manera, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 30, S95-S96<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:I2jIoRS3jIgC" class="gsc_a_at">NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in late-onset Pompe disease (LOPD)</a><div class="gs_gray">B Schoser, R Barohn, B Byrne, O Goker-Alpan, P Kishnani, S Ladha, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 30, S49-S49<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Oj-SLI0tZTcC" class="gsc_a_at">Differences in demographic and phenotypic spectrum of genetically solved and unsolved cases in a large cohort of patients with limb girdle weakness</a><div class="gs_gray">M Mroczek, A Topf, S Specht, K Johnson, L Philips, E England, K Chao, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 30, S92-S92<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IExZWSxeYXUC" class="gsc_a_at">Correlations between quantitative NMRI biomarkers for disease progression and disease activity in muscle of patients with dysferlinopathy</a><div class="gs_gray">H Reyngoudt, F Smith, E Araujo, C de Almeida, I Wilson, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 30, S93-S93<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3x-KLxxGyuUC" class="gsc_a_at">Correlations between 31P NMRS indices and NMRI biomarkers of disease progression in skeletal muscle of patients with dysferlinopathy</a><div class="gs_gray">H Reyngoudt, F Smith, E Araujo, C de Almeida, I Wilson, RF Torron, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 30, S93-S93<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3_f9JqYsqVQC" class="gsc_a_at">An unusual clinical presentation of CTBP1-related syndrome associating muscle dystrophy, cerebellar ataxia and paralytic ileus</a><div class="gs_gray">E El Houwayek, S Coppens, A Topf, J Duff, J Kaleeta, H Kadhim, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 30, S77-S77<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:g30IDTdgJMgC" class="gsc_a_at">Pubertal induction in adolescents with DMD is associated with high satisfaction, gonadotropin release and increased muscle contractile surface area.</a><div class="gs_gray">CL Wood, KG Hollingsworth, E Hughes, S Punniyakodi, R Muni-Lofra, ...</div><div class="gs_gray">European Journal of Endocrinology 1 (aop)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hB2aVRuWZNwC" class="gsc_a_at">DMD–BIOMARKERS &amp; OUTCOME MEASURES: P. 129 Grip strength is a reliable outcome measure throughout the life span of patients with Duchenne muscular dystrophy</a><div class="gs_gray">J Hogrel, V Decostre, I Ledoux, M de Antonio, E Niks, I de Groot, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S84<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:uPCvBZYD9qUC" class="gsc_a_at">MUSCLE IMAGING–MRI: P. 168 Broadening fibroadipose replacement pattern in patients with sarcoglycanopathies: towards whole body MRI approaches</a><div class="gs_gray">LC Comellas, Á Sánchez-Montañez, L Maggi, J Díaz-Manera, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S95-S96<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:jKT558fuBk8C" class="gsc_a_at">LIMB GIRDLE MUSCULAR DYSTROPHIES: P. 156 Differences in demographic and phenotypic spectrum of genetically solved and unsolved cases in a large cohort of patients with limb&nbsp;…</a><div class="gs_gray">M Mroczek, A Töpf, S Specht, K Johnson, L Philips, E England, K Chao, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S92<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ynsZFq2pu0MC" class="gsc_a_at">LIMB GIRDLE MUSCULAR DYSTROPHIES: P. 147 A simple and rapid neutrophils immunoassay for dysferlinopathies</a><div class="gs_gray">D Cox, M Henderson, V Straub, R Barresi</div><div class="gs_gray">Neuromuscular Disorders 30, S89-S90<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:oH8HCDhqVGsC" class="gsc_a_at">DMD &amp; BMD–CLINICAL: P. 51 DMD Hub: demonstrating impact for DMD trials</a><div class="gs_gray">E Heslop, M Guglieri, A Irvin, C Turner, B Crow, E George, A Johnson, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S62-S63<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cww_0JKUTDwC" class="gsc_a_at">AUTOPHAGIC MYOPATHIES/MYOFIBRILLAR MYOPATHIES/DISTAL MYOPATHIES/POMPE DISEASE: P. 03 NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing&nbsp;…</a><div class="gs_gray">B Schoser, R Barohn, B Byrne, O Goker-Alpan, P Kishnani, S Ladha, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S49<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:I-2NeQpV75MC" class="gsc_a_at">MUSCLE IMAGING–MRI: P. 159 Correlations between quantitative NMRI biomarkers for disease progression and disease activity in muscle of patients with dysferlinopathy</a><div class="gs_gray">H Reyngoudt, F Smith, EC de Almeida Araujo, I Wilson, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S93<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-vzq6BoH5oUC" class="gsc_a_at">FROM THE SPINAL CORD TO THE MUSCLE: O. 11 Limb girdle muscular dystrophy R2 and Miyoshi myopathy are not distinct clinical phenotypes in dysferlinopathy</a><div class="gs_gray">U Moore, H Gordish, JD Maneraz, M James, A Mayhew, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S149<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:KIRwYnRZzWQC" class="gsc_a_at">FROM THE SPINAL CORD TO THE MUSCLE: O. 10 European collaboration on the clinical and genetic spectrum of sarcoglycan-deficient muscular dystrophy</a><div class="gs_gray">J Alonso-Pérez, L Gonález-Quereda, C Semplicini, P Gallano, E Pegoraro, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S148-S149<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1wZ_wKGpLuwC" class="gsc_a_at">HEREDITARY NEUROPATHIES &amp; ALS: P. 105 An unusual clinical presentation of CTBP1-related syndrome associating muscle dystrophy, cerebellar ataxia and paralytic ileus</a><div class="gs_gray">E El Houwayek, S Coppens, A Topf, J Duff, J Kaleeta, H Kadhim, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S77<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:GUYAmugLYisC" class="gsc_a_at">DMD–THERAPY: P. 283 Long-term safety and efficacy of golodirsen in male patients with Duchenne muscular dystrophy amenable to Exon 53 skipping</a><div class="gs_gray">F Muntoni, L Servais, V Straub, M Guglieri, A Dugar, M Whalen-Kielback, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S129<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:s2G-WRnXBicC" class="gsc_a_at">LATE BREAKING NEWS ORAL PRESENTATION: LBO 2 A novel form of muscular dystrophy associated with mutations in JAG2</a><div class="gs_gray">S Coppens, S Puusepp, K Õunap, A Barnard, S Donkervoort, R Maroofian, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S166<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-38epGy1wY0C" class="gsc_a_at">LIMB GIRDLE MUSCULAR DYSTROPHIES: P. 144 Patient reported quality of life in limb girdle muscular dystrophy: A cross-sectional survey</a><div class="gs_gray">N Johnson, J Statland, C Weihl, K Bates, A Amato, P Kang, L Lowes, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S88-S89<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:j2GSQqY3pL0C" class="gsc_a_at">MUSCLE IMAGING–MRI: P. 160 Correlations between 31P NMRS indices and NMRI biomarkers of disease progression in skeletal muscle of patients with dysferlinopathy</a><div class="gs_gray">H Reyngoudt, F Smith, EC de Almeida Araujo, I Wilson, RF Torron, ...</div><div class="gs_gray">Neuromuscular Disorders 30, S93<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:U5uP8zs9lfgC" class="gsc_a_at">MUSCLE IMAGING–MRI: P. 162 The use of muscle MRI in the diagnosis of neuromuscular diseases</a><div class="gs_gray">S Xirou, C Lopes, C Bolano, JD Manera, V Straub, C Marini-Bettolo</div><div class="gs_gray">Neuromuscular Disorders 30, S94<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:gFrPXmx1TSsC" class="gsc_a_at">The Role of Magnetic Resonance Imaging in the Diagnosis and Assessment of Patients with Genetic Muscle Diseases</a><div class="gs_gray">V Straub</div><div class="gs_gray">Congenital Dystrophies-Neuromuscular Disorders Precision Medicine: Genomics&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PklR0melJeUC" class="gsc_a_at">Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases:" translating" the translational.</a><div class="gs_gray">P McCormack, S Woods, A Aartsma-Rus, L Hagger, A Herczegfalvi, ...</div><div class="gs_gray">The Ethical Challenges of Emerging Medical Technologies, 259-275<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Ul_CLA4dPeMC" class="gsc_a_at">The MYO-SEQ: beyond the exome. A genotype-phenotype correlation of unsolved LGMD individuals</a><div class="gs_gray">M Mroczek, A Topf, S Specht, J Duff, K Johnson, L Philips, E England, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 27, 71-72<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ehoypfNsBj8C" class="gsc_a_at">3 individuals with mutation in exon 1f of PLEC and myasthenic phenotype</a><div class="gs_gray">M Mroczek, H Durmus, A Topf, J Duff, Y Parman, V Straub</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 27, 1151-1151<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:KqnX2w3egDsC" class="gsc_a_at">MRI as a decision support tool in a large exome sequenced limb-girdle muscular dystrophy cohort</a><div class="gs_gray">M Mroczek, V Straub</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 27, 372-372<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_9Xh93LWpsYC" class="gsc_a_at">NEO1 and NEO-EXT Studies: Long-Term Safety and Exploratory Efficacy of Repeat Avalglucosidase Alfa Dosing for 5.5 Years in Late-Onset Pompe Disease Patients (695)</a><div class="gs_gray">M Dimachkie, R Barohn, B Byrne, O Goker-Alpan, P Kishnani, S Ladha, ...</div><div class="gs_gray">Neurology 94 (15 Supplement)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:uQVPmWFBlwUC" class="gsc_a_at">Four Individuals with a Homozygous Mutation in Exon 1f of thePLECGene and Associated Myasthenic Features</a><div class="gs_gray">V Straub, M Mroczek, H DURMUŞ TEKÇE, A Topf, Y Parman</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4E1Y8I9HL1wC" class="gsc_a_at">NEO1/NEO-EXT studies: Trends over time in exploratory efficacy of repeat avalglucosidase alfa dosing for up to 5.5 years in late-onset Pompe disease (LOPD) patients</a><div class="gs_gray">B Schoser, RJ Barohn, BJ Byrne, O Goker-Alpan, PS Kishnani, S Ladha, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 27, 486-486<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:GiYFt9mpioMC" class="gsc_a_at">EUROPEAN MUSCLE MRI STUDY 1 IN LIMB GIRDLE MUSCULAR DYSTROPHY TYPE R1 (LGMDR1)</a><div class="gs_gray">A Barp, P Laforet, L Bello, G Tasca, J Vissing, M Monforte, E Ricci, ...</div><div class="gs_gray">MUSCLE &amp; NERVE 60, S9-S9<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3BvdIg-l-ZAC" class="gsc_a_at">P. 208Improving recognition of spinal muscular atrophy: a retrospective case note review</a><div class="gs_gray">M Guglieri, H van Ruiten, M Scoto, A Manzur, P Munot, F Muntoni, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S127<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QKtdBID3u5MC" class="gsc_a_at">EP. 83Design of a Phase 2/3 randomized controlled trial of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy amenable to exon 51 skipping</a><div class="gs_gray">K Wagner, L Cripe, M Eagle, F Muntoni, E Niks, H Phan, V Straub, X Hu, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S176-S177<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Gb6Hms-Uo9kC" class="gsc_a_at">P. 175Detection and interpretation of variants in dystroglycanopathy-causing genes in a cohort of 1,566 patients with unexplained limb-girdle muscle weakness</a><div class="gs_gray">A Topf, A Casasus, R Barresi, K Johnson, M Mroczek, J Duff, L Phillips, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S99-S100<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_mQi-xiA4oYC" class="gsc_a_at">O. 18Recessive mutations in the myosin chaperone UNC-45B impair muscle myofibrillar integrity, manifesting as progressive myopathy with eccentric cores</a><div class="gs_gray">S Donkervoort, Y Hu, X Lornage, C Kutzner, M Mroczek, S Neuhaus, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S120<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:N6_Y7JlWxwsC" class="gsc_a_at">P. 336Vision DMD: a phase IIb randomized, double-blind, parallel group, placebo-and active-controlled study to assess the efficacy and safety of vamorolone in boys with&nbsp;…</a><div class="gs_gray">M Guglieri, P Clemens, J Haberlova, I Horrocks, K Selby, R Webster, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S165<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5LPo_wSKItgC" class="gsc_a_at">E-POSTERS–DMD–CLINICAL CARE: EP. 67Vitamin D levels in patients with neuromuscular disease: a retrospective audit</a><div class="gs_gray">G Eglon, L Hastings, S Specht, G McMacken, U Moore, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S172<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:oldoQiaHq2UC" class="gsc_a_at">P. 185The clinical outcome study for dysferlinopathy: quantitative MRI and physiotherapy outcomes to capture disease progression</a><div class="gs_gray">M James, F Smith, H Reyngoudt, I Wilson, A Mayhew, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S103<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:pRWBApOjXDcC" class="gsc_a_at">P. 171A clinical outcome study for dysferlinopathy: biobanking samples collected through a collaborative international multisite study</a><div class="gs_gray">H Hilsden, U Moore, D Cox, J Day, K Jones, D Bharucha-Goebel, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S98<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:AFXcoJnoRH0C" class="gsc_a_at">P. 212Mortality in patients with spinal muscular atrophy over the last 10 years: the UK experience</a><div class="gs_gray">S Specht, M Scoto, A Childs, G Eglon, L Hastings, K Pysden, S Manning, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S128<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4QKQTXcH0q8C" class="gsc_a_at">O. 14B3GNT4 deficiency: a new α-dystroglycanopathy causing late-onset progressive brain atrophy and muscular dystrophy</a><div class="gs_gray">J Vissing, A Töpf, V Straub, T Krag</div><div class="gs_gray">Neuromuscular Disorders 29, S118-S119<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NU-BerS4NX4C" class="gsc_a_at">P. 144A cross sectional and longitudinal miRNA profiling study identified a set of novel free-circulating and exosomal miRNAs dysregulated in plasma from Duchenne muscular&nbsp;…</a><div class="gs_gray">F Catapano, D Scaglioni, K Maresh, V Selby, P Ala, J Domingos, V Ricotti, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S90<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:VnuxuLaQPLMC" class="gsc_a_at">E-POSTERS-OUTCOME MEASURES: EP. 51Expert advice to improve clinical trials: from TACT to ACT</a><div class="gs_gray">J Lee, V Straub, C Turner, A de Luca</div><div class="gs_gray">Neuromuscular Disorders 29, S115-S116<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:C-Rn0OCouf8C" class="gsc_a_at">P. 186Two patients with PURA syndrome in a large cohort of patients with unexplained muscle disease</a><div class="gs_gray">M Mroczek, A Töpf, D Zafeiriou, A Roos, E Bartels, N Kohlschmidt, J Duff, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S103<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kO05sadLmrgC" class="gsc_a_at">EP. 91The DMD-Hub, a collaboration to facilitate trials and increase trial capacity in the UK</a><div class="gs_gray">E Heslop, M Guglieri, C Turner, B Crow, A Peel, E Crossley, A Johnson, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S179<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WIXB4To3Tx4C" class="gsc_a_at">P. 82First clinical and neuropathological description of a myofibrillar myopathy with congenital onset based on a homozygous recessive FLNC mutation</a><div class="gs_gray">H Kölbel, A Roos, K Nolte, K Johnson, A Töpf, L Kollipara, W Kress, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S64-S65<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8RAEygVn5_EC" class="gsc_a_at">E-POSTERS–NEXT GENERATION SEQUENCING: EP. 96" Double trouble" in a large cohort of patients with unexplained muscle weakness</a><div class="gs_gray">A Topf, K Johnson, M Mroczek, L Phillips, J Duff, E Valkanas, E England, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S180<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:pUxgyZctzPYC" class="gsc_a_at">P. 69NEO1 and NEO-EXT studies: exploratory efficacy of repeat avalglucosidase alfa dosing for up to 5 years in participants with late-onset Pompe disease (LOPD)</a><div class="gs_gray">B Schoser, R Barohn, B Byrne, O Goker-Alpan, P Kishnani, S Ladha, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S60-S61<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:gmHTDCtJMcoC" class="gsc_a_at">P. 179European collaboration on clinical and genetic heterogeneity of sarcoglycanopathies</a><div class="gs_gray">J Alonso-Perez, A Nascimiento-Osorio, C Ortez-Gonzalez, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S101<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1EqfMoDn7-AC" class="gsc_a_at">P. 259Feasibility of osteoporosis clinical trials in Duchenne muscular dystrophy: a survey of the opinion of families, young adults and neuromuscular clinicians</a><div class="gs_gray">M Guglieri, S Wong, S Joseph, N Capaldi, M Di Marco, J Dunne, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S142<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:zzCxg_vo7cAC" class="gsc_a_at">P. 187CAPN3 c. 598_612delTTCTGGAGTGCTCTG: another CAPN3 dominant variant?</a><div class="gs_gray">M Mroczek, A Töpf, J Duff, R Barresi, J Hudson, E England, K Chao, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S103<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:a2necdfpwlEC" class="gsc_a_at">P. 254The clinical and genetic spectrum of a UK cohort of paediatric and adult patients with MYH7 gene related skeletal myopathies</a><div class="gs_gray">S Pula, K Brennan, M Bertoli, R Quinlivan, A Manzur, S Robb, R Mein, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S141<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eFf2swCANGcC" class="gsc_a_at">P. 389Global FKRP registry</a><div class="gs_gray">L Murphy, J Laurent, K Mathews, J Stevenson, S Thiele, J Vissing, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S195<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:sJK75vZXtG0C" class="gsc_a_at">P. 306Multicentric MRI study in a cohort of FSHD2 patients: pattern definition and differences between FSHD1 and FSHD2</a><div class="gs_gray">G Tasca, G Giacomucci, M Monforte, J Diaz-Manera, K Mul, RF Torron, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S156<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Nufq_to8ts0C" class="gsc_a_at">EP. 48Informing paediatric clinical research participants: an innovative approach</a><div class="gs_gray">B Crow, C Turner, D Athanasiou, E Vroom, V Straub, R Bendixen, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S115<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DIubQTN3OvUC" class="gsc_a_at">P. 172Identification and characterisation of CAPN3 splicing defect mutations in unexplained cases of LGMD patients from the MYO-SEQ project</a><div class="gs_gray">J Duff, A Topf, D Cox, S Specht, M Mroczek, E England, K Chao, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S98-S99<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ojlX30-wUrgC" class="gsc_a_at">P. 177Measuring what matters in dysferlinopathy–linking functional ability to patient reported outcome measures</a><div class="gs_gray">A Mayhew, M James, H Hilsden, H Sutherland, M Jacobs, S Spuler, J Day, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S100<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:oYLFIHfuHKwC" class="gsc_a_at">P. 220The revised Hammersmith scale (RHS) for spinal muscular atrophy: longitudinal trajectories in a large international cohort of patients with type 2 and 3 SMA</a><div class="gs_gray">D Ramsey, M Scoto, A Mayhew, RM Lofra, M Main, E Milev, E Mazzone, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S131<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ShjGdcaqzI0C" class="gsc_a_at">P. 184Clinical outcome study for dysferlinopathy: a longitudinal examination of the upper limb involvement using physiotherapy outcome measures and T1w MRI</a><div class="gs_gray">M James, R Fernández-Torrón, A Mayhew, L Alfano, R Muni-Lofra, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S102-S103<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:wBLCggQE-ToC" class="gsc_a_at">EP. 52Overnight pulse oximetry for respiratory progression screening in a neuromuscular service</a><div class="gs_gray">M McCallum, A Mayhew, D Moat, J Sodhi, M James, S Specht, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S116<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cSdaV2aYdYsC" class="gsc_a_at">P. 283Reading performance in relation to white matter network connectivity detected with MRI in Duchenne muscular dystrophy</a><div class="gs_gray">J Lionarons, J Hendriksen, A Berns, C Marini-Bettolo, K Hollingsworth, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S149-S150<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qPeb-qHga9sC" class="gsc_a_at">Study Design of STR1VE-EU, a Phase 3 Trial of AVXS-101 Gene-Replacement Therapy (GRT) in Patients With Spinal Muscular Atrophy Type 1 (SMA1) in Europe</a><div class="gs_gray">F Muntoni, G Baranello, C Bruno, S Corti, R Masson, V Straub, G Vita, ...</div><div class="gs_gray">Neuropediatrics 50 (S 02), GNP-FV16<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:B2rIPIGFPLEC" class="gsc_a_at">Resolving the diagnostic odyssey for young patients with rare genetic muscle disease through the application of extended exome sequencing technologies</a><div class="gs_gray">K Johnson, A Topf, M Bertoli, L Phillips, A Blain, M Ensini, M Lek, L Xu, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF HUMAN GENETICS 27, 792-793<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:wuD5JclIwkYC" class="gsc_a_at">TDP43 gene variants in patients with autosomal dominant degenerative myopathy</a><div class="gs_gray">J Zibold, M Wiessner, A Topf, P Petiot, R Stucka, M Dusl, S Krause, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 26, 328-328<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:c1AJUTjuCtUC" class="gsc_a_at">Clinical Outcome Study for Dysferlinopathy: Three years of natural history data for clinical trial readiness</a><div class="gs_gray">V Straub, MK James, AG Mayhew, S Spuler, JW Day, KJ Jones, ...</div><div class="gs_gray">Nervenheilkunde 38 (05), V24<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DquSII9TDu4C" class="gsc_a_at">Longitudinal upper limb muscle MRI in dysferlinopathy: examining the relationship between semi quantitative MRI and physiotherapy outcome measures</a><div class="gs_gray">K Storch, R Fernández-Torrón, MK James, AG Mayhew, J Díaz-Manera, ...</div><div class="gs_gray">Nervenheilkunde 38 (05), P76<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:CMvovTBb2okC" class="gsc_a_at">Clinical Outcome Study in Dysferlinopathy: Medical comorbidities and polytherapy in a large population of dysferlinopathy patients</a><div class="gs_gray">K Storch, S Spuler, JW Day, KJ Jones, DX Bharucha-Goebel, ...</div><div class="gs_gray">Nervenheilkunde 38 (05), P77<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:rqnDXT1GswoC" class="gsc_a_at">TDP43-Varianten bei autosomal dominanter distaler Myopathie</a><div class="gs_gray">J Zibold, M Wiessner, A Topf, P Petiot, R Stucka, M Dusl, S Krause, ...</div><div class="gs_gray">Nervenheilkunde 38 (05), P30<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:j5aT6aphRxQC" class="gsc_a_at">A cross-sectional and longitudinal study on plasma derived miRNAs revealed novel dysregulated signatures in Duchenne muscular dystrophy patients</a><div class="gs_gray">F Catapano, D Scaglioni, K Maresh, J Domingos, P Ala, V Ricotti, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 49, 89-89<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yJjnfzR0HrkC" class="gsc_a_at">MON-LB050 Preliminary Results from the" Observational Study of Clinical Outcomes for Testosterone Treatment of Pubertal Delay in Duchenne Muscular Dystrophy (DMD)(NCT 02571205)"</a><div class="gs_gray">C Wood, V Straub, M Guglieri, T Cheetham</div><div class="gs_gray">Journal of the Endocrine Society 3 (Supplement_1), MON-LB050<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:AFmTUeZ1pmEC" class="gsc_a_at">SAT-530 Establishment of a Glucocorticoid (GC) Regimen to Induce Both Growth Retardation and Osteoporosis in C57BL/10 Muscular Dystrophy Mouse Models</a><div class="gs_gray">C Wood, JSC Wong, V Straub, S Ahmed, C Farquharson</div><div class="gs_gray">Journal of the Endocrine Society 3 (Supplement_1), SAT-530<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8JTMrWI6FdcC" class="gsc_a_at">Outcome measures</a><div class="gs_gray">U Moore, M James, M Jacobs, A Mayhew, S Spuler, J Day, ...</div><div class="gs_gray">Neuromuscular Disorders 29, S37-S208<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ufKn5pxu7C0C" class="gsc_a_at">How Sickle Cell Disease Impairs Skeletal Muscle Function</a><div class="gs_gray">A Messineo, C Gineste, T Sztal, E Mcnamara, D Hahne, N Laing, ...</div><div class="gs_gray">Medicine and Science in Sports and Exercise 51 (1), 4-11<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:T_0gP6tLVL0C" class="gsc_a_at">Clinical outcome study for dysferlinopathy: three years of natural history data for clinical trial readiness</a><div class="gs_gray">M James, A Mayhew, R Lofra, M Jacobs, A Canal, T Duong, R Gee, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 28, S33-S34<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NZNkWSpQBv0C" class="gsc_a_at">Big Data in genetic research: the example of titin gene and titinopathies</a><div class="gs_gray">M Savarese, M Johari, K Johnson, A Torella, A Topf, A Evila, M Arumilli, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF HUMAN GENETICS 26, 423-423<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MGPUR4WVBMEC" class="gsc_a_at">Application of exome sequencing technologies to 1,000 patients affected by limb-girdle weakness of unknown origin</a><div class="gs_gray">K Johnson, A Topf, M Bertoli, L Phillips, A Blain, M Ensini, M Lek, L Xu, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF HUMAN GENETICS 26, 57-57<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RfUwGJFMQ-0C" class="gsc_a_at">Rasch analysis of the individualised neuromuscular Quality of Life Questionnaire administered to patients with dysferlinopathy</a><div class="gs_gray">M James, A Mayhew, M Jacobs, S Spuler, J Day, K Jones, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 28, S35-S35<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:e84hm74t-eoC" class="gsc_a_at">Clinical outcome study in dysferlinopathy: medical comorbidities and polytherapy in a large population of dysferlinopathy patients</a><div class="gs_gray">R Fernandez-Torron, J Diaz-Manera, M James, A Mayhew, S Spuler, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 28, S35-S35<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:X4-KO54GjGYC" class="gsc_a_at">Clinical outcome study in dysferlinopathy: random forest approach to assess the relationship between baseline muscle MRI and longitudinal functional outcome measures</a><div class="gs_gray">J Diaz-Manera, R Fernandez-Torron, M James, A Mayhew, M Jacobs, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 28, S34-S35<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:JH5k92_tO-AC" class="gsc_a_at">Collaborative data collection by TREAT-NMD registries to support post-marketing surveillance in spinal muscular atrophy</a><div class="gs_gray">J Bullivant, V Hodgkinson-Brechenmacher, M Rodrigues, V Straub, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 28, S58-S58<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:E7VqQtBCVmcC" class="gsc_a_at">Development of a conversion method to enable an accurate PUL v. 2 score from PUL v. 1.2 data in a cohort of Duchenne muscular dystrophy patients</a><div class="gs_gray">V Selby, V Ricotti, A Mayhew, D Ridout, J Pitchforth, E Niks, L Servais, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 28, S122-S122<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:6ZzL7HXColQC" class="gsc_a_at">LGMD AUTOSOMAL RESSESSIVE AND DOMINANT: P. 99Limb-girdle muscular dystrophy 2Z in a Bulgarian family</a><div class="gs_gray">T Chamova, A Taneva, M Gospodinova, D Zlatareva, K Johnson, A Töpf, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S59<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:g8uWPOAv7ggC" class="gsc_a_at">SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES: P. 93Collaborative data collection by TREAT-NMD registries to support post-marketing surveillance in spinal muscular atrophy</a><div class="gs_gray">J Bullivant, V Hodgkinson-Brechenmacher, M Rodrigues, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S57-S58<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:lbI08cpqPnQC" class="gsc_a_at">LIMB-GIRDLE MUSCULAR DYSTROPHY I: P. 8Clinical outcome study for dysferlinopathy: three years of natural history data for clinical trial readiness</a><div class="gs_gray">M James, A Mayhew, RM Lofra, M Jacobs, A Canal, T Duong, R Gee, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S33-S34<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kUhpeDhEZMUC" class="gsc_a_at">DMD CLINICAL THERAPIES II: P. 135DMD-HUB: expanding clinical trial capacity for Duchenne muscular dystrophy, 1 year on</a><div class="gs_gray">E Heslop, M Guglieri, K Bushby, C Turner, B Crow, E Crossley, A Johnson, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S70<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:VRfTbSk87rEC" class="gsc_a_at">LIMB-GIRDLE MUSCULAR DYSTROPHY I: P. 9A comparison of the utility between three muscle strength assessment methods in dysferlinopathy</a><div class="gs_gray">N Miller, L Lowes, M James, L Alfano, A Mayhew, E Maron, R Gee, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S34<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ifOnle78iJkC" class="gsc_a_at">LIMB-GIRDLE MUSCULAR DYSTROPHY I: P. 11Clinical outcome study in dysferlinopathy: random forest approach to assess the relationship between baseline muscle MRI and longitudinal&nbsp;…</a><div class="gs_gray">J Diaz-Manera, R Fernández-Torron, M James, A Mayhew, M Jacobs, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S34-S35<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WWeOtg8bX_EC" class="gsc_a_at">NEXT GENERATION SEQUENCING AND EXPERIMENTAL MYOLOGY: P. 377The latin America experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness</a><div class="gs_gray">T Almeida, MG Ehuletche, A Perna, J Bevilacqua, A Dubrovsky, M Franca, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S143<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:R22Rs3tN8aoC" class="gsc_a_at">LIMB-GIRDLE MUSCULAR DYSTROPHY I: P. 12Clinical outcome study in dysferlinopathy: medical comorbidities and polytherapy in a large population of dysferlinopathy patients</a><div class="gs_gray">R Fernandez-Torron, J Diaz-Manera, M James, A Mayhew, S Spuler, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S35<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:aEW5N-EHWIMC" class="gsc_a_at">DUCHENNE MUSCULAR DYSTROPHY-PHYSIOTHERAPY: P. 303Development of a conversion method to enable an accurate PUL v. 2 score from PUL v. 1.2 data in a cohort of Duchenne muscular&nbsp;…</a><div class="gs_gray">V Selby, V Ricotti, A Mayhew, D Ridout, J Pitchforth, E Niks, L Servais, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S122<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:rLGzs9wiiwIC" class="gsc_a_at">LIMB-GIRDLE MUSCULAR DYSTROPHY I: P. 13Rasch analysis of the individualised neuromuscular Quality of Life Questionnaire administered to patients with dysferlinopathy</a><div class="gs_gray">M James, A Mayhew, M Jacobs, S Spuler, J Day, K Jones, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S35<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:rbGdIwl2e6cC" class="gsc_a_at">RASCH ANALYSIS OF THE INDIVIDUALIZED NEUROMUSCULAR QUALITY OF LIFE QUESTIONNAIRE ADMINISTERED TO PATIENTS WITH DYSFERLINOPATHY</a><div class="gs_gray">AG Mayhew, MK James, M Jacobs, J Feng, S Spuler, JW Day, KJ Jones, ...</div><div class="gs_gray">MUSCLE &amp; NERVE 58, S20-S20<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WzTVkKNmPSkC" class="gsc_a_at">DEVELOPMENT OF GOLODIRSEN BY THE SKIP-NMD CONSORTIUM AND DESIGN OF A PHASE 1/2 TRIAL OF GOLODIRSEN FOR THE TREATMENT OF DMD AMENABLE TO EXON 53 SKIPPING</a><div class="gs_gray">J Morgan, M Guglieri, DE Frank, J Domingos, F Schnell, G Dickson, ...</div><div class="gs_gray">MUSCLE &amp; NERVE 58, S12-S13<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:I8rxH6phXEkC" class="gsc_a_at">A phase 1/2 Golodirsen trial developed by the SKIP-NMD consortium to identify potential treatments for Duchenne Muscular Dystrophy: study design and patient characteristics</a><div class="gs_gray">F Muntoni, V Straub, D Frank, AM Seferian, G Dickson, M Guglieri, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 25, 83-84<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Examining longitudinal functional changes in Dysferlinopathy: The JAIN Clinical Outcome Study (P5. 429)</a><div class="gs_gray">L Lowes, M James, A Mayhew, L Alfano, M Jacobs, S Spuler, KJ Jones, ...</div><div class="gs_gray">Neurology 90 (15 Supplement)<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:n3vGvpFsckwC" class="gsc_a_at">DMD HUB: expanding clinical trial capacity for Duchenne muscular dystrophy in the UK</a><div class="gs_gray">E Heslop, M Guglieri, K Bushby, C Turner, B Davis, N Litchfield, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S38<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:R-LXmdHK_14C" class="gsc_a_at">An international collaboration applying targeted whole exome sequencing to detect causative variants in 1001 patients affected by limb-girdle weakness of unknown origin</a><div class="gs_gray">K Johnson, M Bertoli, L Phillips, A Blain, M Ensini, A Töpf, M Lek, L Xu, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S39<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4Yq6kJLCcecC" class="gsc_a_at">Translating discovery science into treatments for patients: observational cohort studies at the MRC Centre for Neuromuscular Diseases</a><div class="gs_gray">A Bellin, KM Bushby, P Chinnery, L Germain, D Kozyra, J Holton, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S37<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4e5Qn2KL_jwC" class="gsc_a_at">Longitudinal upper limb muscle MRI in dysferlinopathy: examining the relationship between semi quantitative MRI and physiotherapy outcome measures</a><div class="gs_gray">R Fernández-Torrón, MK James, A Mayhew, M Eagle, RM Lofra, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S6-S7<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:sfnaS5RM6jYC" class="gsc_a_at">Dystrophin quantification in Duchenne and Becker muscular dystrophy: correlation between dystrophin protein and clinical phenotype</a><div class="gs_gray">V Sardone, J Domingos, S Torelli, A Jones, M Ellis, R Phadke, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S7-S8<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:iyewoVqAXLQC" class="gsc_a_at">Clinical research activity in the Newcastle MRC Centre for Neuromuscular Disease</a><div class="gs_gray">A Peel, C Jordison, L Brown, B Davis, A Robertson, C Dyer, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S39-S40<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ji7lAbPyDbYC" class="gsc_a_at">Clinical Outcome Study of Dysferlinopathy: what are the best outcome measures for dysferlinopathy patients?</a><div class="gs_gray">MK James, M Jacobs, A Mayhew, J Feng, S Spuler, JW Day, KJ Jones, ...</div><div class="gs_gray">Neuromuscular Disorders 28, S6<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BCdnXsLIVDwC" class="gsc_a_at">Corrigendum to “A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy”[Neuromuscular disorders 27/11 (2017) 1043–1046]</a><div class="gs_gray">PYK Van den Bergh, Y Sznajer, V Van Parys, W van Tol, RA Wevers, ...</div><div class="gs_gray">Neuromuscular disorders 28 (1), 101<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:vD2iS2Kej30C" class="gsc_a_at">BVES loss-of-function mutations in limb-girdle muscular dystrophy 2X with cardiac conduction disorders</a><div class="gs_gray">I Nelson, W De Ridder, B Asselbergh, B De Paepe, M Beuvin, ...</div><div class="gs_gray">23rd International annual congress of the World Muscle Society (WMS 2018) 28&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hefNtdE4IMkC" class="gsc_a_at">MULTIDISCIPLINARY 4D IMAGING OF PLANT DEVELOPMENT, METABOLITE TRANSPORT AND ENVIRONMENTAL PROCESSES IN-VIVO</a><div class="gs_gray">MJ Lusa, MP Sarparanta, JJM Immanen, JAA Serra, P Raumonen, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cNe27ouKFcQC" class="gsc_a_at">Muscle MRI in dysferlinopathy patients: Pattern recognition and implications for clinical trials</a><div class="gs_gray">J Díaz-Manera, R Fernandez-Torron, JL Rossello, M James, A Mayhew, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery, and Psychiatry<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:idthP5jqfYAC" class="gsc_a_at">Development of Next Generation Sequencing Genetic Panel for Recessive Limb-Girdle Muscular Weakness in Latin America.</a><div class="gs_gray">A Perna, M del Rosario Guecaimburu Ehuletche, T Almeida, J Bevilacqua, ...</div><div class="gs_gray">Annual Symposium of the Society for the Study of Inborn Errors of Metabolism&nbsp;…<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:KS-xo-ZNxMsC" class="gsc_a_at">Pompe Disease</a><div class="gs_gray">AP Murphy, V Straub</div><div class="gs_gray">Neurometabolic Hereditary Diseases of Adults, 99-120<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qmtmRrLr0tkC" class="gsc_a_at">Brain imaging indicates genotype-phenotype association in Duchenne muscular dystrophy</a><div class="gs_gray">N Doorenweerd, CM Bettolo, KG Hollingsworth, JGM Hendriksen, ...</div><div class="gs_gray">PERGAMON-ELSEVIER SCIENCE LTD<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:W5xh706n7nkC" class="gsc_a_at">PO195 Outcome measures for duchenne muscular dystrophy: implications for trials</a><div class="gs_gray">J Domingos, M Eagle, A Moraux, J Butler, V Decostre, D Ridout, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery and Psychiatry 88, A63<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5nxA0vEk-isC" class="gsc_a_at">The clinical outcome study of dysferlinopathy: Muscle MRI pattern at baseline and longitudinal changes over one year</a><div class="gs_gray">M Mori-Yoshimura, R Fernandez-Torrón, J Meredith, M Jabobs, F Smith, ...</div><div class="gs_gray">Journal of the Neurological Sciences 381, 819<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Og1tA8FjbJAC" class="gsc_a_at">European reference network for rare neuromuscular diseases: EURO-NMD</a><div class="gs_gray">T Evangelista, R Leary, M Hails, H Lochmüller, K Bushby</div><div class="gs_gray">Neuromuscular Disorders 27, S241<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LK8CI43ZvvMC" class="gsc_a_at">Congenital muscular dystrophy with cataracts and mild cognitive impairment cause by mutations in INPP5K: Overlapping Marinesco-Sjögren syndrome and dystroglycanopathy</a><div class="gs_gray">A Nascimento, C Ortez, C Jou, M Alarcón, A Bates, A Topf, D Itzep, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S110<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:tHtfpZlB6tUC" class="gsc_a_at">Brain imaging indicates genotype-phenotype association in Duchenne muscular dystrophy</a><div class="gs_gray">N Doorenweerd, C Bettolo, K Hollingsworth, J Hendriksen, E Niks, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S249<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qe6vwMD2xtsC" class="gsc_a_at">Patient's perception around disease progression and influential factors in spinal muscle atrophy</a><div class="gs_gray">RM Lofra, M Eagle, A Fort, D Ramsey, M Scoto, F Muntoni, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S130<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:zGdJYJv2LkUC" class="gsc_a_at">Is cardiac dysfunction a feature of dysferlinopathy? Data from the clinical outcome study of dysferlinopathy</a><div class="gs_gray">RF Torron, E Harris, J Bourke, K Bettinson, H Hilsden, S Spuler, J Day, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S145<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Anoctamin 5 muscular dystrophy mimicking metabolic myopathy</a><div class="gs_gray">H Durmus, R Scalco, A Gardiner, A Manole, A Schapira, J Morrow, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S144<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:FiDNX6EVdGUC" class="gsc_a_at">Injection site reactions as a consequence of long-term subcutaneous administration of drisapersen in Duchenne muscular dystrophy</a><div class="gs_gray">E Niks, R Van Doorn, J Domingos, M Guglieri, M Pane, A Mauro, A Virgili, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S216-S217<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">Failure to attend neuromuscular clinic appointments: reasons and interventions</a><div class="gs_gray">S Cameron, G Eglon, L Hastings, V Straub, H Lochmüller, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S131-S132<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">A case of severe encephalopathy and movement disorder due to mutations in the TRAPPC11 gene</a><div class="gs_gray">A Nascimento, C Ortez, J Colomer, D Natera, A Frongia, M Alarcon, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S111-S112<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Does the performance of upper limb capture functional variations in dysferlinopathy?</a><div class="gs_gray">M James, A Mayhew, D Moat, M Eagle, E Maron, R Gee, K Rose, B Drogo, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S145-S146<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Two novel mutations in the FHL1 gene extending the phenotypic spectrum</a><div class="gs_gray">E Strehle, K Johnson, V Rakocevic-Stojanovic, S Peric, M Farrugia, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S138-S139<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Detection of TRIM32 variants associated with LGMD2H in a large cohort of patients with unexplained limb-girdle weakness</a><div class="gs_gray">K Johnson, A Töpf, M Bertoli, L Phillips, W De Ridder, J Baets, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S142-S143<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">DMD HUB: Expanding clinical trial capacity for Duchenne muscular dystrophy in the UK</a><div class="gs_gray">E Heslop, V Straub, M Guglieri, C Turner, B Davis, E Crossley, A Johnson, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S100<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Identification and characterisation of ATP2A1 variants through whole exome sequencing</a><div class="gs_gray">K Johnson, AM Arroyo, M Zulaica, R Fernández-Torrón, AL de Munain, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S229<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Examining the relationship between Dixon quantitative MRI and physiotherapy functional outcome measures in dysferlinopathy</a><div class="gs_gray">RF Torron, M James, F Smith, N Azzabou, I Wilson, H Reyngoudt, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S146<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Clinical outcome study of dysferlinopathy: what are the best outcome measures for dysferlinopathy patients?</a><div class="gs_gray">M James, M Jacobs, A Mayhew, J Feng, S Spuler, J Day, K Jones, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S227<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Audit of unplanned hospital admissions for patients with neuromuscular disorders in Cumbria and the north east of England</a><div class="gs_gray">E Elliott, M Guglieri, T Evangelista, H Lochmüller, V Straub, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S241<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ufrVoPGSRksC" class="gsc_a_at">Longitudinal proteomic analysis of sera allows to non-invasively monitor disease progression in Duchenne muscular dystrophy</a><div class="gs_gray">P Spitali, R Tsonaka, K Hettne, Z Koeks, A Roos, V Straub, JP Domingos, ...</div><div class="gs_gray">Neuromuscular Disorders 27, S168<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">THE MRC CENTRE FOR NEUROMUSCULAR DISEASES OBSERVATIONAL COHORTS: A TOOL TO TRANSLATE DISCOVERY SCIENCE INTO TREATMENTS FOR PATIENTS</a><div class="gs_gray">A Bellin, E Mathews, J Morrow, G Ramdharry, H Houlden, F Muntoni, ...</div><div class="gs_gray">Annual Scientific Meeting of the Muscle-Study-Group on Neuromuscular&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:KTwcwpFFj4wC" class="gsc_a_at">Fracture incident rate and growth in a nationwide cohort of boys with Duchenne Muscular Dystrophy</a><div class="gs_gray">S Joseph, K Bushby, M Guglieri, I Horrocks, V Straub, SF Ahmed, ...</div><div class="gs_gray">Bone Abstracts 6<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">Characterisation of skeletal developmental in mouse models of Duchenne Muscular Dystrophy</a><div class="gs_gray">C Wood, SC Wong, V Straub, SF Ahmed, C Farquharson</div><div class="gs_gray">Bone Abstracts 6<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:bKqednn6t2AC" class="gsc_a_at">Fracture incident rate and growth in a nationwide cohort of boys with Duchenne muscular dystrophy (Presented on behalf of The UK North Star Clinical Network)</a><div class="gs_gray">S Joseph, K Bushby, M Guglieri, I Horrocks, V Straub, SF Ahmed, ...</div><div class="gs_gray">European Journal of Paediatric Neurology 21, e231<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Impact of three decades of improvements in standards of care on clinical outcomes in Duchenne muscular dystrophy</a><div class="gs_gray">HJA van Ruiten, AC Jimenez-Moreno, E Elliot, A Mayhew, M James, ...</div><div class="gs_gray">European Journal of Paediatric Neurology 21, e235-e236<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">The international clinical outcome study in dysferlinopathy</a><div class="gs_gray">R Ghaoui, J Meredith, R Fernandez-Torron, U Moore, J Diaz-Manera, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 88 (5), e1-e1<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qCaWouos7ogC" class="gsc_a_at">Clinical Outcomes in Duchenne MuscularDystrophy: A Study of 5345 Patients fromthe TREAT-NMD DMD Global Database</a><div class="gs_gray">Z Koeks, C Bladen, D Salgado, E van Zwet, O Pogorleyova, G McMacken, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3lUAU8Oskd0C" class="gsc_a_at">NGS as a diagnostic tool for unexplained limb-girdle muscles weakness: Results of European MYO-SEQ project in 75 Polish patients</a><div class="gs_gray">A Lusakowska, K Johnson, A Topf, M Bertoli, L Phillips, V Straub, M Lek, ...</div><div class="gs_gray">Acta Neurobiologiae Experimentalis 77 (Suppl. 1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yY3RG6sOEgwC" class="gsc_a_at">Myotubular and Centronuclear Myopathy Patient Registry: Accelerating the pace of research and treatment</a><div class="gs_gray">J Bullivant, K Napier, M Radochonski, L Render, A Hunter, M Spring, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S40<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:2ywjKiB__4kC" class="gsc_a_at">Functional outcome measures and muscle MRI pattern recognition in dysferlinopathy: The JAIN COS Study</a><div class="gs_gray">R Fernandez-Torron, M James, J Diaz Manera, A Mayhew, ...</div><div class="gs_gray">European Journal of Neurology, 96-97<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">Is cognitive impairment progressive in the mdx mouse?</a><div class="gs_gray">E Bagdatlioglu, P Porcari, E Greally, A Roos, AM Blamire, V Straub</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S9<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">NHE1 inhibition as a potential therapy to attenuate DMD pathology</a><div class="gs_gray">P Ioannou, U Burki, E Greally, S Laval, S Schaefer, V Straub</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S11<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:wvYxNZNCP7wC" class="gsc_a_at">Audit of unplanned hospital admissions for patients with neuromuscular disorders in the North East</a><div class="gs_gray">E Elliott, H van Ruiten, M Guglieri, T Evangelista, H Lochmüller, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S38<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ziOE8S1-AIUC" class="gsc_a_at">Clinical research activity in the Newcastle MRC Centre for Neuromuscular Disease</a><div class="gs_gray">A Peel, B Davis, J Maddison, C Boyd, V Straub, H Lochmüller, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S42-S43<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:q-HalDI95KYC" class="gsc_a_at">Semi-quantitative muscle MRI in dysferlinopathy patients: pattern recognition and implications for clinical trials</a><div class="gs_gray">J Díaz-Manera, R Fernandez-Torrón, J Llauger, M James, A Mayhew, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S14<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Muscle magnetic resonance imaging in VCP-related multi-system proteinopathy (IBMPFD): is the clue in the “fat pockets”?</a><div class="gs_gray">R Fernandez-Torrón, C Marini-Bettolo, H Lochmüller, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S44<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">An audit on the reasons why patients failed to attend the Newcastle University Trust Hospitals’ Neuromuscular Clinics, at the John Walton Muscular Dystrophy Research Centre&nbsp;…</a><div class="gs_gray">S Cameron, G Eglon, L Hastings, V Straub, M Guglieri, H Lochmüller, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S38-S39<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Development of a robust disease specific functional measure suitable for trials in ambulant and non-ambulant individuals with dysferlinopathy</a><div class="gs_gray">M James, A Mayhew, M Eagle, U Moore, RM Lofra, H Hilsden, K Bettinson, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S11<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HE397vMXCloC" class="gsc_a_at">Telethonin gene mutations detected by next generation sequencing</a><div class="gs_gray">J Hudson, S Cameron, E Graham, T Evangelista, V Straub, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S15<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Developing digital tools for improving patient and family engagement in paediatric clinical research</a><div class="gs_gray">O Veldhuizen, C Turner, M Hails, R Bendixen, V Straub</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S42<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Myofibrillar myopathy phenotype due to recessive mutations in MEGF10</a><div class="gs_gray">E Harris, A Töpf, J Hudson, R Barresi, K Bushby, H Lochmüller, V Straub</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S9<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Clinical characterisation of a large international congenital titinopathy cohort</a><div class="gs_gray">EC Oates, KS Yau, K Jones, JE Smith, S Donkervoort, L Swanson, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S37<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">The TREAT-NMD Advisory Committee for Therapeutics (TACT): facilitating drug development in neuromuscular rare diseases</a><div class="gs_gray">C Turner, V Straub, K Wagner</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S37<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:35N4QoGY0k4C" class="gsc_a_at">Global FKRP registry</a><div class="gs_gray">A Robertson, L Bindoff, JP Laurent, K Mathews, A Rutkowski, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S6<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Clinical outcome study for dysferlinopathy: Sensitivity of outcome measures over one-year</a><div class="gs_gray">U Moore, M James, A Mayhew, M Jacobs, J Feng, E Harris, ...</div><div class="gs_gray">Neuromuscular Disorders 1 (27), S8<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:EsEWqaRxkBgC" class="gsc_a_at">MRC biobank Newcastle–A five-year review of the John Walton Muscular Dystrophy Research Centre experience</a><div class="gs_gray">A Roos, D Cox, M Reza, M Guglieri, V Straub, H Lochmüller</div><div class="gs_gray">Neuromuscular Disorders 26, S207<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">Analysis of a large international cohort confirms that recessively inherited loss-of-function TTN mutations cause prenatal or infant-onset muscle disease, often complicated by&nbsp;…</a><div class="gs_gray">E Oates, K Yau, S Donkervoort, L Swanson, S Brammah, A Topf, I Richard, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S89<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:An6A6Jpfc1oC" class="gsc_a_at">Identification of sequence variants in eight genes associated with dystroglycanopathies using whole exome sequencing</a><div class="gs_gray">L Phillips, A Töpf, K Johnson, M Bertoli, L Xu, M Lek, K Claeys, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S166<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Long-term follow up of a benign congenital GBE1 deficiency: Report of three siblings</a><div class="gs_gray">C Ortez, A Nascimento, C Jimenez-Mallebrera, C Jou, M Llano, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S200<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">Exercise intolerance and myalgia: First clinical sign of a primary alpha-sarcoglycanopathy</a><div class="gs_gray">C Ortez, C Jou, J Campistol, A Nascimento, C Jimenez-Mallebrera, A Topf, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S92<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4MWp96NkSFoC" class="gsc_a_at">A recessive TTN founder mutation causes a distal myopathy phenotype in a Serbian cohort</a><div class="gs_gray">A Topf, JN Glumac, S Perić, M Cassop-Thompson, M Bertoli, K Johnson, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S113-S114<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:URolC5Kub84C" class="gsc_a_at">Application of exome sequencing technologies: A case study of patients with unexplained limb-girdle muscle weakness harbouring GAA mutations</a><div class="gs_gray">K Johnson, M Bertoli, L Phillips, A Töpf, K Claeys, VR Stojanovic, S Perić, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S108-S109<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials</a><div class="gs_gray">J Domingos, M Eagle, A Moraux, J Butler, V Decostre, D Ridout, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S185<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_B80troHkn4C" class="gsc_a_at">LGMD2D intrafamilial clinical heterogeneity caused by alternative splicing of SGCA gene</a><div class="gs_gray">L Gonzalez-Quereda, P Gallano, E Gallardo, M Rodriguez, C Lleixa, ...</div><div class="gs_gray">Neuromuscular Disorders 26, S91<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ybfzIt2tCtgC" class="gsc_a_at">A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy: O3131</a><div class="gs_gray">J Vissing, R Barresi, N Witting, M van Ghelue, L Gammelgaard, L Bindoff, ...</div><div class="gs_gray">European Journal of Neurology 23<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4n0clTBhZ78C" class="gsc_a_at">Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials (vol 134, pg 3547, 2011)</a><div class="gs_gray">K Anthony, S Cirak, S Torelli, G Tasca, L Feng, V Arechavala-Gomeza, ...</div><div class="gs_gray">Brain 139<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:V_vSwabWVtYC" class="gsc_a_at">Corrigendum to “Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT)”[Neuromuscular Disorders 25 (2015) 937&nbsp;…</a><div class="gs_gray">E Landfeldt, A Mayhew, M Eagle, P Lindgren, CF Bell, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 26 (4), 329<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Erratum: Dystrophin quantification and clinical correlations in Becker muscular dystrophy: Implications for clinical trials (Brain (2011) 134 (3547-3559</a><div class="gs_gray">K Anthony, S Cirak, S Torelli, G Tasca, L Feng, V Arechavala-Gomeza, ...</div><div class="gs_gray">Brain 139 (4), e27<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Ei5r6KrKXVQC" class="gsc_a_at">NHE1 inhibition as a potential therapy to attenuate DMD pathology</a><div class="gs_gray">P Ioannou, U Burki, E Greally, S Laval, S Schaefer, V Straub</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 26, S12-S12<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WM2K3OHRCGMC" class="gsc_a_at">Cerebral diffusion weighted magnetic resonance spectroscopy suggests membrane damage or structural deficits in neuronal and glial cells in Duchenne muscular dystrophy patients</a><div class="gs_gray">N Doorenweerd, E Ercan, MT Hooijmans, J Burakiewicz, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 26, S9-S9<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:s1ouQE5r0WUC" class="gsc_a_at">Pattern recognition by semiquantitative radiological analysis in a large and multinational cohort of dysferlin patients</a><div class="gs_gray">V Straub, R Fernandez-Torron, J LLauger Rossello, J Diaz-Manera, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 26, S16-S16<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:w7CBUyPWg-0C" class="gsc_a_at">Clinical research activity in the Newcastle MRC centre for neuromuscular disease</a><div class="gs_gray">B Davis, J Maddison, J Worley, V Straub, H Lochmuller, D Turnbull, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 26, S41-S41<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RJNGbXJAtMsC" class="gsc_a_at">Global FKRP registry</a><div class="gs_gray">A Robertson, O Schreiber-Katz, L Bindoff, JP Laurent, K Mathews, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 26, S15-S16<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8p8iYwVyaVcC" class="gsc_a_at">Association Study of Exon Variants in the NF-ÎºB and TGFÎ² Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy</a><div class="gs_gray">L Bello, J Punetha, H Gordish-Dressman, M Giri, EP Hoffman, A Barp, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3A3nxV7CjKIC" class="gsc_a_at">Diffusion MR investigation at 7T of a mouse model of Duchenne muscular dystrophy</a><div class="gs_gray">P Porcari, E Greally, V Straub, AM Blamire</div><div class="gs_gray">ISMRM workshop on Breaking the barriers in Diffusion MRI<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:U0iAMwwPxtsC" class="gsc_a_at">Investigating the CNS in mouse models for Duchenne muscular dystrophy</a><div class="gs_gray">E Bagdatlioglu, P Porcari, D O'Hogain, E Greally, S Laval, A Blamire, ...</div><div class="gs_gray">9th UK Annual Neuromuscular Research Conference<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Vno172sVVMwC" class="gsc_a_at">The UK Myotonic Dystrophy Patient Registry</a><div class="gs_gray">N Nikolenko, L Wood, C Turner, D Hilton-Jones, A Atalaia, ...</div><div class="gs_gray">14th International Congress on Neuromuscular Diseases (ICNMD XIV)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-yGd096yOn8C" class="gsc_a_at">Phase 1 safety and pharmacokinetics of the novel enzyme replacement therapy neoGAA in treatment-naive and alglucosidase alfa-treated late-onset Pompe disease patients</a><div class="gs_gray">S Ladha, P Laforet, E Mengel, A Pestronk, J Pouget, B Schoser, V Straub, ...</div><div class="gs_gray">Molecular Genetics and Metabolism 2 (117), S117-S118<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hMsQuOkrut0C" class="gsc_a_at">A peculiar case of LGMD with rimmed vacuoles</a><div class="gs_gray">V Ponzalino, L Vercelli, L Chiadò Piat, E Vittonatto, S Boschi, S Bortolani, ...</div><div class="gs_gray">16° Congresso Nazionale Associazione Italiana di Miologia, 62-62<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Why are some patients with Duchenne muscular dystrophy (DMD) dying early?</a><div class="gs_gray">H VAN RUITEN, C MARINI-BETOLLO, M EAGLE, H LOCHMULLER, ...</div><div class="gs_gray">Developmental Medicine &amp; Child Neurology 58<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eI34FqJmdUoC" class="gsc_a_at">Novel variant blossom: From pathology to next generation sequencing to cellular biology</a><div class="gs_gray">W Zhu, S Mitsuhashi, W Liang, T Ito, I Nishino</div><div class="gs_gray">Neuromuscular Disorders 25, S298<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:wLxue7F8ec0C" class="gsc_a_at">A latent factor-based composite timed motor performance index representing mobility is sensitive to stage of disease and 1-year progression in Duchenne muscular dystrophy</a><div class="gs_gray">E Henricson, R Abresch, E Goude, A Nicorici, E deBie, C McDonald</div><div class="gs_gray">Neuromuscular Disorders 25, S229<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nqdriD65xNoC" class="gsc_a_at">ScanBank–The development of an online database for neuromuscular MRI scans</a><div class="gs_gray">O Veldhuizen, C Wood, A Murphy, R Thompson, NS Krogh, V Straub</div><div class="gs_gray">Neuromuscular Disorders 25, S272<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Hck25ST_3aIC" class="gsc_a_at">A novel phenotype associated with STIM1 gene: A case report of a patient with a painful myopathy</a><div class="gs_gray">M Neri, E Harris, C Scotton, A Topf, M Fang, J Wang, R Barresi, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S255-S256<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">The importance of dosage analysis in dysferlinopathy</a><div class="gs_gray">J Hudson, E Graham, R Charlton, M Guglieri, K Bushby, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S231-S232<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Collaboration in NeurOmics: Enabling effective data-sharing and maximising impact in neuromuscular disease</a><div class="gs_gray">C Turner, K Bushby, L Johnston, H Lochmüller, O Riess, B Wirth, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S298<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yFnVuubrUp4C" class="gsc_a_at">A novel mutation in PIEZO2 in a family presenting with autosomal dominant myopathy, ptosis, external ophthalmoplegia and distal symphalangism</a><div class="gs_gray">M Bertoli, A Topf, E Harris, S Laval, A Sarkozy, H Lochmüller, S Lynch, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S276-S277<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Clinical data and MRI findings in two brothers with limb girdle muscular dystrophy due to LAMA2 mutations</a><div class="gs_gray">E Harris, A Topf, M McEntagart, C Sewry, V Straub</div><div class="gs_gray">Neuromuscular Disorders 25, S235<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:tuHXwOkdijsC" class="gsc_a_at">TREAT-NMD (translational research in Europe, assessment and treatment for neuromuscular disorders)</a><div class="gs_gray">A Aartsma-Rus, E Hoffman, F Bucella, K Flanigan, J Kirschner, A Kole, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S271<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Developing digital tools for improving patient and family engagement in paediatric clinical research</a><div class="gs_gray">O Veldhuizen, C Turner, M Hails, V Straub</div><div class="gs_gray">Neuromuscular Disorders 25, S271-S272<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">The TREAT-NMD Advisory Committee for Therapeutics (TACT): An innovative de-risking model to foster orphan drug development</a><div class="gs_gray">D Wells, E Heslop, C Csimma, V Straub, J McCall, K Nagaraju, K Wagner, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S271<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials</a><div class="gs_gray">V Ricotti, M Eagle, J Butler, V Decostre, R Deborah, A Moraux, K Anthony, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S229<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5ugPr518TE4C" class="gsc_a_at">RYR1-related exertional rhabdomyolysis: Expanding spectrum and diagnostic challenges</a><div class="gs_gray">A Gardiner, R Scalco, M Parton, M Hanna, R Pitceathly, E Zanoteli, ...</div><div class="gs_gray">Neuromuscular Disorders 25, S257-S258<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:abG-DnoFyZgC" class="gsc_a_at">NHE1 inhibition as a potential therapeutic strategy to attenuate DMD pathology</a><div class="gs_gray">P Ioannou, U Burki, S Laval, S Schaefer, V Straub</div><div class="gs_gray">Neuromuscular Disorders 25, S291-S292<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:maZDTaKrznsC" class="gsc_a_at">Congenital myotonic dystrophy–implications for cardiology screening</a><div class="gs_gray">A Murphy, A Porter, J Bourke, V Straub</div><div class="gs_gray">Neuromuscular Disorders 25, S212<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Stratified cohorts and natural history studies at the MRC Centre for Neuromuscular diseases–a tool to translate discovery science into treatments for patients: 4</a><div class="gs_gray">C Blochet, I Skorupinska, P Machado, E Mathews, J Morrow, ...</div><div class="gs_gray">Muscle &amp; Nerve 52<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:F9HO9s0W2bwC" class="gsc_a_at">A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD)</a><div class="gs_gray">F Muntoni, T Voit, L Servais, PY Baudin, V Straub, E Mercuri, J Bain, ...</div><div class="gs_gray">HUMAN GENE THERAPY CLINICAL DEVELOPMENT 26 (2), 92-95<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:2l5NCbZemmgC" class="gsc_a_at">THE VALUE OF NEXT GENERATION SEQUENCING IN DIAGNOSING NEUROMUSCULAR DISORDERS</a><div class="gs_gray">V Straub</div><div class="gs_gray">EUROPEAN JOURNAL OF NEUROLOGY 22, 6-7<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:i_7YvbSbtFEC" class="gsc_a_at">The TREAT-NMD advisory committee for therapeutics (TACT)</a><div class="gs_gray">E Heslop, C Csimma, V Straub, J McCall, K Nagaraju, KR Wagner, ...</div><div class="gs_gray">Orphanet Journal of Rare Diseases 10 (1)<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:uWiczbcajpAC" class="gsc_a_at">A Phase 4 Prospective Study in Patients with Adult Pompe Disease Treated with Alglucosidase Alfa (S50. 002)</a><div class="gs_gray">B Thurberg, P Carlier, J Kissel, B Schoser, A Pestronk, R Barohn, ...</div><div class="gs_gray">Neurology 84 (14 Supplement)<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:iKswqCX-FLkC" class="gsc_a_at">Lochmüller H, Bushby K. Development and Psychometric Analysis of the</a><div class="gs_gray">E Landfeldt, A Mayhew, M Eagle, P Lindgren, CF Bell, M Guglieri, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IT1MJ6E3JesC" class="gsc_a_at">Bushby K, Lochmüller H, Morris C. Muscle-Derived Proteins as Serum</a><div class="gs_gray">PM Burch, O Pogoryelova, R Goldstein, D Bennett, M Guglieri, V Straub</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:CCeGMaHljPEC" class="gsc_a_at">Korinthenberg R, Flanigan KM, Kaufmann P, McNeil E, Mendell J, Hesterlee S, Wells DJ, Bushby K. The TREAT-NMD advisory committee for therapeutics</a><div class="gs_gray">E Heslop, C Csimma, V Straub, J McCall, K Nagaraju, KR Wagner, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eH23hyXCXa4C" class="gsc_a_at">In vivo diffusion MR study at 7T of hindlimb muscles in a mouse model of Duchenne muscular dystrophy</a><div class="gs_gray">P Porcari, E Greally, V Straub, AM Blamire</div><div class="gs_gray">ISMRM 23rd Annual Scientific Meeting &amp; Exhibition<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:XDrR66g3YHsC" class="gsc_a_at">Diffusion MR study at 7T of hindlimb muscles in dystrophic mice</a><div class="gs_gray">P Porcari, E Greally, V Straub, AM Blamire</div><div class="gs_gray">8th UK Neuromuscular Translational Research Conference<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:9shLKfS_uJEC" class="gsc_a_at">Investigating the effect of dystrophin deficiency on brain function in mouse models of Duchenne muscular dystrophy</a><div class="gs_gray">E Bagdatlioglu, E Greally, P Porcari, S Laval, A Blamire, V Straub</div><div class="gs_gray">8th UK Neuromuscular Translational Research Conference<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:L24QuVWYgZ0C" class="gsc_a_at">Consortium for Products Across Europe in Duchenne Muscular Dystrophy (SCOPE-DMD)</a><div class="gs_gray">V Straub, O Veldhuizen, M Bertoli, M Eagle, G Campion, I Ferreira, ...</div><div class="gs_gray">Human Gene Therapy Clinical Development<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:jSAVyFp_754C" class="gsc_a_at">Lowering the age of diagnosis of Duchenne muscular dystrophy: 007</a><div class="gs_gray">H VAN RUITEN, V STRAUB, K BUSHBY, M GUGLIERI</div><div class="gs_gray">Developmental Medicine &amp; Child Neurology 57<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:OzeSX8-yOCQC" class="gsc_a_at">GP 281: Detection of homozygous and compound heterozygous deletions in TRIM32 in LGMD patients analyzed by a combined strategy of CGH-array and Massive Parallel Sequencing</a><div class="gs_gray">J Nectoux, R de Cid, S Baulande, F Leturcq, JA Urtizberea, ...</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 901-902<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:H_jBuBxbQIAC" class="gsc_a_at">LI 2: The ABC of autosomal recessive limb girdle muscular dystrophy</a><div class="gs_gray">V Straub</div><div class="gs_gray">Neuromuscular Disorders 24 (9-10), 850<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">GP 313: Intrafamilial heterogeneity in an alpha-dystroglycanopathy due to GDP-Mannose Pyrophosphorylase B (GMPPB) mutations</a><div class="gs_gray">M Bertoli, T Evangelista, A Sarkozy, A Schaefer, P Goldsmith, R Barresi, ...</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 915-916<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Ade32sEp0pkC" class="gsc_a_at">GP 120: The Sodium/Hydrogen Exchanger (NHE-1): A promising novel target for DMD</a><div class="gs_gray">U Burki, E Greally, S Laval, S Schäfer, V Straub</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 836<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:lgwcVrK6X84C" class="gsc_a_at">GP 116: SCOPE-DMD, an EU FP7 funded consortium for skipping trail across Europe in Duchenne muscular dystrophy</a><div class="gs_gray">O Veldhuizen, G Campion, A Morgan, H Aygun, S Wojczewski, T Voit, ...</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 830<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:0izLItjtcgwC" class="gsc_a_at">GP 161: Improving the diagnosis of Duchenne muscular dystrophy</a><div class="gs_gray">M Guglieri, HJA van Ruiten, V Straub, K Bushby</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 853-854<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:8d8msizDQcsC" class="gsc_a_at">GP 280: Preserved expression of truncated telethonin in a patient with LGMD2G</a><div class="gs_gray">V Straub, NP Davies, R Barresi, C Morris, C Pickthall, K Bushby</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 901<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">GP 125: Manganese enhanced muscle MRI as a sensitive outcome measure of dystrophin restoration in the mdx mouse</a><div class="gs_gray">E Greally, AM Blain, ST Ahmed, SH Laval, AM Blamire, V Straub</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 838<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-FonjvnnhkoC" class="gsc_a_at">GP 111: Development of an ultrasensitive ELISA method for the determination of phosphorodiamidate morpholino oligonucleotide (PMO) levels in biological samples</a><div class="gs_gray">U Burki, A Blain, S Laval, V Straub</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 828<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:vbGhcppDl1QC" class="gsc_a_at">GO 14: The burden of Duchenne muscular dystrophy: An international, cross-sectional study</a><div class="gs_gray">E Landfeldt, P Lindgren, CF Bell, C Schmitt, M Guglieri, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 853<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">TP 24: Alglucosidase alfa reduces lysosomal glycogen in skeletal muscle biopsies of patients with late-onset Pompe disease (LOPD)</a><div class="gs_gray">BL Thurberg, A van der Ploeg, JT Kissel, B Schoser, A Pestronk, ...</div><div class="gs_gray">Neuromuscular Disorders 24 (9), 871-872<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">Expanding The Clinical And Genetic Spectrum Of MYH7 Related Skeletal Myopathies In The United Kingdom (P3. 302)</a><div class="gs_gray">K Brennan, A Sarkozy, C Longman, M Guglieri, T Polvikoski, M Farrugia, ...</div><div class="gs_gray">Neurology 82 (10 Supplement)<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:t-hv7AR41mYC" class="gsc_a_at">P58 Psycho-organic symptoms as early manifestation of adult onset POMT1-related muscular dystrophy</a><div class="gs_gray">J Haberlova, Z Mitrović, R Barresi, K Bushby, V Straub, I Barić, ...</div><div class="gs_gray">Neuromuscular Disorders 24, S22<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:D_tqNUsBuKoC" class="gsc_a_at">P76 Clinical research activity in the Newcastle MRC centre for neuromuscular disease</a><div class="gs_gray">J Maddison, B Davis, J Worley, G Kenyon, V Straub, H Lochmuller, ...</div><div class="gs_gray">Neuromuscular Disorders 24, S27<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LXmCCkuhhTsC" class="gsc_a_at">P77 Collagen XII; novel disease-causing candidate gene for Bethlem-like patients</a><div class="gs_gray">GT Farsani, D Hicks, S Laval, J Collins, A Sarkozy, E Martoni, A Shah, ...</div><div class="gs_gray">Neuromuscular Disorders 24, S27<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:EPG8bYD4jVwC" class="gsc_a_at">P34 Reducing the cost of MRI in neuromuscular clinical trials: acceleration of fat-fraction measurement in Becker muscular dystrophy by combined compressed sensing and parallel&nbsp;…</a><div class="gs_gray">KG Hollingsworth, DM Higgins, M McCallum, L Ward, A Coombs, V Straub</div><div class="gs_gray">Neuromuscular Disorders 24, S16<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-nhnvRiOwuoC" class="gsc_a_at">P12 Hypertrophy in cardiomyocytes isolated from mdx embryos</a><div class="gs_gray">M Ritso, E Roberts, S Wright, T Slater, S Laval, K Bushby, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 24, S10<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">P40 BIOIMAGE-NMD (BIOIMAGE-Neuromuscular Diseases)</a><div class="gs_gray">O Veldhuizen, G Campion, B Aguilera, H Kan, J Verschuuren, P Carlier, ...</div><div class="gs_gray">Neuromuscular Disorders 24, S17<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:fFSKOagxvKUC" class="gsc_a_at">P16 Towards a consensus on biochemical outcome measures for Duchenne muscular dystrophy clinical trials</a><div class="gs_gray">S Torelli, K Anthony, V Arechavala-Gomeza, LE Taylor, A Vulin, ...</div><div class="gs_gray">Neuromuscular Disorders 24, S11<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">P23 SCOPE-DMD (Exon Scipping COnsortium for Products across Europe in Duchenne Muscular Dystrophy)</a><div class="gs_gray">O Veldhuizen, G Campion, I Ferreira, H Aygun, S Wojczewski, T Voit, ...</div><div class="gs_gray">Neuromuscular Disorders 24, S12<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Se3iqnhoufwC" class="gsc_a_at">P1 Peptide-conjugated phosphodiamidate morpholino treatment in mdx mice: cardiac dystrophin restoration and function</a><div class="gs_gray">A Blain, E Greally, G McCLorey, C Godfrey, SH Laval, M Gait, M Wood, ...</div><div class="gs_gray">Neuromuscular Disorders 24, S7<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:pQTOvowfQioC" class="gsc_a_at">O. 1 Collagen XII as a new disease gene for Bethlem-like myopathy</a><div class="gs_gray">D Hicks, GT Farsani, S Laval, J Collins, E Martoni, A Shah, Y Zou, M Koch, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (9), 739<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">O. 2 Collagen type XII: A new congenital matrix and muscle disease</a><div class="gs_gray">Y Zou, D Zwolanek, Y Hu, G Schreiber, K Brockmann, Y Izu, Z Tian, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (9), 739-740<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:YohjEiUPhakC" class="gsc_a_at">P. 5.9 Clinical and molecular analysis of a large cohort of patients with anoctaminopathy</a><div class="gs_gray">A Sarkozy, D Hicks, J Hudson, SH Laval, R Barresi, M Guglieri, E Harris, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (9), 766<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:EYYDruWGBe4C" class="gsc_a_at">P. 1.6 Investigating collagen VI biosynthesis and assembly in the context of ALG2 impairment in Ullrich/CMS-like family</a><div class="gs_gray">GT Farsani, D Hicks, M Salih, MZ Seidhamed, J Cossins, D Beeson, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (9), 743<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:EkHepimYqZsC" class="gsc_a_at">P. 1.2 Natural history of pulmonary function in collagen VI-related myopathies: An international study</a><div class="gs_gray">AR Foley, S Quijano-Roy, J Collins, V Straub, M McCallum, N Deconinck, ...</div><div class="gs_gray">Neuromuscular Disorders 23 (9), 741-742<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:D_sINldO8mEC" class="gsc_a_at">ASSOCIATION STUDIES ARTICLE</a><div class="gs_gray">T Müller, S Mizumoto, I Suresh, Y Komatsu, J Vodopiutz, M Dundar, ...</div><div class="gs_gray">Human Molecular Genetics 22 (18)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:zUl2_INMlC4C" class="gsc_a_at">Expanding the Clinical Phenotype of Agrin-Associated Congenital Myasthenic Syndrome (S45. 003)</a><div class="gs_gray">A Chaouch, T Torbergsen, J Muller, K Bushby, V Straub, A Abicht, ...</div><div class="gs_gray">Neurology 80 (7 Supplement), S45. 003-S45. 003<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:e3CVSTJ63dQC" class="gsc_a_at">Date deposited: 19th December 2013</a><div class="gs_gray">S Rodger, H Lochmuller, A Tassoni, K Gramsch, K Konig, K Bushby, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Dystrophinopathies</a><div class="gs_gray">TA Willis, V Straub</div><div class="gs_gray">Neuromuscular Imaging, 199-207<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:f2IySw72cVMC" class="gsc_a_at">Beta-Blockers</a><div class="gs_gray">A Blain, E Greally, S Laval, A Blamire, V Straub</div><div class="gs_gray">Left and Right Ventricular Function, and In-Vivo Calcium Influx in Muscular<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">EXOME SEQUENCING IN THREE FAMILIES WITH CYTOPLASMIC BODY MYOPATHY WITH EARLY RESPIRATORY FAILURE</a><div class="gs_gray">P Chinnery, G Pfeffer, H Griffin, H Elliott, R Barresi, V Straub, B Udd, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery and Psychiatry 83, A22<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">GP 32 Progressive core myopathy with dilated cardiomyopathy, respiratory failure and severe scoliosis caused by a novel mutation in the MYH7 gene</a><div class="gs_gray">A Sarkozy, T Polvikoski, M Eagle, H Lochmüller, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 22 (9), 817-818<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">GP 9 Basement membrane pathology associated with FKRP and fukutin deficiency in zebrafish</a><div class="gs_gray">A Wood, AP Cumine, J Müller, SH Laval, K Bushby, H Lochmüller, ...</div><div class="gs_gray">Neuromuscular Disorders 22 (9), 814<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">SP 46 Rare disease policies: An important perspective for neuromuscular disorders</a><div class="gs_gray">S Lynn, H Lochmuller, V Straub, K Bushby</div><div class="gs_gray">Neuromuscular Disorders 22 (9), 897<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">SP 39 BIO-NMD: An update on the discovery and validation of biomarkers for Neuromuscular Diseases (NMDs)–An EU funded FP7 project</a><div class="gs_gray">A Ferlini, V Straub</div><div class="gs_gray">Neuromuscular Disorders 22 (9), 883<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:olpn-zPbct0C" class="gsc_a_at">TP 31 Biochemical and clinical variability of Becker muscular dystrophy: Predicting optimal target exons for exon skipping therapy in Duchenne muscular dystrophy</a><div class="gs_gray">K Anthony, V Arechavala-Gomeza, V Ricotti, S Torelli, L Feng, G Tasca, ...</div><div class="gs_gray">Neuromuscular Disorders 22 (9), 862<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">DP 18 Manganese enhanced MRI as an outcome measure in assessing skeletal muscle calcium uptake in muscular dystrophy mouse models</a><div class="gs_gray">E Greally, A Blain, AM Blamire, G MacGowan, SH Laval, V Straub</div><div class="gs_gray">Neuromuscular Disorders 22 (9), 823<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">165 Novel ANO5 gene mutations, c. 989dupT and c. 2018A→ G causing Limb Girdle Muscular dystrophy 2L</a><div class="gs_gray">J Panicker, H Lochmuller, K Bushby, V Straub, D Hicks, A Sarkozy, P Ray</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 83 (3), e1-e1<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SP6oXDckpogC" class="gsc_a_at">1106 The clinical phenotypic spectrum of GFPT1 associated congenital myasthenic syndrome</a><div class="gs_gray">A Chaouch, JS Mueller, V Guergueltcheva, F Muntoni, K Bushby, V Straub, ...</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 83 (3), e1-e1<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QAOzB4mb83kC" class="gsc_a_at">TP 31 Biochemical and clinical variability of Becker muscular dystrophy: Predicting optimal target exons for exon skipping therapy in Duchenne muscular dystrophy</a><div class="gs_gray">V Arechavala-Gomeza, V Ricotti, S Torelli, L Feng, G Tasca, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 22 (9), 862<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Y9VhQm-5nPIC" class="gsc_a_at">Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene associated myopathies (vol 33, pg 981, 2012)</a><div class="gs_gray">A Sarkozy, V Straub, H Lochmuller, F Norwood, K Bushby, A Klein, S Lillis, ...</div><div class="gs_gray">Human Mutation<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:sJPMR1oEGYQC" class="gsc_a_at">P20 Targeting the endogenous stress response in a mouse model of SBMA</a><div class="gs_gray">A Gray, N Nirmalananthan, B Malik, J Dick, M Hanna, L Greensmith</div><div class="gs_gray">Neuromuscular Disorders, S12<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:A8cqit5AE6sC" class="gsc_a_at">Moving forward with TACT: 2 years on</a><div class="gs_gray">E Heslop, K Bushby, C Csimma, V Straub, DJ Wells</div><div class="gs_gray">Neuromuscular Disorders 22, S33-S33<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:27LrP4qxOz0C" class="gsc_a_at">O05 Exome sequencing in three families with cytoplasmic body myopathy with early respiratory failure</a><div class="gs_gray">G Pfeffer, H Griffin, H Elliott, V Straub, R Baresi, B Udd, PF Chinnery</div><div class="gs_gray">Neuromuscular Disorders, S4-S5<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QsaTk4IG4EwC" class="gsc_a_at">P02 Development of in vivo imaging techniques to determine the biodistribution of antisense oligonucleotides in dystrophin deficient muscular dystrophy</a><div class="gs_gray">U Burki, A Blain, I Wilson, G Launay, T Coursindel, R Maxwell, M Carroll, ...</div><div class="gs_gray">Neuromuscular Disorders, S7<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3bvyWxjaHKcC" class="gsc_a_at">MRC NMD Centre Biobank: An overview</a><div class="gs_gray">M Reza, D Johnson, D Cox, S Laval, A Chaouch, R Barresi, J Morgan, ...</div><div class="gs_gray">United Kingdom Neuromuscular Translational Research Conference<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:0CzhzZyukY4C" class="gsc_a_at">P89 Cardiac MRI in LGMD2I patients</a><div class="gs_gray">TA Willis, KG Hollingsworth, BJ Dixon, GA MacGowan, AM Blamire, ...</div><div class="gs_gray">Neuromuscular Disorders, S32<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ODE9OILHJdcC" class="gsc_a_at">Identification of novel variants in patients with non-collagen VI Bethlem myopathy by the emerging technology of exomic sequencing</a><div class="gs_gray">D Hicks, E Martoni, V Straub, H Lochmuller, SH Laval, K Bushby</div><div class="gs_gray">United Kingdom Neuromuscular Translational Research Conference<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">P76 Bethlem myopathy presenting as a limb girdle muscular dystrophy</a><div class="gs_gray">L De Waele, A Mayhew, V Straub</div><div class="gs_gray">Neuromuscular Disorders, S28<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:gsN89kCJA0AC" class="gsc_a_at">P18 Beta-blocker/ACE-inhibitor combination treatment in mdx mice</a><div class="gs_gray">A Blain, E Greally, G MacGowan, S Laval, A Blamire, K Gillender, ...</div><div class="gs_gray">Neuromuscular Disorders, S12<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">P13 Assessing viral rescue therapies for Duchenne muscular dystrophy</a><div class="gs_gray">M Ritso, E Dick, M Reza, S Laval, K Bushby, V Straub, C Denning, ...</div><div class="gs_gray">Neuromuscular Disorders, S10<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SdhP9T11ey4C" class="gsc_a_at">P92 Manganese enhanced MRI as a useful in vivo outcome measure in assessing skeletal muscle calcium uptake in mouse models of muscular dystrophy</a><div class="gs_gray">E Greally, A Blain, AM Blamire, G MacGowan, SH Laval, V Straub</div><div class="gs_gray">Neuromuscular Disorders, S32-S33<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Clinical research activity in Newcastle MRC centre</a><div class="gs_gray">J Maddison, V Straub, H Lochmuller, D Turnbull, P Chinnery, M Trennell, ...</div><div class="gs_gray">United Kingdom Neuromuscular Translational Research Conference<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-f6ydRqryjwC" class="gsc_a_at">P29 Investigating basement membranes in FKRP and fukutin deficient zebrafish</a><div class="gs_gray">AJ Wood, JS Müller, SH Laval, H Lochmüller, K Bushby, R Barresi, ...</div><div class="gs_gray">Neuromuscular Disorders, S14-S15<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:UebtZRa9Y70C" class="gsc_a_at">P70 A single in-frame deletion in the CAPN3 gene is linked to muscular dystrophy with a dominant pattern of inheritance</a><div class="gs_gray">M Henderson, J Hudson, J Marsh, R Charlton, V Straub, H Lochmüller, ...</div><div class="gs_gray">Neuromuscular Disorders, S26<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">P11 Optimal dystrophin mini-construct for gene delivery to skeletal muscle</a><div class="gs_gray">M Reza, S Laval, F Muntoni, K Bushby, V Straub, J Morgan, H Lochmüller</div><div class="gs_gray">Neuromuscular Disorders, S10<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Correlation of internally deleted dystrophin and dystrophin-associated protein expression with clinical severity in Becker muscular dystrophy</a><div class="gs_gray">K Anthony, S Cirak, S Torelli, G Tasca, L Feng, V Arechavala-Gomeza, ...</div><div class="gs_gray">Neuromuscular Disorders<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MqTxh1vmwXEC" class="gsc_a_at">Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring Duchenne muscular dystrophy (DMD) disease progression</a><div class="gs_gray">VD Nadarajah, M Putten, A Chaouch, P Garrood, V Straub, HB Ginjaar, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QVtou7C4vgoC" class="gsc_a_at">P2. 21 Dysferlin-mediated membrane repair system contributes to maintenance of skeletal muscle cell viability in mouse models for muscular dystrophy</a><div class="gs_gray">T Toda, M Kanagawa, Z Lu, C Ito, A Kuga, M Hozoji-Inada, A Sudo, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 667<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:lYAcb2jw7qUC" class="gsc_a_at">P3. 41. Clinical and genetic findings in a large cohort of patients with congenital myopathies due to mutations in the skeletal muscle ryanodine receptor (RYR1) gene</a><div class="gs_gray">A Klein, S Lillis, I Oprea, M Scoto, S Robb, A Manzur, V Straub, H Roper, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 694<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BJrgspguQaEC" class="gsc_a_at">P3. 43 An adult-onset, slowly progressive axial myopathy with cataracts due to mutations in the skeletal muscle ryanodine receptor (RYR1) gene</a><div class="gs_gray">S Løseth, S Lillis, T Torbergsen, C Jonsrud, S Lindal, P Maddison, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 695<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:7wO8s98CvbsC" class="gsc_a_at">P4. 17 Manganese enhanced MRI (MEMRI) as an outcome measure for cardiac function in the mdx mouse</a><div class="gs_gray">AM Blain, E Greally, SH Laval, A Blamire, H Lochmuller, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 709<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:DUooU5lO8OsC" class="gsc_a_at">P1. 48 Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring Duchenne muscular dystrophy (DMD) disease progression</a><div class="gs_gray">VD Nadarajah, M van Putten, A Chaouch, P Garrood, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 656<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LI9QrySNdTsC" class="gsc_a_at">P4. 36 Develoment of pluripotent stem celss as vectors for viral gene therapy</a><div class="gs_gray">M Ritso, E Dick, M Reza, S Laval, K Bushby, V Straub, C Denning, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 715<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">P2. 22 Quantitative MRI in LGMD2I; a longitudinal study</a><div class="gs_gray">TA Willis, KG Hollingsworth, ML Sveen, J Morrow, J Vandenheede, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 667<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">P1. 52 BIO-NMD: Discovery and validation of biomarkers for neuromuscular diseases (NMDs)–An EU funded FP7 project</a><div class="gs_gray">V Straub, A Aartsma-Rus, CAK Szigyarto, C Béroud, P Bonaldo, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 657<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">P3. 49 Myopathy associated with mutations in CHKB in three UK patients</a><div class="gs_gray">R Quinlivan, I Nishino, S Mitsuahashi, C Ayoyama, C Sewry, F Muntoni, ...</div><div class="gs_gray">Neuromuscular Disorders 21 (9), 697<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:rbm3iO8VlycC" class="gsc_a_at">S151A mutation in the delta-sarcoglycan gene causes a mild phenotype of cardiomyopathy</a><div class="gs_gray">R Bauer, D Rutschow, C Goehringer, S Schinkel, V Straub, HA Katus, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 32, 160-160<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kzcSZmkxUKAC" class="gsc_a_at">Dried Blood Spot Testing—The Newcastle Experience Over a Twelve Month Period</a><div class="gs_gray">T Willis, H Lochmuller, K Bushby, V Straub</div><div class="gs_gray">Clinical Therapeutics 33 (6), S10<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:mKu_rENv82IC" class="gsc_a_at">In Vivo Myocardial Calcium Influx is Increased in the Delta-sarcoglycan Deficient Mouse Model of Muscular Dystrophy Cardiomyopathy. Role Of The L-Type Calcium Channel.</a><div class="gs_gray">E Greally, BJ Davison, A Blain, SH Laval, AM Blamire, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders: United Kingdom Neuromuscular Translational Research&nbsp;…<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-jrNzM816MMC" class="gsc_a_at">Hypertrophic hollow visceral myopathy, Rippling muscle disease and congenital lipodystrophy associated with PTRF mutation.: 19.</a><div class="gs_gray">R Shukla, S Wood, C Baillie, V Straub, G Kokai, M Dalzell, L McCann</div><div class="gs_gray">Pediatric &amp; Developmental Pathology 14 (2)<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:rOcdG6UcVlcC" class="gsc_a_at">O10 Quantitative magnetic resonance imaging of neuromuscular diseases in adults</a><div class="gs_gray">JS Thornton</div><div class="gs_gray">Neuromuscular Disorders, S4<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cBPnxVikjH8C" class="gsc_a_at">Clinical and genetic findings in a large cohort of patients with congenital myopathies due to mutations in the skeletal muscle ryanodine receptor (RYR1) gene</a><div class="gs_gray">A Klein, S Lillis, I Oprea, M Scoto, S Robb, A Manzur, V Straub, H Roper, ...</div><div class="gs_gray">16th International Congress of the World Muscle Society 21<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:YB4bud6kWLwC" class="gsc_a_at">P09 Patient-specific viral rescue therapies for Duchenne muscular dystrophy</a><div class="gs_gray">M Ritso, E Dick, M Reza, S Laval, V Straub, C Denning, H Lochmüller</div><div class="gs_gray">Neuromuscular Disorders, S9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-6RzNnnwWf8C" class="gsc_a_at">An adult-onset, slowly progressive axial myopathy with cataracts due to mutations in the skeletal muscle ryanodine receptor (RYR1) gene</a><div class="gs_gray">S Løseth, S Lillis, T Torbergsen, C Jonsrud, S Lindal, P Maddison, ...</div><div class="gs_gray">Abstracts/Neuromuscular Disorders 21, 639-751<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Systemic administration of AVI-4658, a phosphorodiamidate morpholino oligomer to induce exon 51 skipping, is well tolerated and restores dystrophin expression in male children&nbsp;…</a><div class="gs_gray">S CIRAK, V ARECHAVALA-GOMEZA, M GUGLIERI, L FENG, S TORELLI, ...</div><div class="gs_gray">Developmental Medicine &amp; Child Neurology 53<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Dem6FJhTUoYC" class="gsc_a_at">1FC2. 3 The Identification of a Viable Outcome Measure in the Collagen VI Myopathies Promotes Progress Toward Clinical Trials</a><div class="gs_gray">AR Foley, S Quijano-Roy, J Collins, V Straub, N Deconinck, EM Mercuri, ...</div><div class="gs_gray">European Journal of Paediatric Neurology, S12-S13<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WC23djZS0W4C" class="gsc_a_at">P74 An MRI study of the effects of metoprolol on in vivo cardiac calcium homeostasis</a><div class="gs_gray">A Blain, E Greally, S Laval, V Straub, G MacGowan</div><div class="gs_gray">Neuromuscular Disorders, S28<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">P75 Muscle MRI findings in LGMD2L</a><div class="gs_gray">A Sarkozy, P Hicks, J Miller, MC Walter, P Reilich, A Radunovic, ...</div><div class="gs_gray">Neuromuscular Disorders, S28<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:e_rmSamDkqQC" class="gsc_a_at">Generating stable FKRP mutant zebrafish lines with zinc finger nucleases</a><div class="gs_gray">AJ Wood, CD Jepson, SH Laval, K Bushby, H Lochmuller, R Barresi, ...</div><div class="gs_gray">Neuromuscular Disorders: United Kingdom Neuromuscular Translational Research&nbsp;…<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">P63 A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophy</a><div class="gs_gray">P Hicks, A Sarkozy, N Muelas, K Koehler, A Huebner, G Hudson, ...</div><div class="gs_gray">Neuromuscular Disorders, S24-S25<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">3FC2. 2 Muscle MRI in congenital myopathies due to Ryanodine receptor type 1 (RYR1) gene mutations</a><div class="gs_gray">A Klein, H Jungbluth, E Clement, S Lillis, S Abbs, P Munot, M Pane, ...</div><div class="gs_gray">European Journal of Paediatric Neurology, S28<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Pyridostigmine-responsive limb-girdle congenital myasthenic syndrome with frequent tubular aggregates</a><div class="gs_gray">J Müller, J Senderek, M Dusl, V Guergueltcheva, S Laval, K Bushby, ...</div><div class="gs_gray">Neuromuscular disorders 21 (Supplement 1), S13-S14<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:mB3voiENLucC" class="gsc_a_at">P62 The identification of a viable outcome measure in the collagen VI myopathies promotes progress toward clinical trials</a><div class="gs_gray">AR Foley, S Qmijano-Roy, J Collins, V Straub, N Deconinck, E Mercuri, ...</div><div class="gs_gray">Neuromuscular Disorders, S24<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qUcmZB5y_30C" class="gsc_a_at">P08 Optimal dystrophin mini-construct for gene delivery to skeletal muscle</a><div class="gs_gray">M Reza, S Laval, JE Morgan, F Muntoni, K Bushby, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders, S9<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Phenotype, Genetics and Natural History in 146 Patients with SEPN1-Related Myopathy: On the Way to Therapeutic Trials in a Rare Disorder</a><div class="gs_gray">E Malfatti, VG Martinez, M Von der Hagen, D Chabalier, S Quijano-Roy, ...</div><div class="gs_gray">Neurology 76 (9), A363-A363<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">1FC2. 1 Exon skipping and dystrophin restoration in Duchenne Muscular Dystrophy patients after systemic phosphorodiamidate morpholino oligomer treatment</a><div class="gs_gray">S Cirak, V Arechavala-Gomeza, M Guglieri, L Feng, S Torelli, K Anthony, ...</div><div class="gs_gray">European Journal of Paediatric Neurology, S12<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">CONGENITAL MYOPATHY EHLERS-DANLOS OVERLAP SYNDROME CAUSED BY THE DEFICIENCY OF AN ENZYME INVOLVED IN PROTEIN FOLDING IN THE ENDOPLASMIC RETICULUM: IDENTIFICATION AND&nbsp;…</a><div class="gs_gray">C Fauth, M Baumann, C Giunta, B Krabichler, F Rueschendorf, ...</div><div class="gs_gray">JOURNAL OF INHERITED METABOLIC DISEASE 34, S239-S239<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kF1pexMAQbMC" class="gsc_a_at">P1. 24 Mutations in ANO5 represent a common cause of non-dysferlin LGMD2B and Miyoshi myopathy</a><div class="gs_gray">D Hicks, A Sarkozy, N Muelas, A Huebner, G Hudson, R Barresi, J Miller, ...</div><div class="gs_gray">Neuromuscular Disorders 20 (9), 607<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">P4. 27 Muscle MRI findings in anoctaminopathy</a><div class="gs_gray">A Sarkozy, D Hicks, J Miller, MC Walter, P Reilich, H Lochmuller, ...</div><div class="gs_gray">Neuromuscular Disorders 20 (9), 666<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">P1. 02 Abnormal angiogenesis in zebrafish models for FKRP and fukutin deficiency</a><div class="gs_gray">AJ Wood, CD Jepson, SH Laval, KM Bushby, H Lochmüller, R Barresi, ...</div><div class="gs_gray">Neuromuscular Disorders 20 (9), 599-600<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">P4. 25 Functional outcome measures in limb girdle muscular dystrophy 2I: Correlations with MRI</a><div class="gs_gray">M Eagle, A Mayhew, TA Willis, H Lochmuller, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 20 (9), 665-666<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:yCjxvIMm6_oC" class="gsc_a_at">Y.-M. Kuo, Z. Li, Y. Jiao, N. Gaborit, AK Pani, BM Orrison, BG Bruneau, BI Giasson</a><div class="gs_gray">RJ Smeyne, MD Gershon, RL Nussbaum, B Royer-Pokora, M Busch, ...</div><div class="gs_gray">Human Molecular Genetics 19 (9)<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hQUaER0FWQ4C" class="gsc_a_at">O04 Results of a systemic antisense study in Duchenne muscular dystrophy</a><div class="gs_gray">F Muntoni, SS Cirak, M Guglieri, V Arechavala, JE Morgan, L Feng, ...</div><div class="gs_gray">Neuromuscular Disorders 20, S2<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:UmS_249rOGwC" class="gsc_a_at">P07 Translation related clinical trials in duchenne muscular dystrophy (DMD) in the UK</a><div class="gs_gray">R Choudhury, G Barreto, K Ganeshaguru, S Cirak, M Scoto, F Muntoni, ...</div><div class="gs_gray">Neuromuscular Disorders 20, S6-S7<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kw52XkFRtyQC" class="gsc_a_at">MRI in LGMD2I: a qualitative and quantitative analysis using the 3 point Dixon technique</a><div class="gs_gray">T Willis, KG Hollingsworth, AM Blamire, A Mayhew, M Eagle, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 20, S29-S29<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:z_wVstp3MssC" class="gsc_a_at">P35 Immortalisation and characterisation of muscle stem cells</a><div class="gs_gray">M Ritso, L Jørgensen, S Laval, V Straub, K Bushby, H Lochmüller</div><div class="gs_gray">Neuromuscular Disorders 20, S14<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:d4tt_xEv1X8C" class="gsc_a_at">Oral bisphosphonates as prophylaxis of steroid induced osteoporosis in Duchenne muscular dystrophy</a><div class="gs_gray">A SARKOZY, S PEARCE, M EAGLE, G VITA, M GUGLIERI, V STRAUB, ...</div><div class="gs_gray">Developmental Medicine &amp; Child Neurology 52, 1-2<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nPT8s1NX_-sC" class="gsc_a_at">P15 Modelling the role of dystroglycan glycosylation in angiogenesis using zebrafish</a><div class="gs_gray">A Wood, C Jepson, S Laval, K Bushby, H Lochmüller, R Barresi, J Müller, ...</div><div class="gs_gray">Neuromuscular Disorders, S9<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:pS0ncopqnHgC" class="gsc_a_at">Blocking calcium influx with streptomycin worsens myocardial pathology in the mdx mouse model of muscular dystrophy</a><div class="gs_gray">A Blain, E Greally, L Jorgensen, S Laval, K Bushby, G MacGowan, ...</div><div class="gs_gray">United Kingdom Neuromuscular Translational Research Conference<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Differential diagnosis and misdiagnosis of Pompe disease in adults</a><div class="gs_gray">V Straub</div><div class="gs_gray">Clinical Therapeutics, S67<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">O14 Clinical applications of MRI in muscular dystrophy</a><div class="gs_gray">V Straub, K Hollingsworth</div><div class="gs_gray">Neuromuscular Disorders, S4<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Editorial commentaries</a><div class="gs_gray">ISJ Merkies, RAC Hughes, CJ Fowler, J Chataway, L Klinge, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">P14 The first UK family with Ano5-associated myopathy</a><div class="gs_gray">A Sarkozy, G Marlow, R Bashir, D Hicks, R Barresi, S Laval, H Lochmüller, ...</div><div class="gs_gray">Neuromuscular Disorders, S9<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">P85 Recurrent BAG3 gene mutation in a British family with two siblings with severe myofibrillar myopathy</a><div class="gs_gray">A Sarkozy, C McKenna, V Straub, H Lochmüller, LG Goldfarb, K Bushby</div><div class="gs_gray">Neuromuscular Disorders, S28<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:sA9dB-pw3HoC" class="gsc_a_at">Response to letter from Bernardi</a><div class="gs_gray">D Hicks, A Lampe, S Laval, V Allamand, C Jimenez-Mallebrera, M Walter, ...</div><div class="gs_gray">Brain 132 (10), e122-e122<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:z8nqeaKD1nsC" class="gsc_a_at">GP 6.08 The evaluation of novel therapeutic strategies for the treatment of dysferlinopathy</a><div class="gs_gray">M Hornsey, Y Chiu, L Jorgensen, L Klinge, S Laval, R Barresi, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 586<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hGdtkIFZdKAC" class="gsc_a_at">TP 2.07 Attenuation of adverse effects of prednisolone on δ-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism</a><div class="gs_gray">AM Blain, R Bauer, G MacGowan, E Greally, S Laval, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 581-582<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">GP 6.05 Attenuated muscle regeneration is a key factor in dysferlinopathy</a><div class="gs_gray">YH Chiu, SH Laval, LH Jorgensen, MA Hornsey, L Klinge, R Charlton, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 585<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ce2CqMG-AY4C" class="gsc_a_at">EM. P. 4.08 Chain-specific antibody testing of collagen VI: An additional pre-screening strategy for the diagnosis of Bethlem myopathy</a><div class="gs_gray">R Charlton, M Henderson, J Richards, D Hicks, M Reza, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 609<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:jFemdcug13IC" class="gsc_a_at">GP 10.02 Does δ-sarcoglycan-associated autosomal dominant cardiomyopathy exist?</a><div class="gs_gray">A Sarkozy, R Bauer, J Hudson, HD Müller, C Sommer, G Dekomien, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 620<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:AXkvAH5U_nMC" class="gsc_a_at">TP 2.08 The stretch-activated calcium channel candidate proteins TRPC1 and 3 present a distinctly different expression pattern in mdx mice</a><div class="gs_gray">LH Jorgensen, SH Laval, H Brinkmeier, V Straub, K Bushby, H Lochmuller</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 582<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">MP 5.01 Magnetic resonance imaging of cardiac function in mouse models for muscular dystrophy associated cardiomyopathy</a><div class="gs_gray">E Greally, BJ Davison, R Patel, A Blain, S Laval, H Lochmüller, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 627<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nRpfm8aw39MC" class="gsc_a_at">EM. P. 4.05 Bethlem myopathy; new insights on prevalence, phenotypic variability and genetic heterogeneity</a><div class="gs_gray">J Collins, D Hicks, A Sarcozy, A Lampe, F Norwood, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 608<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:MLfJN-KU85MC" class="gsc_a_at">GP 13.11 Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne muscular dystrophy</a><div class="gs_gray">A Sarkozy, T Cheetham, S Pearce, D Rawlings, M Eagle, GL Vita, ...</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 642<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">MP 1.06 An international registry for FKRP (fukutin-related protein) patients-the first international registry</a><div class="gs_gray">TA Willis, MC Walter, KMD Bushby, H Lochmuller, V Straub</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 547-548<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Treat-NMD-An European network for neuromuscular diseases</a><div class="gs_gray">S Baumeister, C Scholz, V Straub, C Mueller-Reible, T Sejersen, ...</div><div class="gs_gray">MEDIZINISCHE GENETIK 21 (3), 375-380<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">GP 13.10 Early cardiomyopathy in DMD</a><div class="gs_gray">GL Vita, R Kirk, H Lochmüller, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 642<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Defective membrane tubulation in dysferlin-deficient muscular dystrophy</a><div class="gs_gray">L Klinge, S Thoms, I Cierny, V Straub, K Bushby, J Gaertner</div><div class="gs_gray">EUROPEAN JOURNAL OF PEDIATRICS 168 (3), 382-382<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:uAPFzskPt0AC" class="gsc_a_at">Attenuation of adverse cardiac effects in prednisolone-treated d-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism</a><div class="gs_gray">R Bauer, A Blain, E Greally, H Lochmüller, K Bushby, GA MacGowan, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">O7-6 Restoration of dystrophin in DMD: a single blind, placebo-controlled dose escalation study using Morpholino oligomer AVI-4658</a><div class="gs_gray">M Kinali, V Arechavala-Gomeza, L Feng, S Cirak, D Hunt, C Adkin, ...</div><div class="gs_gray">European Journal of Paediatric Neurology, S17<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:isC4tDSrTZIC" class="gsc_a_at">TP 2.07 Attenuation of adverse effects of prednisolone on d-sarcoglycan-deficient cardiomyopathy by mineralocorticoid-receptor-antagonism</a><div class="gs_gray">R Bauer, G MacGowan, E Greally, S Laval, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 19 (8), 581-582<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:NMlhSUseqAsC" class="gsc_a_at">GP 10.06 Abnormal T-tubule morphology in dysferlin deficient muscle</a><div class="gs_gray">L Klinge, C Sewry, S Laval, MA Hornsey, Y Chiu, V Straub, R Barresi, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 791<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hSRAE-fF4OAC" class="gsc_a_at">GO 4 Neuromuscular junction formation in Dok-7 deficient zebrafish embryos</a><div class="gs_gray">JS Müller, P Thornhill, K Bushby, V Straub, H Lochmuller</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 781<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:zCSUwVk65WsC" class="gsc_a_at">DP 2.02 Development of a nurse led multidisciplinary clinic for myotonic dystrophy type 1</a><div class="gs_gray">C Harling, M Guglieria, G Bell, J Bourke, M McCallum, M Eagle, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 743<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:5MTHONV0fEkC" class="gsc_a_at">DP 3.04. Inclusion body myopathy with Paget’s disease and frontotemporal dementia (IBMPFD): Extending the clinical features in a large pedigree</a><div class="gs_gray">R Barresi, TD Miller, AP Jackson, R Charlton, J Stone, V Straub</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 766<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">DP 2.03 Clinical follow up in a large cohort of patients affected by myotonic dystrophy type 1</a><div class="gs_gray">C Harling, M Guglieri, G Bell, J Bourke, M McCallum, M Eagle, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 743-744<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">TP 4.08 In-vivo direct and indirect myocardial effects of captopril in the mdx mouse</a><div class="gs_gray">R Bauer, VW Straub, A Blain, K Bushby, GA Mac Gowan</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 814<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">GP 2.11 Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of FKRP</a><div class="gs_gray">P Thornhill, D Bassett, H Lochmüller, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 738<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:p__nRnzSRKYC" class="gsc_a_at">DP 3.09 Caveolinopathy–New mutations and additional symptoms</a><div class="gs_gray">A Aboumousa, J Hoogendijk, R Barresi, R Charlton, R Herrmann, T Voit, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 767<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">GP 4.01 Is assessment of respiratory function a good outcome measure for SMA II and III?</a><div class="gs_gray">M Guglieri, M Eagle, M McCallum, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 760<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">GP 10.10 Dysferlin does not play an essential role in skeletal myoblast fusion</a><div class="gs_gray">Y Chiu, SH Laval, H Lochmuller, MA Hornsey, L Klinge, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 792-793<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:J-pR_7NvFogC" class="gsc_a_at">TO 1 Cyclosporin A as a potential treatment for collagen VI-related muscular dystrophy: A cellular study of mitochondrial dysfunction and its rescue</a><div class="gs_gray">D Hicks, AK Lampe, SH Laval, V Allamand, C Jimenez-Mallebrera, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 831<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eflP2zaiRacC" class="gsc_a_at">DP 3.10 Partial caveolin 3 deficiency in acquired rippling muscle disease</a><div class="gs_gray">M Mirabella, R Charlton, EM Valente, S Petrini, A d’Amico, M Roberts, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 767-768<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BqipwSGYUEgC" class="gsc_a_at">GP 14.13 Phenotypic characterization of two unrelated UK families with X-linked myopathy and an identical mutation in the FHL1 gene</a><div class="gs_gray">A Sarkozy, K Bushby, D Hilton-Jones, CF Dougan, H Lochmüller, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 819<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">GP 8.11 Steroid treatment causes deterioration of myocardial function in the delta-sarcoglycan deficient mouse model for dilated cardiomyopathy</a><div class="gs_gray">R Bauer, GA Mac Gowan, A Blain, K Bushby, VW Straub</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 785<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">TI 1. Translational research in neuromuscular diseases–where do we stand?</a><div class="gs_gray">V Straub</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 830<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">GP 10.05 Preclinical drug trials investigating potential treatments for dysferlin deficiency</a><div class="gs_gray">MA Hornsey, L Klinge, SH Laval, R Barresi, H Lochmuller, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 791<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">TP 4.09 Left ventricular remodeling after steroid therapy in the mdx mouse</a><div class="gs_gray">R Bauer, GA Mac Gowan, A Blain, K Bushby, VW Straub</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 814<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">GP 6.01 Establishing the parameters for clinical trials of antisense oligonucleotide therapy in Duchenne muscular dystrophy</a><div class="gs_gray">M Kinali, V Arechavala-Gomeza, L Feng, A Glover, M Guglieri, ...</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 773<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">Amyloidosis associated with dysferlin-deficient muscular dystrophy</a><div class="gs_gray">S Spuler, M Carl, V Straub, SA Moore, C Rocken</div><div class="gs_gray">NEUROLOGY 70 (11), A310-A310<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Welcome to Newcastle</a><div class="gs_gray">V Straub, K Bushby, J Miller, E Strehle, M Eagle</div><div class="gs_gray">Neuromuscular Disorders 18, 686-688<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Clinical follow up in a large cohort of patients affected by Myotonic Dystrophy type</a><div class="gs_gray">C Harling, M Guglieri, G Bell, J Bourke, M McCallum, M Eagle, M Stewart, ...</div><div class="gs_gray">British Human Genetics Conference 2008<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Testing therapies in neuromuscular disease: Oral presentations</a><div class="gs_gray">D Hicks, AK Lampe, SH Laval, V Allamand, C Jimenez-Mallebrera, ...</div><div class="gs_gray">Neuromuscular Disorders: 13th International Congress of the World Muscle Society<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">Dystrophin positive revertant fibres do not increase with age in Duchenne muscular dystrophy</a><div class="gs_gray">V ARECHAVALA-GOMEZA, M KINALI, L FENG, M GUGLIERI, G EDGE, ...</div><div class="gs_gray">Developmental Medicine &amp; Child Neurology 50<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Spectrum of brain involvement in muscular dystrophies with defective dystroglycan glycosylation</a><div class="gs_gray">E CLEMENT, E MERCURI, C GODFREY, S ROBB, M KINALI, V STRAUB, ...</div><div class="gs_gray">Developmental Medicine &amp; Child Neurology 50<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">GP 12.10 Delayed development and learning difficulties as a predominant symptom in female carriers of Duchenne and Becker muscular dystrophy</a><div class="gs_gray">A Aboumousa, M Eagle, J Bourke, V Straub, K Bushby</div><div class="gs_gray">Neuromuscular Disorders 18 (9), 806-806<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Oral session 15</a><div class="gs_gray">S Quasthoff, C Windpassinger, B Schoser, S Hochmeister, V Straub, ...</div><div class="gs_gray">Eighteenth Meeting of the European Neurological Society 7–11 June 2008, Nice&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Development of a nurse led multidisciplinary clinic for myotonic dystrophy type 1</a><div class="gs_gray">C Harling, M Guglieri, G Bell, J Bourke, M McCallum, M Eagle, M Stewart, ...</div><div class="gs_gray">British Human Genetics Conference 2008<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Not forCommercial Distribution</a><div class="gs_gray">V Straub</div><div class="gs_gray">Clinical Therapeutics 30, S6-S7<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:v6i8RKmR8ToC" class="gsc_a_at">Das Muskeldystrophie-Netzwerk MD-NET</a><div class="gs_gray">H Lochmüller, V Straub</div><div class="gs_gray">Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 50 (12), 1518-1523<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:FsLZdJ3BAzkC" class="gsc_a_at">Dysferlinopathy with very late onset and untypical clinical presentation</a><div class="gs_gray">L Klinge, A Dean, P Dixon, R Charlton, L Anderson, R Barresi, K Bushby</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 17 (9-10), 789-789<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:AzKEL7Gb_04C" class="gsc_a_at">GP 1.01 Long term steroid use in non-ambulatory patients with Duchenne muscular dystrophy</a><div class="gs_gray">M Eagle, M MCallum, M Guglieri, V Straub, K Bushby</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 772<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eAlLMO4JVmQC" class="gsc_a_at">GP 9.07 MRI in Duchenne muscular dystrophy: Quantification of fat infiltration and gadolinium uptake using whole-muscle regions of interest</a><div class="gs_gray">P Garrood, K Hollingsworth, P Thelwall, D Birchall, M Eagle, K Bushby, ...</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 816-817<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:CB2v5VPnA5kC" class="gsc_a_at">GP 8.02 Laminin β1 staining in muscle biopsies referred for suspected limb-girdle muscular dystrophy</a><div class="gs_gray">A Aboumousa, R Charlton, R Barresi, C Fiorillo, L Anderson, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 810<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nZcligLrVowC" class="gsc_a_at">GP 4.12 Analysis of the diagnostic strategy for limb girdle muscular dystrophy 2A in the UK</a><div class="gs_gray">E Groen, R Charlton, R Barresi, L Anderson, M Eagle, J Hudson, ...</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 790-791<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">CP 1.14 Early-onset myopathy with cardiac involvement not-related to mutations in M-line titin: An emerging phenotype?</a><div class="gs_gray">C Vincitorio, V Carmignac, M Beuvin, B Estournet, S Quijano-Roy, ...</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 838<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:u9iWguZQMMsC" class="gsc_a_at">GP 8.05 Muscle biopsy immunoanalysis and genetic outcome</a><div class="gs_gray">C Fiorillo, R Charlton, J Hudson, A Aboumousa, V Straub, R Barresi, ...</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 811<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:blknAaTinKkC" class="gsc_a_at">GP 12.11 Do revertants increase with age in Duchenne muscular dystrophy boys?</a><div class="gs_gray">V Arechavala-Gomeza, M Kinali, L Feng, G Edge, D Hunt, J Lehovsky, ...</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 842<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">GP 1.09 Myoglobinuria in steroid-treated Duchenne muscular dystrophy</a><div class="gs_gray">P Garrood, M Eagle, P Jardine, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 17 (9), 774<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">020 INCLUSION BODY MYOPATHY WITH PAGET’S DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA: CLINICAL FEATURES OF A LARGE PEDIGREE</a><div class="gs_gray">TD Miller, J Stone, R Baresi, CM Smart, D Summers, A Jackson, ...</div><div class="gs_gray">Journal Of Neurology, Neurosurgery, &amp; Psychiatry 78 (9)<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Membrane damage induces dysferlin translocation in early myogenesis</a><div class="gs_gray">L Klinge, S Laval, V Straub, R Barresi, K Bushby</div><div class="gs_gray">EUROPEAN JOURNAL OF PEDIATRICS 166 (3), 283-284<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RtRctb2lSbAC" class="gsc_a_at">PP 7 03 Development of a diagnostic algorithm for patients with a Bethlem myopathy clinical phenotype</a><div class="gs_gray">AK Lampe, D Hicks, J Hudson, SH Laval, KM Flanigan, C Bönnemann, ...</div><div class="gs_gray">Neuromuscular Disorders 16 (9), 714<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:4aZ_i-5WJEQC" class="gsc_a_at">PP 6 10 Sarcoglycanopathy–Can immunoanalyses accurately predict the genotype?</a><div class="gs_gray">R Charlton, L Klinge, G Dekomien, JT Epplen, K Bushby, V Straub</div><div class="gs_gray">Neuromuscular Disorders 16 (9), 697<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:48xauSegjOkC" class="gsc_a_at">PP 6 09 Damage-induced dysferlin translocation in C2C12 myotubes requires the full length protein</a><div class="gs_gray">L Klinge, SH Laval, V Straub, K Bushby</div><div class="gs_gray">Neuromuscular Disorders 16 (9), 696-697<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:evX43VCCuoAC" class="gsc_a_at">PP 5 01 RYR1 genotype–phenotype correlative and functional studies in a large cohort of core myopathy patients with RYR1 mutations</a><div class="gs_gray">H Zhou, H Jungbluth, S Treves, E Bertini, V Straub, K Bushby, C Sewry, ...</div><div class="gs_gray">Neuromuscular Disorders 16 (9), 687<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">GP 8 07 Phenotypic variability associated with desmin gene mutations</a><div class="gs_gray">A Sarkozy, L Goldfarb, R Charlton, M Eagle, PM Chinnery, V Straub, ...</div><div class="gs_gray">Neuromuscular Disorders 16 (9), 708<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:7H_jS4BsgvYC" class="gsc_a_at">Central nervous system involvement in Duchenne Muscular Dystrophy</a><div class="gs_gray">V Yayla, AE Oge, SA Kalem, A Gokyigit, G Purcu, H Gurvit, Y Parman, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 16, S120-S120<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Inflammation in dystrophies</a><div class="gs_gray">V Straub</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 16, S146-S146<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:u0Mu_IsstPMC" class="gsc_a_at">PMCID: PMC2169361.</a><div class="gs_gray">I Nishino, RI Kelley, H Somer, V Straub, KD Mathews, SA Moore, ...</div><div class="gs_gray">Cancer Biol Ther 5 (4), 441-8<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:AYInfyleIOsC" class="gsc_a_at">Autosomal centronuclear myopathy due to mutations in the skeletal muscle ryanodine receptor gene</a><div class="gs_gray">H Jungbluth, H Zhou, E Bertini, V Straub, K Bushby, S Robb, S Treves, ...</div><div class="gs_gray">DEV MED CHILD NEUROL 48, 30-31<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:isU91gLudPYC" class="gsc_a_at">Severe phenotype in early-onset facioscapulohumeral muscular dystrophy</a><div class="gs_gray">L Klinge, M Eagle, D Haggerty, V Straub, K Bushby</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 15 (9-10), 708-709<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:6yz0xqPARnAC" class="gsc_a_at">On the classification, natural history and treatment of the myopathies' 50 years on: population study of muscle disease in the Northern region of England</a><div class="gs_gray">F Norwood, C Harling, P Chinnery, L Anderson, K Bushby, V Straub</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 15 (9-10), 734-734<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Results of the ENMC workshop on medical management in glycogen storage disease type II</a><div class="gs_gray">V Straub, A van der Ploeg</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 15 (9-10), 711-711<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">Bone density in patients with Duchenne muscular dystrophy (DMD)</a><div class="gs_gray">M Eagle, D Rawlings, V Straub, K Bushby</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 15 (9-10), 689-689<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Limb girdle muscular dystrophies-Dominant forms; Poster presentations</a><div class="gs_gray">JE Hoogendijk, R Herrmann, M Eagle, ME Roberts, T Voit, KMD Bushby, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 15 (9-10), 677-678<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:vVJNg6_NJEsC" class="gsc_a_at">Diagnostik kongenitaler Muskeldystrophien</a><div class="gs_gray">A von Moers, V Straub, E Wilichowski</div><div class="gs_gray">Nervenheilkunde 24 (04), 210-215<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:CdxZDUztZiMC" class="gsc_a_at">The most common mutation in FKRP causing limb girdle muscular dystrophy type 2I (LGMD2I) may have occurred only once</a><div class="gs_gray">P Frosk, K Bushby, M Zatz, V Straub, CR Greenberg, K Wrogemann</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 14 (8-9), 579-579<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:a0OBvERweLwC" class="gsc_a_at">Experience of applying the UK consensus on the use of corticosteroids in DMD</a><div class="gs_gray">M Eagle, A Manzur, V Straub, K Bushby</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 14 (8-9), 581-581<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ALROH1vI_8AC" class="gsc_a_at">Muscle-eye-brain disease due to homozygous founder mutation in FKRP in Northern Germany and Denmark</a><div class="gs_gray">C Kutzick, R Herrmann, V Straub, A Steinbrecher, S Cirak, C Korenke, ...</div><div class="gs_gray">Neuromuscular Disorders: 9th International Congress of the World Muscle Society<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Gene expression profiling in dysferlin-deficient marine muscle: differential gene expression in proximal and distal muscle groups</a><div class="gs_gray">M Poppe, SH Laval, N Pocock, I Wappler, LM Cree, F Haldane, H Peters, ...</div><div class="gs_gray">Neuromuscular Disorders: 9th International Congress of the World Muscle Society<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Cell culture, biochemical and microarray analyses of dysferlin</a><div class="gs_gray">SH Laval, LM Cree, F Haldane, I Wappler, M Poppe, H Lochmuller, ...</div><div class="gs_gray">Neuromuscular Disorders<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">A common founder mutation in FKRP causes limb girdle muscular dystrophy type 21 (LGMD21) in both Hutterite and European populations.</a><div class="gs_gray">P Frosk, CR Greenberg, A Poulin, R Lamont, E Nylen, M Zaik, V Straub, ...</div><div class="gs_gray">AMERICAN JOURNAL OF HUMAN GENETICS 73 (5), 388-388<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:-95Q15plzcUC" class="gsc_a_at">Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease</a><div class="gs_gray">T Toda, K Taniguchi, K Kobayashi, K Saito, H Yamanouchi, A Ohnuma, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 13 (7-8), 636-636<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Comparison of respiratory function in different subgroups of congenital muscular dystrophy</a><div class="gs_gray">C Dohna-Schwake, U Mellies, R Ragette, V Straub, H Teschler, T Voit</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 13 (7-8), 656-656<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:dhFuZR0502QC" class="gsc_a_at">Mild muscle-eye-brain disease is compatible with preserved vision and normal-appearing supra-but not infratentorial brain structures on MRI</a><div class="gs_gray">A Steinbrecher, J Vajsar, U Grieben, J Sperner, V Straub, K Kobayashi, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 13 (7-8), 637-637<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Diagnostics in congenital muscular dystrophies</a><div class="gs_gray">A von Moers, V Straub, E Wilichowski</div><div class="gs_gray">NERVENHEILKUNDE 22 (4), 210-215<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qwy9JoKyICEC" class="gsc_a_at">Prenatal diagnosis in a family with muscle-eye-brain disease</a><div class="gs_gray">V Straub, R Herrmann, S Hertel, K Taniguchi, K Kobayashi, T Toda, T Voit</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 12 (7-8), 743-744<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:IRz6iEL74y4C" class="gsc_a_at">Tissue distribution and subcellular localization of zeta-sarcoglycan</a><div class="gs_gray">C Kutzick, R Herrmann, B Neumann, N Kawaguchi, V Straub, M Zaik, ...</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 12 (7-8), 733-733<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Neuropathological findings of fetal tissues in Walker-Warburg syndrome</a><div class="gs_gray">A Steinbrecher, R Herrmann, V Straub, G Stoltenburg-Didinger, T Voit</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 12 (7-8), 744-744<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Tissue distribution of zeta-sarcoglycan, a novel member of the sarcoglycan family</a><div class="gs_gray">C Kutzick, R Herrmann, B Neumann, V Straub, M Zaik, N Kawaguchi, ...</div><div class="gs_gray">JOURNAL OF THE NEUROLOGICAL SCIENCES 199, S84-S84<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Skeletal muscle fiber damage in dystrophic mice detected by contrast agent-enhanced MRI</a><div class="gs_gray">V Straub, H Amthor, J Weber, T Voit, M Forsting, T Egelhof</div><div class="gs_gray">JOURNAL OF THE NEUROLOGICAL SCIENCES 199, S49-S49<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">First description of a recessive form of Central Core Disease, transitorily presenting as Multi-minicore Disease and associated with a homozygous mutation in RYR1.</a><div class="gs_gray">A Ferreiro, N Monnier, NB Romero, JP Leroy, C Bonneman, V Straub, ...</div><div class="gs_gray">EUROPEAN JOURNAL OF HUMAN GENETICS 10, 247-247<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:10A3hb2jUxYC" class="gsc_a_at">98th ENMC International Workshop on Congenital Muscular Dystrophy (CMD), 7th Workshop of the International Consortium on CMD, 2nd Workshop of the MYO CLUSTER project GENRE26&nbsp;…</a><div class="gs_gray">V Straub, K Bushby, F Muntoni, L Merlini, J Hewitt, S Quijano-Roy, ...</div><div class="gs_gray">Neuromuscular Disorders<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:jtI9f0ekYq0C" class="gsc_a_at">Differentiated diagnosis of muscular dystrophies by means of immunological methods in 2001</a><div class="gs_gray">W Kress, R Gold, P Fischer, D Heuss, V Straub, C Bonnemann</div><div class="gs_gray">NERVENHEILKUNDE 21 (1), 46-48<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Deficiency of alpha-dystroglycan in muscle-eye-brain disease (vol 291, pg 1283, 2002)</a><div class="gs_gray">H Kano, K Kobayashi, R Herrmann, M Tachikawa, H Manya, I Nishino, ...</div><div class="gs_gray">Biochemical and Biophysical Research Communications 293 (5), 1579-1579<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:hC7cP41nSMkC" class="gsc_a_at">SEPN1 mutations cause classical multi-minicore disease: reappraising the nosology of early-onset myopathies</a><div class="gs_gray">A Ferreiro, S Quijano-Roy, C Pichereau, B Moghadaszadeh, N Goemans, ...</div><div class="gs_gray">PERGAMON-ELSEVIER SCIENCE LTD 12 (7-8), 720-720<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:s9ia6_kGH2AC" class="gsc_a_at">Exhaled nitric oxide concentrations are reduced in patients with Duchenne muscular dystrophy</a><div class="gs_gray">V Straub, F Ratjen, H Amthor, T Voit, H Grasemann</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 11 (6-7), 641-641<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:BzfGm06jWhQC" class="gsc_a_at">Prolonged survival and improvement of heart and skeletal muscle function under enzyme replacement therapy in infantile Pompe disease</a><div class="gs_gray">E Dittmar, K Gorlinger, U Neudorf, T Bosbach, V Straub, T Voit</div><div class="gs_gray">NEUROMUSCULAR DISORDERS 11 (6-7), 665-665<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:kQqwFFzsCTwC" class="gsc_a_at">Gene replacement therapy for muscular dystrophy</a><div class="gs_gray">KP Campbell, KH Holt, F Duclos, LE Lim, V Straub, B Davidson, ...</div><div class="gs_gray">University of Iowa<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:J6OZcwVsj5AC" class="gsc_a_at">δ-sarcoglycan antibodies</a><div class="gs_gray">KP Campbell, D Jung, F Duclos, V Straub, J Mcpherson</div><div class="gs_gray">University of Iowa<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">δ-sarcoglycan antibodies</a><div class="gs_gray">KP Campbell, D Jung, F Duclos, V Straub, J McPherson</div><div class="gs_gray">US Patent 6,211,340<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism in the pathogenesis of ischemic cardiomyopathy and muscular dystrophy</a><div class="gs_gray">RD Cohn, R Coral-Vazquez, SA Moore, JA Hill, RM Weiss, R Davisson, ...</div><div class="gs_gray">CIRCULATION 100 (18), 493-493<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism in the pathogenesis of cardiomyopathy and muscular dystrophy.</a><div class="gs_gray">R Coral-Vazquez, RD Cohn, SA Moore, JA Hill, RM Weiss, R Davisson, ...</div><div class="gs_gray">AMERICAN JOURNAL OF HUMAN GENETICS 65 (4), A5-A5<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:cWzG1nlazyYC" class="gsc_a_at">SEVERE MUSCULAR DYSTROPHY AND CARDIOMYOPATHY IN MICE DEFICIENT IN DELTA-SARCOGLYCAN</a><div class="gs_gray">S Moore, R Coral, R Cohn, V Straub, R Williamson, K Campbell</div><div class="gs_gray">Journal of Neuropathology and Experimental Neurology 58 (5)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:vkuYBMKU6wEC" class="gsc_a_at">δ-sarcoglycan nucleic acid sequences</a><div class="gs_gray">KP Campbell, D Jung, F Duclos, V Straub, J Mcpherson</div><div class="gs_gray">University of Iowa<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Functional restoration of the sarcoglycan and dystroglycan complexes in the cardiomyopathic hamster.</a><div class="gs_gray">KH Holt, LE Lim, VW Straub, F Duclos, DP Venzke, JC Lee, RD Anderson, ...</div><div class="gs_gray">AMERICAN JOURNAL OF HUMAN GENETICS 61 (4), A355-A355<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:U_HPUtbDl20C" class="gsc_a_at">Immunohistochemical analysis of myodystrophy mouse muscle</a><div class="gs_gray">KD Mathews, SA Moore, VW Straub, KA Mills, KP Campbell</div><div class="gs_gray">NEUROLOGY 48 (3), 6131-6131<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:TlpoogIpr_IC" class="gsc_a_at">Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.</a><div class="gs_gray">V Straub, R Crosbie, MD Henry, JS Chamberlain, KP Campbell</div><div class="gs_gray">MOLECULAR BIOLOGY OF THE CELL 7, 3467-3467<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Lokalisation und subzelluläre Verteilung von Dystrophin in Skelettmuskelfasern</a><div class="gs_gray">V Straub</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:sbeIDTyQOFgC" class="gsc_a_at">Skeletal Muscle</a><div class="gs_gray">C Smith, M Davies</div><div class="gs_gray">University of London Board of Studies in Physiology<span class="gs_oph">, 1979</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1979</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Oo_WeVVXg5wC" class="gsc_a_at">8Validation of genetic modifiers for</a><div class="gs_gray">JC van den Bergen, M Hiller, S Böhringer, L Vijfhuizen, HB Ginjaar, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:_n8fIOMweQoC" class="gsc_a_at">Serum matrix m Serum matrix metalloproteinase etalloproteinase etalloproteinase-9 (MMP-9) as a biomarker for biomarker for biomarker for monitoring monitoring disease&nbsp;…</a><div class="gs_gray">VD Nadarajah, M van Putten, A Chaouch, P Garrood, V Straub, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:SgM-ki2adj0C" class="gsc_a_at">Digenic Inheritance Involving a Muscle Specific Protein Kinase and the Giant Titin Protein Causes a Skeletal Muscle Myopathy</a><div class="gs_gray">A Topf, I Zaharieva, V Di Leo, A Vihola, N Wali, M Savarese, K Laricchia, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:o-PowTg_VKEC" class="gsc_a_at">New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy</a><div class="gs_gray">V Straub, P Gallano, C Semplicini, E Pegoraro, V Zangaro, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:HqhvjgTjE9cC" class="gsc_a_at">Imaging in Neuromuscular Disease 2019</a><div class="gs_gray">A Blamire, P Carlier, H Kan, L Rufibach, S Spuler, V Straub, G Strijkers, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:I9gX6wnfuA8C" class="gsc_a_at">PMCID: PMC1222290.</a><div class="gs_gray">H Mitsuhashi, S Takahashi, M Takeuchi, R Herrmann, V Straub, B Talim, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:ujxm2eEBZHIC" class="gsc_a_at">Fat fraction determination by quantitative MRI in a global, natural history study of dysferlinopathy over four years</a><div class="gs_gray">FE Smith, I Wilson, H Reyngoudt, E Caldas, R Fernandez-Torrón, ...</div><div class="gs_gray">Imaging in Neuromuscular Disease 2019, 36<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:Tfl4UtY-dJUC" class="gsc_a_at">Joachim Schessl</a><div class="gs_gray">B Schoser, R Schröder, CA Sewry, MC Sharma, W Stenzel, V Straub, ...</div><div class="gs_gray">Muscle Disease: Pathology and Genetics<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:l6Q3WhenKVUC" class="gsc_a_at">12th UK Neuromuscular Translational Research Conference</a><div class="gs_gray">V Straub</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:qE4H1tSSYIIC" class="gsc_a_at">Imaging in Neuromuscular Disease 2017</a><div class="gs_gray">V Straub, H Kan, P Carlier, A Blamire, T Yousry, G Strijkers, D Ribeiro, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:PaBasH6fAo0C" class="gsc_a_at">Selected Proceedings From the 4th European Symposium: Steps Forward in Pompe Disease</a><div class="gs_gray">S Waldek, M Roberts, C Angelini, T Mongini, L Vercelli, RJ Pomponio, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:35r97b3x0nAC" class="gsc_a_at">Kate Bushby</a><div class="gs_gray">V Straub, A Lennox, W Hughes</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=C7N_dwsAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=C7N_dwsAAAAJ:aqlVkmm33-oC" class="gsc_a_at">ACCELERATING TRANSLATIONAL RESEARCH BY INTERNATIONAL NETWORKING—THE TREAT-NMD MODEL</a><div class="gs_gray">V Straub</div><div class="gs_gray">Харків, 2009, 139<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–883</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>